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The Transmissible Spongiform Encephalopathies (TSEs) or “prion” diseases are a 
group of fatal neurodegenerative diseases the aetiology of which is not fully 
understood. These diseases are characterised by a number of pathological changes in 
the central nervous system (CNS) including; vacuolation of the neuropil, gliosis and 
deposition of PrPSc; the abnormal form of the host glycoprotein PrP. Although the 
major pathology in these diseases is associated with the CNS the immune system is 
central to the pathogenesis of many natural and experimental TSEs including natural 
scrapie in sheep, chronic wasting disease in free ranging and captive deer and variant 
CJD (vCJD) in humans. Unlike many infectious diseases where deficiencies in 
immune function are opportunistic for the invading pathogen a competent immune 
system is required for efficient TSE infection via peripheral routes. As infection of 
the lymphoid tissues in many TSEs can occur many months before the detection of 
infectivity in the CNS, the determination of those cells in the lymphoid system has 
been the focus of much research and a number of studies now point towards the 
importance of the follicular dendritic cell (FDC), a long-lived radio resistant cell, in 
TSE pathogenesis.  The involvement of FDCs in peripheral TSE pathogenesis relates 
to the inability of ionising radiation to influence pathogenesis, the association of PrP 
protein with FDCs in both uninfected and infected lymphoid tissues, and the 
demonstration that TSE pathogenesis is severely impaired in mice devoid of these 
cells.  The aims of this thesis were to further understand the role of FDCs in the 
pathogenesis of a range of mouse-adapted experimental TSE strains and to determine 
if peripherally acquired TSE infections are influenced by host age or by stimulation 
of the immune system. Using chimaeric mouse models where a mismatch in the 
iv 
 viii
expression of PrP protein between FDCs and lymphoid/myeloid cells was produced, 
further evidence for a critical role for in the pathogenesis of the ME7 TSE strain was 
produced. Although these findings produced strong evidence that FDCs were 
important for the ME7 strain the possibility that different TSE strains may target 
different cell types in the peripheral lymphoid system was explored using a range of 
mice with specific immunological defects. Infection of these mice with several 
experimental TSE strains showed that the presence of mature FDCs was also 
important for the pathogenesis of the strains tested.  Clinical cases of vCJD have 
been confined almost exclusively to young adults, although the reasons behind this 
apparent age-related susceptibility are not fully understood. The capacity of the 
immune system to mediate immune responses to pathogens declines with age as a 
result of impaired lymphocyte and FDC function.  As FDCs are critically involved in 
the pathogenesis of many TSEs, including vCJD, it was hypothesised that an aging 
immune system may impair disease pathogenesis. Peripheral infection of senescent 
mice failed to produce clinical disease during lifespan, although evidence of disease 
transmission, was detected in a proportion of aged mice. These findings demonstrate 
that this inefficient disease transmission, as a consequence of age, may lead to 
considerable levels of sub-clinical disease within the population. Finally the 
influence of immune system stimulation, by the generation of a humoral immune 
response, on peripheral TSE pathogenesis was investigated. These findings 
demonstrated that immunisation can influence pathogenesis, but only during the 
early stages of infection prior to spread to the CNS.  These data imply that 
modulation of the immune system does not alter TSE pathogenesis once disease has 
been initiated in the CNS.  Finally, these studies have found some preliminary 
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evidence that TSE infection may induce FDC activation suggesting that TSE 
infection may influence the immune response.  Together, these data show that a 
functional immune system and specifically, the presence of mature FDCs, are central 
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1.1Transmissible spongiform encephalopathies 
 
1.1.1 The Transmissible Spongiform Encephalopathies  
 
TSEs are invariably fatal and are characterised by pathological changes in the central 
nervous system including vacuolation (Dickinson et al, 1968; Fraser, 1976), gliosis and 
the accumulation of an abnormal form of the host sialoglycoprotein, PrP (Bolton et al, 
1982) (Bruce et al, 1989b) (McBride et al, 1992).  
 
The diseases that are collectively known as the transmissible spongiform encephalopathies 
(TSEs) are arguably some of the most intriguing and perplexing diseases known to man. 
Over the last 50 years these diseases have been the subject of extensive debate on their 
origins and aetiology. The nature of these unique agents still remains controversial despite 
extensive research throughout the world. The characteristics of the TSEs however provide 
many barriers to understanding and researching these diseases. These barriers include; the 
prolonged incubation periods of disease, which in some cases can exceed the animal’s 
lifespan (Dickinson et al, 1975); the lack of an ante-mortem diagnostic test, the resistance 
to standard de-contamination methods (Taylor, 2000) and the uncertainty over the nature 
of the TSE agent (Chesebro, 1998). In addition, there are a number of factors that control 
the transmission of these diseases including; genotype of the host (Dickinson et al, 1968) 
(Dickinson & Outram, 1988) (Bruce et al, 1991) (Hunter, 2007), route of infection, 
(Eklund et al, 1967) (Kimberlin & Walker, 1979) infectious dose, age of host (Outram et 






1.1.2 History of TSEs 
 
Much of the understanding of the TSEs today originates from the study of natural 
scrapie (Hunter, 2007). Scrapie, a natural disease of sheep and goats, is the most 
studied member of the TSEs. Scrapie was first recognised over 300 years ago, 
although it is likely it has existed for many hundreds of years. The term “scrapie”is 
derived from a characteristic clinical sign; pruritus. Other names for the disease have 
included “traben” (to trot) and “tremblante” (to tremble); again both of these terms 
represent clinical symptoms of infection. Although most of the scientific research on 
the nature of this disease has occurred in the last century there were reports in the 
literature of its potentially infective nature as early as 1759 (Leopoldt, 1759). This 
was recorded in a German publication “A shepherd must isolate such an animal (with 
scrapie) from healthy stock immediately because it is infectious and can cause 
serious harm to the flock” (Leopoldt, 1759). 
 
During the late 18th and early 19th century several theories on the causal nature of the 
disease were put forward. These ranged from the supernatural to the more plausible 
where the possibility of an infective agent was suggested. In addition, in 1886 it was 
suggested that a “hereditary factor” may influence susceptibility to these diseases 
(Dammann, 1886) 
 
In 1899 a French scientist (Besnoit & Morel, 1898) presented findings on the lack of 
transmissibility of scrapie. In these studies brain and blood from scrapie infected 
sheep were inoculated into healthy sheep; after only a few months observation he 
reported that the disease could not be transmitted. This time period of observation 
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would now be considered far too short to observe clinical signs of scrapie as the 
incubation periods of disease can range from approximately 7 months to many years. 
(Foster & Dickinson, 1988; Hunter et al, 1997) (Hunter, 2007). In 1936 however the 
first demonstration of the scrapie agent’s infective nature was demonstrated (Cuille 
& Chelle, 1936). 
 
In 1946 at the National Veterinary Medical Association of Great Britain and Ireland 
Annual Congress, evidence of scrapie transmission as a result of louping ill vaccine 
was presented (Gordon, 1946). Louping–ill is a viral disease spread by the tick 
Ixodes ricinus. This inadvertent discovery was suggested as early as 1936 where 
farmers, whose sheep had received a vaccination for Louping-ill approximately 2 
years earlier, noted disease symptoms now known to be consistent with those of 
natural scrapie. The components of the vaccine had been treated with 10% formalin 
which inactivated the louping ill virus but not the scrapie agent. This was possibly 
the first demonstration that TSE agents were resistant to standard decontamination 
methods with formalin (Taylor, 2000).  
 
The next TSE to be identified was Creutzfeldt-Jakob disease (CJD), which was first 
described in the early 1920’s by Hans Gerhard Creutzfeldt (Creutzfeldt, 1920) and 
Alfons Maria Jakob (Jakob, 1921). They described a rare neurodegenerative 
condition which was initially called “spastic pseudosclerosis”. Creutzfeldt-Jakob 
disease is recognised in different forms; sporadic, iatrogenic, familial (Gambetti et al, 
2003) and more recently as (new) variant CJD (Will et al, 1996). Extensive research 
in the 20th century and the discovery of a number of other similar conditions 
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affecting both humans and animals led to the classification of this group of diseases 
as transmissible spongiform encephalopathies or “prion” diseases (Bolton et al, 
1982). A summary of the key discoveries and the diseases that comprise the “TSEs” 
are provided in Table 1.1 
 6
Table 1.1: A summary of TSEs and the year of discovery 
TSE                              Abbreviation      Year         Reference 
Classical scrapie in small 
ruminants (sheep and goats) Scrapie,  1732 
Not defined 
Sporadic Creutzfeldt–Jakob 




syndrome in humans GSS 1936 
(Gerstmann et al, 1936) 
Kuru in humans Kuru 1957 (Zigas & Gadusek, 1957). 
Transmissible mink 
encephalopathy in captive mink TME 1965 
(Hartsough & Burger, 1965) 
Iatrogenic Creutzfeldt–Jakob 
disease in humans  iCJD 1974 
(Duffy et al, 1974) 
Chronic wasting disease in deer 
and elk CWD 1980 
(Williams & Young, 1980) 
Fatal familiar insomnia in 
humans FFI 1986 
(Lugaresi et al, 1986) 
Bovine spongiform 
encephalopathy in cattle BSE 1987 
(Wells et al, 1987) 
BSE (feline spongiform 
encephalopathy) in domestic cats FSE 1990 
(Leggett et al, 1990) 
Familial Creutzfeldt–Jakob 
disease in humans CJD, fCJD 1991 
(Goldfarb et al, 1991a) 
New variant of Creutzfeldt–
Jakob disease in humans vCJD 1996 
(Will et al, 1996) 
vCJD and BSE are the same 
agent strain vCJD/BSE 1997 
(Bruce et  al., 1997) 






(Benestad et al, 2003) 
Atypical form of BSE in cattle BASE-1 2003 (Yamakawa et al, 2003) 





1.1.3 Nature of the TSE agent 
 
The virus hypothesis 
Over the years the TSES have been classified under a number of terms including that 
of the “slow virus diseases or infections”. The concept of “slow viruses” was 
originally put forward by the Icelandic physician and scientist Dr Bjorn Sigurdsson 
as a result of his research on Maedi-Visna (Sigurdsson et al, 1957). Maedi is a slowly 
progressive interstitial pneumonia of adult sheep while Visna affects the central 
nervous system causing encephalomyelitis; both these conditions are caused by the 
same virus (Gudnadottir, 1974). The properties of these diseases; long incubation 
periods of disease, a protracted course of illness and targeting to the central nervous 
system and lymphoid tissues shared many similarities with scrapie. In later years 
Maedi-Visna was shown to be caused by a Lentivirus, a subgroup of the 
Retroviruses. Other examples of viral infections with prolonged incubation periods 
include; human immunodeficiency virus infection (HIV) and the canine distemper 
virus.  
 
Previous studies using UV irradiation (Alper et al, 1966) (Alper et al, 1978) 
suggested that critical target was not nucleic acid (Alper et al, 1966). However, it is 
possible that shielding of the critical target molecule of the infectious agent by other 
molecules may have influenced this resistance (Diringer et al, 1994; Diringer et al, 
1983). Using target theory calculations, some workers have concluded that the 
maximum genome size for the TSE agent would be very small (Alper et al, 1978) 
(Bellinger-Kawahara et al, 1988.). Interestingly, the inactivation spectrum for scrapie 
obtained from these studies appeared similar to intact tobacco mosaic virus, a well-
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characterised RNA virus (Diringer et al, 1983). Despite these comparisons, no 
conventional viruses have been detected.  Although, it is still conceivable that such 
an agent; either a DNA or a RNA virus is yet to be discovered.  
 
The virino hypothesis 
The virino hypothesis is based on the theory that a very small nucleic acid or some 
form of informational molecule forms part of the scrapie specific genome (Dickinson 
& Outram, 1988). This theory was first postulated (Dickinson & Outram, 1988) in an 
attempt to characterise the unique properties of the TSE agents. Although attempts to 
isolate a classical virus from these diseases have failed, this hypothesis was based on 
the possibility that the virino nucleic acid is “virus like” and encapsulated by a 
protein coat, possibly an informational hybrid between the agent's genome and 
protective host proteins. Although research has failed to define whether the TSE 
agent is a “virino” it is possible that encapsulation of the virino nucleic acid has 
“prevented” the detection of a specific informational molecule for these diseases.  
 
Much of the evidence for the virino hypothesis is based on the existence of a number 
of defined TSE strains (Bruce, 1993; Bruce & Fraser, 1991; Bruce et al, 1992; Bruce 
et al, 1991). The reproducibility of these strains, following multiple passage within 
the same species and on occasion through other species, suggests that some form of 
informational molecule controls these defined characteristics (Bruce & Dickinson, 
1987). In addition mutation of some experimental TSE strains has been observed 
supporting the hypothesis that some form of informational molecule may be present 
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(Bruce & Dickinson, 1987). Indeed, “virino” like agents exist in the form of plant 





The prion hypothesis 
In the 1960s Tikvah Alper and colleagues suggested that the causal agent of scrapie 
did not contain a nucleic acid molecule (Alper et al, 1967; Alper et al, 1966). This 
suggestion was based on studies using ionising and ultraviolet radiation which the 
researchers found to have no effect on the transmissibility of scrapie. As most 
conventional viruses containing DNA or RNA would have been inactivated by this 
treatment it was assumed that the scrapie agent was not a conventional virus. The 
“protein only” hypothesis was first suggested in 1967 by J.S Griffith (Griffith, 1967) 
in an attempt to explain Tikvah Alper’s findings. He suggested that the infectious 
agent was in-fact a protein which was capable of replicating within the body.  
  
This theory was further extrapolated by the researcher Stanley Prusiner who was 
awarded the Nobel Prize in 1997 for research into the origin and causal agent of the 
TSEs where he identified an unusual class of infectious particles termed “prions”. 
His research constituted a novel theory in that the TSE agent was composed almost 
completely, if not entirely, of infectious protein molecules termed “prions” 
(proteinaceaus particles) (McKinley et al, 1983). The term prion was first published 
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in 1982 (Prusiner, 1982). This theory was based partly on the fact that research had 
failed to uncover a conventional informational molecule.  
 
The protein-only hypothesis states that the infectious agent or “prion” is identical to 
the abnormal form of PrPSc (Prusiner, 1982). The mechanism of infection is thought 
to occur via recruitment of the normal form of the protein, PrPc, from newly infected 
cells (Prusiner, 1982). A number of studies have produced evidence which favour the 
prion hypothesis. These include the generation of infectivity in neuroblastoma cells 
(Race et al, 1988) and the cell free conversion of PrPc into PrPSc by Caughey and 
colleagues (Caughey et al, 1995)   
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The precise mechanism by which PrPc is converted to PrPSc is not fully understood 
although several models to explain this process have been produced, including; the 
template assisted model (Harrison et al, 1999; Huang et al, 1996) and the nucleation-
polymerisation model (Caughey et al, 1995; Thirumalai et al, 2003). Perhaps some of 
the most controversial or compelling data supporting the protein only hypothesis was 
provided by studies which demonstrated that mammalian prions synthesised from 
PrPc under appropriate conditions were capable of producing disease in transgenic 
mice over-expressing PrP, but not in wild-type mice (Legname et al, 2004) although 
subsequent passage of brain material from the transgenic mice produced disease in 
wild-type mice. Criticisms of the failure of this study to produce disease in wild-type 
mice were explained by; the structure of the converted PrP and “priming” or 
sensitisation of the animal to infection by the over expression of PrP in the transgenic 
model (Legname et al, 2004)   
 
Notably, other researchers have demonstrated the conversion of PrPc into the 
abnormal protease resistant form, PrPSc. In these studies the acquisition of proteinase 
K resistance could be demonstrated, but in contrast to the studies described above 
this acquisition of proteinase K resistance did not result in the generation of 
infectivity (Hill et al, 1999a).  Moreover, some studies have shown that transmission 
of infectivity can occur in the absence of detectable PrPSc (Lasmezas et al., 1997; 
(Barron et al, 2007; Lasmezas et al, 1997). 
 
More recently, the detection of abnormal PrP in the absence of clinical symptoms of 
disease or infectivity has been demonstrated in transgenic mice inoculated with brain 
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material from a human case of Gerstmann-Straussler-Scheinker syndrome (GSS) 
(Piccardo et al, 2007)  
 
Although it is widely accepted that both the normal and abnormal forms of PrP are 
intrinsic to the disease process, the protein only-hypothesis still remains controversial 
within the field of TSE research. One of the major criticisms of this hypothesis is that 
the existence of strains would require some form of informational molecule (Bruce & 
Dickinson, 1987). However, it has been suggested that the molecular basis for strain 
variation results from conformational alterations in structure of PrPSc which results in 
strain variation (Bessen & Marsh, 1994) (Collinge et al, 1996). 
  
 
1.1.4 Genetic influences on TSE pathogenesis  
 
The influence of host genetics controls a number of factors including; resistance or 
susceptibility to specific TSE strains or agent, length of disease incubation period 
and pathological changes in the central nervous system (Dickinson & MacKay, 1964; 
Goldmann et al, 1994) (Hunter, 2007). 
 
In the 1960s studies by Alan Dickinson and others led to the discovery of a gene 
which was responsible for the control of scrapie incubation periods in sheep and 
mice (Dickinson et al, 1968). This gene was designated Sinc in mice and Sip in 
sheep. Subsequent studies following the discovery of PrP protein (Hope et al, 1986) 
have confirmed that Sinc and the gene encoding PrP protein, (Prnp) are the same 
(Hunter et al, 1987) (Hunter et al, 1992; Moore et al, 1998).  In mice, two alleles of 
this gene (Prnp) have been recognised (designated a and b), encoding proteins that 
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differ by two amino acids, at codons 108 and 189.  In humans the PrP gene is defined as 
PRNP. The influence of host genetics can be demonstrated below in data shown below 
(Table 1.2) which demonstrates the differences in incubation period in two lines of 
inbred mice challenged with the ME7 or 22A strains of scrapie  (Dickinson et al, 1968). 
 
Table 1.2. Influence of PrP (Sinc) genotype on TSE incubation period in mice. 
     Mouse strain 
    C57BL   VM  
Genotype   Prnpa   Prnpb 
    SincS7    Sincp7 
 
Agent    mean incubation period in days 
ME7    165   299 
22A    443   205 
Extracted from Dickinson et al 1968. Data demonstrates the influence of the PrP gene.  
(Dickinson et al, 1968)  
 
In studies of natural sheep scrapie the influence of host genetics has a profound 
effect on the susceptibility to infection (Goldmann et al, 1994) (Hunter et al, 1996) 
(Elsen et al, 1999) (Tranulis, 2002) (Hunter, 2007). Indeed so great was the influence 
of genetics that the disease was originally considered to be a genetic condition 
(Parry, 1962.; Parry, 1983.)   
 
Prior to the discovery of PrP protein and the determination that genetics influenced 
natural scrapie pathogenesis it was clear that some breeds of sheep were more 
susceptible to infection than others. Initial studies carried out in the 1950’s using a 
range of sheep breeds provided evidence for breed specific susceptibility (Hunter, 
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2007)  These “susceptible” breeds included Herdwick, Swaledale and South Country 
Cheviot. In order to understand the influence on genetics on the susceptibility to 
natural scrapie the development of specific lines was initiated, using scrapie 
challenge to select susceptible/resistant lines (Hunter, 2007). The most widely 
studied flock produced from these initial studies is the NPU Cheviot sheep flock 
which was initiated in 1961. From these studies two lines of sheep, a positive and 
negative line were produced based on their susceptibility to the experimental strain 
SSBP-1 (Scrapie Sheep Brain Pool-1) (Pattison & Millson, 1961). Analysis of the 
PrP gene in sheep has determined that polymorphisms at codons 136, 154 and 171 
have profound effects on the susceptibility to infection (Foster & Dickinson, 1988; 
Goldmann et al, 1994). The first codon known to be polymorphic was codon 171 
where either arginine (R) or glutamine (Q) could occur. Subsequently two other 
codons were found to be important: 136 with valine (V) or alanine (A) and 154 with 
histidine (H) or arginine (R). The presence of the VRQ/VRQ genotype in some breeds, 
notably Cheviot, generally denotes susceptibility to natural scrapie (Hunter et al, 1997) 
(Hunter, 2007). The incidence of natural scrapie in the NPU Cheviot flock (described 
above) is extremely high, with almost all animals with the susceptible genotype 
developing natural scrapie in their lifetime (Hunter, 2007). Interestingly this 
susceptibility may vary between breeds. In Suffolk sheep for example, the ARQ/ARQ 
genotype confers susceptibility whereas this same genotype in Cheviot sheep confers 
resistance suggesting that some other factors may also contribute to TSE susceptibility 
(Hunter, 2007). The understanding of the effects of these polymorphisms on the 
susceptibility to infection has lead to the introduction of the national scrapie plan. The 
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aim of the national scrapie plan is to reduce the frequency of susceptible genotypes, 
theoretically reducing the frequency of infection within the sheep population.  
  
In familial human TSEs the presence of specific mutations on the PrP gene are 
clearly associated with disease (Gambetti et al, 2003; Goldfarb et al, 1991a). 
However, controversy exists over whether the presence of these mutations alone 
cause disease or if their presence influences susceptibility to infection. One of the 
most common mutations associated with familial CJD, the E200K, occurs at codon 
200 in the PrP gene and has been most widely studied in a cluster of cases occurring 
amongst Libyan Jews (Goldfarb et al, 1991b). The presence of clinical variability in 
individuals with this mutation, and the variation in the penetrance in different 
geographical cluster areas however may argue against a genetic condition.  
 
Moreover, transgenic mice carrying a mutation which has been closely linked to the 
development of Gerstmann–Struässler–Scheinker (GSS) disease in humans 
(Gerstmann et al, 1936), do not develop clinical symptoms of disease during lifespan, 
suggesting the presence of this mutation alone is not sufficient to produce disease 
(Manson et al, 1999; Piccardo et al, 2007). 
 
In both sCJD and vCJD a common polymorphism, with either methionine or valine 
present at codon 129 of the PRNP gene, appears to influence susceptibility to 
infection and incubation period of disease. Analysis of this polymorphism within the 
population demonstrates that approximately 38% of Europeans are homozygous for 
the methionine allele, 51% are heterozygous, and 11% are homozygous for the valine 
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allele (Gambetti et al, 2003). In sCJD a number of sub-types appear to exist where 
there is variation between genotype and disease susceptibility (Gambetti et al, 2003). 
In contrast, all clinical cases of vCJD studied so far have occurred in individuals 
homozygous for methionine at codon 129 (Will et al, 1996). The discovery of vCJD 
in an asymptomatic individual heterozygous for this polymorphism at codon 129 
suggests that future cases of vCJD may occur in these individuals. This individual 
received a blood transfusion from a vCJD infected donor (Llewelyn et al, 2004). 
Indeed, analysis of survivors of the kuru epidemic has shown that most elderly 
survivors of these traditional mortuary feasts were  heterozygous at codon 129 (Mead 
et al, 2003). 
 
 
1.1.5 The role of PrP protein 
 
 
PrP is a host encoded glycoprotein which can be divided into two distinct forms 
based on their biochemical characteristics (Hope et al, 1986). PrPc, the normal form 
of this protein, is located on the cell membrane where it is attached via a C-terminal 
glycosyl-phosphatidyl-inositol (GPI) anchor (Stahl et al, 1987). There are two N-
glycosylation sites on the polypeptide chain (Asn 181 and Asn 197). PrPc is readily 
digested by proteinase K and can be liberated from the cell surface by the enzyme 
phosphatidyl inositol-specific phospholipase C (PIPLC), which cleaves the 
phosphatidyl inositol glycolipid anchor.  
 
The abnormal, or disease specific form is termed PrPSc (Hope et al, 1986), although it 
has also been described as PrPres (to denote the resistant form) or PrPd (to denote the 
disease specific form) (Gonzalez et al, 2003). An intermediate form designated PrP* 
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has also been postulated, following the conversion of PrPc to PrPSc in conjunction 
with Protein X (Kaneko et al, 1997).  In contrast to PrPc, PrPSc is detergent insoluble 
and partially degraded by proteinase K (Somerville et al, 1986). The proteinase-K-
resistant component of the PrPSc isoform is thought to consist of a 27–30-kDa core 
(Bolton et al, 1985).  In terms of conformation PrPc has a high alpha-helical content 
(Pan et al, 1993) while PrPSc folds into a structure that is primarily beta-sheet in 
content (Caughey, 1991). PrP is highly conserved among mammals and widely 
expressed in early embryogenesis (Manson et al, 1992).  
 
Although the accumulation of PrPSc is a feature of TSE infection the function of PrPc 
remains to be fully defined. Mice homozygous for disrupted PrP genes appear 
developmentally and behaviourally normal (Bueler et al, 1993; Manson et al, 1994b; 
Weissmann & Flechsig, 2003).  PrP protein is essential for TSE agent replication as 
transgenic mice devoid of the PrP gene (PrP-/- mice) are resistant to TSE infection 
(Bueler et al, 1993; Manson et al, 1994a; Manson et al, 1994b).  Studies in PrP-/- 
mice have demonstrated that PrP may be important for the regulation of circadian 
rhythms (Tobler et al, 1996) 
 
As PrPc is localised to synaptic membranes (Herms et al, 1999) roles in synaptic 
transmission and neuronal excitability have been postulated and electrophysiological 
studies have suggested that long term potentiation (Johnston et al, 1998) and GABA 
receptor mediated inhibition may be impaired in PrP deficient mice (Collinge et al, 
1994), although variability in these findings have been reported (Herms et al, 1995).    
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PrPc has been shown to bind copper (Todorova-Balvay et al, 2005; Viles et al, 1999) 
with the major copper binding site identified at the N terminal region. The binding of 
copper to PrPc has been shown to be highly pH dependent (Pappalardo et al, 2004). 
The functional relevance of copper binding by PrPc is not fully understood but it is 
thought it may function in a number of ways including; the regulation of copper 
homeostasis in the synapse (Herms et al, 1999). PrPc has also been implicated as a 
neuroprotective molecule, especially in relation to pro-oxidative insults (Brown et al, 
1998; Brown et al, 1997a; Herms et al, 1999). Studies in PrP deficient mice have 
demonstrated a significant reduction in the viability of PrP deficient cerebellar 
granule neurons in comparison with wild-type mice following exposure to hydrogen 
peroxide (Brown et al, 1998).  
 
In the immune system PrPc is expressed on the surface of FDCs (McBride et al, 
1992) (Brown et al, 2000a; Ritchie et al, 1999)and at much lower levels on the 
surface of lymphocytes (Cashman et al, 1990; Mabbott et al, 1996; Mabbott et al, 
1997). Within the immune system the role of PrP protein remains to be elucidated, 
although a possible function in T cell activation (Mabbott et al, 1997) and in the 














1.2 TSE strains 
 
 
1.2.1 Generation of experimental TSE strains 
 
A number of distinct TSE strains have been isolated in mice from a range of natural 
scrapie, BSE and CJD sources. In the 1960’s studies in goats (Pattison & Millson, 1961; 
Pattison & Smith, 1963) experimentally infected with an experimental source of natural 
scrapie designated SSBP/1 (Pattison & Millson, 1961) produced a number of 
experimental scrapie strains (Chandler, 1961; Dickinson & Outram, 1988). The history 
of SSBP/1 began in 1945 following the preparation of a brain pool from 3 sheep of 
cheviot origin with symptoms of natural scrapie. Serial passage of this brain pool was 
continued in cheviot sheep with very little deviation in disease characteristics during 
these passages. In the goat transmission studies the source of the SSBP/1 inoculum was 
obtained from the 18th passage of this brain pool (Pattison & Millson, 1961; Pattison & 
Smith, 1963).  
 
Following infection of the goats with the SSBP-1 brain pool, two distinct types of 
clinical symptoms “drowsy” and “scratching” were observed in the affected goats. 
Subsequent passage in goats of brain material from each distinct type produced the 
same distinct clinical symptoms as before. In- fact these different characteristics were 
maintained through a number of passages in goats leading the researchers to conclude 
that two different scrapie strains had been isolated from the original transmission 




Subsequent studies in mice (Chandler, 1961) (Chandler, 1962) (Dickinson et al, 1986) 
determined that the “two distinct” strains isolated from the “drowsy” and “scratching” 
goat studies actually contained a mixture of strains. Although initial studies to transmit 
the “scratching” isolate to lines of inbred mice were unsuccessful, the “drowsy” or 
“chandler” isolate successfully transmitted to mice (Chandler, 1961) (Chandler, 1962). 
Further transmission studies in mice determined that this isolate contained the 139A, 
79A and 79V scrapie agent strains, while the “scratching” strain contained the 22C and 
22H strains (Dickinson et al, 1986). Further passage of the “drowsy” or “chandler” 
isolate at the Rocky Mountain Laboratory (Montana, USA) led to the designation of the 
RML isolate, although it is believed that this may in-fact be a mixture of both the 139A 
and 79A strains. 
 
Interestingly, sub-passage in mice of the SSBP/1 material used to conduct the original 
studies in goats produced the 22A, 22C, 22H, 22F and 22L strains but not the 139A, 
79A or 79V strains (Dickinson et al, 1986). A number of possibilities for this 
phenomenon exist. Potentially the goats that produced the “drowsy” line were naturally 
infected with another scrapie strain. Alternatively, as the goats used in the studies were 
outbred, some genetic component may have led to the selection of different strains.  
 
The majority of the studies described in this thesis have used the ME7 strain of scrapie 
(Zlotnik & Rennie, 1965). This strain was isolated as a result of a series of 
experiments which began with the intragastric transmission, to mice, of pooled 
spleen material from a number of cases of Suffolk sheep with natural scrapie (Zlotnik 
& Rennie, 1965). These initial attempts to transmit this spleen pool intragastrically 
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resulted in clinical and neurological symptoms of disease primarily in the group 
initially termed ME.7 (Zlotnik & Rennie, 1965). Subsequent passage of brain material 
from these brains led to the eventual isolation of the strain that is now referred to as 
ME7. Notably the experimental ME7 scrapie strain has often been isolated from 
sources of natural sheep scrapie in the past (Bruce et al, 2002). The ME7 scrapie 
strain is particularly useful due to its extensive use in many studies at this unit and 
elsewhere, providing essential information on the pathogenesis of this strain. In 
addition, this strain is known to target peripheral lymphoid tissues (Bruce et al, 2000; 






1.2.2 Human TSE infections  
Kuru 
In the 1950’s “kuru” was identified by several researchers notably Carlton Gadjusek, 
and Michael Alpers (Alpers, 1965; Zigas & Gadusek, 1957) This disease was found 
almost exclusively amongst the Fore tribe of the eastern highlands of Papua New 
Guinea. This particular tribe participated in endocannibalism; a ritualistic form of 
cannibalism involving the consumption of deceased relatives (Gajdusek, 1963; 
(Alpers, 1965). This traditional practice was later shown to be responsible for the 
transmission of kuru (Collinge et al, 2006; Mathews et al, 1968). In addition to the 
oral consumption of infected tissues, other ritualistic practices, such as coating the 
body with the remains of the deceased, may have contributed to the epidemic 
(Hornabrook & Moir, 1970; Mathews et al, 1968). Transmission of TSEs via the skin 
 22
(scarification) is known to be an effective route of disease transmission (Taylor et al, 
1996) (Mohan et al, 2004). The kuru epidemic reached its peak in the 1960’s with an 
estimated 1,100 victims of the disease. The disproportionate ratio of female to male 
victims was later explained by the predominant consumption of brain material, 
containing high levels of infectivity, by women and infants (Gajdusek & Alpers, 
1966), in comparison to the male members of the tribe who mainly consumed muscle 
from the deceased (Hornabrook & Moir, 1970).   
 
The cause of this disease epidemic proved extremely difficult to identify and various 
possibilities were considered; including heavy metal poisoning and toxins from 
plants or animal sources being suggested as potential causes of the condition. 
Notably, some similarities with natural scrapie were suggested in 1959 (Hadlow, 
1959). In addition it was believed initially that this disease may have been purely a 
genetic condition with no infectious component. This possibility was eventually 
ruled out due to the high frequency of disease within the population; such a lethal 
genetic condition would have been removed from the gene pool and could not have 
been maintained in the population at such high levels. In addition, the occurrence in 
individuals who were not genetically related also disproved this theory (Hornabrook 
& Moir, 1970). Initial transmission studies to mice from CNS and peripheral tissues 
of victims of kuru were deemed negative (Gajdusek & Gibbs, 1964), however these 
studies were terminated after a period of only 3 months which clearly would not have 
been long enough to produce disease in rodent models. The transmission of kuru to 
primates in the 1960’s (Gajdusek et al, 1966) demonstrating its infectious nature, and 
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the similarity of the brain pathology to natural scrapie (Hadlow, 1959) placed the 
disease within the group of diseases that are now know as TSEs 
 
Creutzfeldt-Jakob disease (CJD) 
CJD was first recognised in the 1920’s (Creutzfeldt, 1920; Jakob, 1921) and is now 
defined in several forms: Classical or Sporadic CJD, Variant CJD, familial CJD and 
iatrogenic CJD.  
 
Sporadic CJD  
Sporadic CJD (sCJD) occurs worldwide at a rate of approximately 1 case per 
million/annum.  The disease is generally confined to older individuals with an 
average age of onset approximately 68 years, although there have been some cases in 
younger individuals (Murray et al, 2008). The duration of the clinical stage of sCJD 
is generally much shorter than that of vCJD with a median duration of illness of 4-5 
months compared to 13-14 months for vCJD.  In addition the clinical and 
pathological characteristics differ for the two forms (Gambetti et al, 2003).  
 
Variant CJD 
In 1996 a “new variant” of CJD was described in 10 individuals with a clinical and 
pathological phenotype distinct from that of sCJD (Will et al, 1996). Since the 
identification of variant CJD (vCJD) there have been almost 200 cases of the disease 
worldwide, the majority of which have occurred in the United Kingdom (UK) (for 
current figures see: http://www.cjd.ed.ac.uk). Epidemiological and transmission 
studies have produced compelling evidence to show that this disease has been caused 
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by the consumption of BSE contaminated foodstuffs (Brown et al, 1997b). During 
the BSE epidemic in the 1980’s it was estimated that almost 500,000 infected cattle 
were slaughtered for consumption; suggesting that the number of people exposed to 
potentially infective doses through food may have been extremely high (Valleron et 
al, 2001). This factor and the clinical and pathological similarities of vCJD with kuru 
suggested that the route of transmission was most likely through oral transmission 
(ingestion) of BSE contaminated food. In addition, transmission of brain material 
from vCJD affected individuals into mice produces a “signature” undistinguishable 
from that of BSE (Bruce et al, 1997). The components of this signature include; 
incubation period in specific mouse strains (Bruce et al, 1997), lesion profiles in 
brain and PrPSc glycoform analysis (Somerville et al, 2005). One of the most striking 
and distressing features of vCJD is the young age of those affected with a mean age 
of death of 29 years (Boelle et al, 2004; Ghani et al, 2000). The reasons for this 
apparent age related susceptibility are not fully understood although it is possible that 
age related immune-system dysfunction may contribute to this phenomenon. This 
will be discussed in detail in chapter 4. 
In addition to the differences in clinical symptoms of disease between vCJD 
(Ironside, 2003) and sCJD (Gambetti et al, 2003) there are notable differences in the 
targeting of infection within the body. In vCJD, like many cases of natural scrapie, 
the peripheral lymphoid becomes infected early in infection (Hill et al, 1999a; Hill et 
al, 1999b; Hill et al, 1997). In contrast infectivity has not been detected in lymphoid 
tissues of sCJD (Hill et al, 1999b). The recent transmission of vCJD to 4 individuals, 
most probably via blood transfusion (all four cases had received transfusions of non-
leucodepleted red blood cells between 1996 and 1999) has raised concerns over the 
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possibility of a secondary epidemic of vCJD within the population (Llewelyn et al, 
2004; Peden et al, 2004; Wroe et al, 2006).   
Notably, there have been no recorded cases of sCJD arising from blood transfusion. 
This may relate to the differences in targeting between sCJD and vCJD where 
infection of the peripheral lymphoid organs may contribute to the dissemination of 
infectivity into the bloodstream. 
 
 
Genetic or Familial CJD 
Familial CJD is classified into many haplotypes based on the PRNP mutation and 
codon 129 (and other polymorphic codons) on the mutant allele (Gambetti et al, 
2003; Goldfarb et al, 1991a). A great deal of controversy surrounds the aetiology of 
the familial forms of these diseases. The existence of these mutations is thought to 
pre-dispose these individuals to the disease. The clinical and pathological symptoms 
of this form of the disease can vary depending on the mutation present and the age of 





1.2.3 Natural TSE infections of animals 
 
Bovine spongiform encephalopathy  
 
In 1986 a new disease in cattle, with neuropathology consistent with a spongiform 
encephalopathy, was identified (Wells et al, 1987). This disease was termed bovine 
spongiform encephalopathy (BSE). The cause of this disease was later related to the 
feeding of cattle with ruminant derived meat and bone meal contaminated with a 
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TSE agent (Taylor, 2000; Wilesmith, 1993). It is thought that changes in the 
rendering process used to produce meat and bone meal allowed the survival of TSE 
infectivity. Although the nature of the infecting agent remains controversial one of 
the most plausible theories is that BSE arose from a cattle adapted scrapie agent, 
although strain typing studies have failed to demonstrate any similarities with pre-
existing scrapie strains, perhaps with the exception of the experimental strain 
CH1641 (Hope et al, 1999). Other theories include the possibility that some form of 
rare natural spongiform encephalopathy, present within the cattle population, was 
somehow amplified as a result of the modified rendering process (Priola & Vorberg, 
2004). BSE has spread to a number of species, including domestic and large cats, 
exotic ungulates (Nyala and Kudu) and humans as vCJD (Bruce, 1997).  Perhaps a 
more provocative hypothesis is the possibility that BSE in cattle might have arisen in 
the UK after the incorporation in animal food products of human remains imported 
from India (Colchester & Colchester, 2005). 
 
Strikingly, transmission studies to panels of inbred mouse lines demonstrated that a 
single strain of agent was responsible for BSE in cattle which was indistinguishable 
from the infecting strain responsible for vCJD, FSE and the cases in the exotic 
ungulates (Bruce et al, 1997). More recently, the identification of a possible natural 
field transmission of the BSE agent to goats in has been documented in France (Eloit 
et al, 2005).  
 
Atypical TSEs in ruminants: Nor98, atypical scrapie and BASE  
 
In 1998 an atypical form of scrapie, termed Nor98, was detected in Norwegian sheep 
(Benestad et al, 2003). The characteristics of Nor98 include its unusual 
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neuropathology and western blot banding pattern which demonstrates an unusual 
band of low molecular weight (mass approximately 10–12 kDa). This is in contrast 
to that of “classical” scrapie where the disease specific form of PrP is detected as 
three bands between 18 and 29 kDa corresponding to the un-, mono- and di-
glycosylated disease specific forms of PrP (Baron et al, 2007). Active surveillance of 
small ruminants throughout the European Union (EU) to detect these “atypical” cases 
of scrapie has since identified the presence of atypical forms of scrapie in a number 
of countries including France, Belgium and Germany (Baron et al, 2007; Buschmann 
et al, 2004). Notably, a number of these cases were identified in sheep with 
genotypes normally associated with resistance to classical scrapie or BSE, such as 
those with the A136 H154 Q171 or A136 R154 R171 genotypes (Buschmann et al, 
2004). Interestingly, retrospective analysis of an unusual case of scrapie detected in 
1989 indicate that this may have been a case of Nor98 scrapie suggesting that this 
strain may have been present in certain breeds of sheep for many years (Bruce et al, 
2007). Initial suggestions that these atypical forms may not have been TSEs have 
been ruled out following the transmission of 10 French atypical isolates and three 
Norwegian Nor98 cases to transgenic mice over-expressing the ovine PrP (V136 R154 
Q171 allele) of the sheep PrP gene (Arsac et al, 2007). 
Since the introduction of active surveillance methods for the detection of TSEs in 
ruminants a number of atypical TSE cases have also been identified in cattle. These 
include the identification of a novel TSE in cattle from Italy with unusual pathology 
in the form of amyloid plaques in the CNS (Casalone et al, 2004). This has since led 
to the definition of a new form of BSE termed: bovine amyloidotic spongiform 
encephalopathy (BASE).  
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Following this initial discovery, other variations in the BSE phenotype have since 
been reported in Japan (Nakamitsu et al, 2006; Yamakawa et al, 2003) and other 
European countries (Biacabe et al, 2004; Buschmann et al, 2006). Although the 
BASE isolates appear to have different molecular and neuropathological phenotypes 
from that of classical BSE transmission of brain material from atypical BSE cases 
has produced striking results. Transmission to wild-type mice produced a molecular 
and neuropathological ”signature” indistinguishable from that of classical BSE, 
whereas the characteristics of the BASE strain were preserved in transmissions to 
transgenic mice expressing bovine PrP (Capobianco et al, 2007). Interestingly the 
glycoform patterns of the BASE isolates closely resemble those found in some cases 










1.3 The central nervous system in TSE pathogenesis 
 
 
1.3.1 Clinical and pathological characteristics of experimental TSEs  
 
In the brain pathological signs of disease include vacuolation, gliosis and the 
deposition of the abnormal form of PrP protein (Bruce et al, 1989b). The presence of 
vacuolation is one of the most defining pathological features of TSE infection and is 
thought to result from neuronal loss (Jeffrey et al, 1994b). Almost without exception, 
vacuolation of the grey matter is a feature of all TSE infections although the intensity 
and targeting varies between strains (Fraser & Dickinson, 1973). Indeed the scoring 
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system used to construct a “lesion profile” is based on the intensity of vacuolar 
change within 9 defined grey matter and 3 defined white matter areas (Dickinson et 
al, 1968; Fraser & Dickinson, 1968). The specific pathology observed in brain is 
dependent not only on TSE strain but also on the PrP genotype of the host. For 
example; infection of CVF1 mice, an F1 cross between C57BL (Prnpa) and VM 
(Prnpb) mice, with the ME7 strain of scrapie produces a severe pathology in the 
pyramidal cell layer of the CA1 layer of the hippocampus (Scott & Fraser, 1984). 
This pathology is not observed in the C57BL or VM mouse strains when challenged 
with ME7. 
 
In addition, the deposition of amyloid, consisting of PrPSc in the form of amyloid 
plaques is a feature of a number of strains including; kuru (Collinge et al, 2006), the 
experimental strain 87V (Bruce, 1984; Bruce & Fraser, 1975) and also in variant 
CJD (Will et al, 1996). In a number of neurodegenerative diseases inflammation in 
the CNS is a key feature (Perry, 2007). This is characteristically displayed in 
multiple sclerosis where T cells and macrophages infiltrate the brain resulting in 
degeneration of myelin and axons. In both acute and chronic neurodegeneration 
conditions, including TSE disease, activated microglia can be detected in the CNS 
(Betmouni et al, 1996; Perry, 2007). In studies using the ME7 strain of scrapie 
activated microglia could be detected from 12-13 weeks after intracerebral challenge 
(Betmouni et al, 1996) coincident with behavioural changes in the infected mice 
(Perry, 2004). Although the exact cause of TSE associated neurodegeneration is not 
fully understood, accumulation of PrPSc in the CNS is thought to contribute to these 
pathological changes. PrPSc has been shown to have neurotoxic effects on cultured 
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cells of neuronal origin (Salmona et al, 1997; Selvaggini et al, 1993). The topological 
distribution of PrPSc correlates with vacuolation in many TSEs (Bruce, 1984; Bruce 
et al, 1989b) although this is not the case in all TSEs. Recently the accumulation of 
PrP in the absence of vacuolar changes has been demonstrated in a case of human 
GSS and in subsequent transmission studies to mice (Piccardo et al, 2007). 
 
Other potential mechanisms for TSE associated neurodegeneration have included a 
potential role for the complement system (Gasque et al, 2000), specifically 
complement component C5 (Mabbott & Bruce, 2004). In certain neurodegenerative 
conditions such as multiple sclerosis overproduction of complement may contribute 
to neurodegeneration and inflammation (Kirschfink, 1997; Niculescu et al, 2004). 
However studies in complement component C5 deficient mice found no effects on 
neuropathology or incubation period of disease suggesting that C5 is not involved in 












1.3.2 Cellular targeting of PrPSc in the CNS 
Following infection, PrPSc accumulates in the CNS although there are dramatic 
differences in the distribution and appearance of PrPSc between TSE strains. In 
addition there are several pathological forms of PrPSc found within infected brain 
which include, amyloid plaques, diffuse granular staining of the neuropil and 
accumulation around neurons (Bruce et al, 1989b; Jeffrey et al, 1994a; McBride et 
al, 1998). For example, with the 87V strain of scrapie amyloid plaques are frequent 
and abnormal accumulations of PrP in brain are precisely targeted to areas of 
vacuolation (Bruce & Fraser, 1975; Jeffrey et al, 1994a) whereas in the ME7 strain 
of scrapie fewer amyloid plaques are present and PrP pathology is more widely 
distributed throughout the brain(Bruce et al, 1989b; Bruce et al, 1994b). In addition 
to host PrP genotype influencing pathology, in the form of vacuolar changes, the 
deposition of PrP in the brain also appears to be controlled by the PrP gene (Manson 
et al, 1994b). In conjunction with the lesion profile, the specific targeting of PrPSc in 




















1.4 The peripheral lymphoid system in TSE pathogenesis 
 
 
1.4.1 The importance of the lymphoid system in TSE pathogenesis  
Although the main consequence of TSE infection is CNS degeneration, the 
peripheral lymphoid system plays an important role in pathogenesis (Bruce et al, 
2000; Eklund et al, 1967; Fraser & Dickinson, 1978; Mabbott et al, 1998). Following 
infection by peripheral route (e.g. intraperitoneal or oral) most experimental TSE 
agents replicate in spleen and lymph nodes prior to neuroinvasion (Kimberlin & 
Walker, 1979; Kimberlin & Walker, 1989).  During this period there are no clinical 
signs of disease and indeed, the detection of infectivity in spleen precedes that of the 
CNS by many weeks or longer (Dickinson and Fraser 1969; Dickinson 1975; 
Dickinson and Outram 1975).  
 
Notably, some TSEs do not appear to involve or depend on the peripheral lymphoid 
system for pathogenesis. These TSEs include sCJD in humans which does not appear 
to target or infect lymphoid tissues (Gambetti et al, 2003), BSE in cattle (with 
exception of targeting to the distal ileum) (Fraser et al, 1988), and in some classical 
and atypical strains of natural scrapie there appears to be no involvement of 
lymphoid tissues.  
 
This is contrast to sheep experimentally infected with BSE where there is extensive 
lymphoid system involvement (Houston et al, 2000) (Foster et al, 2001a); Hunter et 
al., 2002 ; (Hunter, 2003; Hunter et al, 2002). In addition, humans affected with 
variant CJD have extensive lymphoid tissue involvement with significant levels of 
infectivity being detected in lymph nodes and tonsil 
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(Bruce et al, 2001; Hill et al, 1999a; Hill et al, 1999b).  
 
In studies involving the surgical removal of the spleen (splenectomy) significant 
prolongation of incubation period was observed with both the ME7 and 139A strains 
(Fraser et al, 1992b; Fraser & Dickinson, 1970; Fraser & Dickinson, 1978; Kimberlin 
& Walker, 1989) although this was dependent on route of infection and time of 
splenectomy. When mice were splenectomised prior to or up to 42 days after 
intraperitoneal injection with ME7 a significant prolongation of incubation was 
observed (Fraser & Dickinson, 1978). Splenectomy after this timepoint had no effect 
on incubation period, although it is likely that the spread of disease to the spinal cord 
would have been initiated by this stage of infection. In studies involving 
subcutaneous infection with the ME7 strain the effect on incubation period was 
generally not significant, although under normal circumstances this route of infection 
results in high levels of infectivity in spleen. In addition, intragastric infection of 
splenectomised mice with the 139A strain (Kimberlin & Walker, 1989) did not result 
in prolongation of incubation period.  It is likely that some routes of infection, for 
example the intraperitoneal route, depend more on the presence of the spleen than 
other routes, such as the oral or subcutaneous route. These effects are almost 
certainly related to the sequential infection of specific lymphoid tissues which may 
vary depending on the route of infection. In addition to route of infection, the effect 
of splenectomy is also strain and species dependent. For example, splenectomy has 
no effect on the intraperitoneal infection with 263K in hamsters (Kimberlin & 




1.4.2 Initial attempts to identify the cellular targets for TSE agent replication in 
the peripheral lymphoid system 
 
The recognition that lymphoid tissues contained high levels of infectivity and the 
effects of splenectomy on peripheral pathogenesis demonstrated the important role of 
these tissues in TSE pathogenesis. A series of experiments conducted by Fraser and 
colleagues (Fraser & Farquhar, 1985; Fraser & Farquhar, 1987) (Fraser et al, 1989) 
(Fraser et al, 1992b) suggested that the cell type or types critical for scrapie 
pathogenesis were post-mitotic, long-lived and radiation resistant. In these studies 
mice infected with scrapie via a number of peripheral routes were subjected to a 
variety of sub-lethal and lethal doses of ionising radiation. Mice receiving lethal 
doses of radiation were subsequently reconstituted with isologous bone marrow. 
Thorough analysis of the results of these extensive studies (approximately 70 
experiments in total) concluded that there was no evidence that irradiation altered 
incubation period of disease. In addition, irradiation was found to have no effect on 
the levels of infectivity in lymphoid tissues suggesting that the cells involved in 
replication or accumulation of infectivity were unaffected by ionising radiation.   
 
Studies attempting to elucidate the cellular basis for TSE infectivity in lymphoid 
tissues found that isolation of spleen pulp contained lower levels of infectivity than 
whole spleens (Lavelle et al, 1972). Extrapolation of these studies (Clarke & 
Kimberlin, 1984a) by the separation of scrapie infected spleens into “stromal” or 
“pulp” fractions found that the greatest levels of infectivity (approximately 10 fold 
higher) were within the stromal fraction. It is likely that the stromal fractions would 
have represented splenic capsule, trabeculae and other cell types (described as fixed 
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cells) which may have included dendritic cells, some macrophage populations and 
significantly follicular dendritic cells (FDCs). The pulp fraction is likely to have 
contained lymphocytes, red blood cells, polymorphonuclear cells and possibly some 




1.4.3 Cellular targeting of the normal and disease specific forms of PrP in the 
peripheral lymphoid system 
 
Although it cannot be assumed that cellular expression of PrP means that these cells 
participate in replication, it seems likely that the localisation of PrPc or accumulations 
of PrPSc in specific cell types indicate an involvement in some aspect of the disease 
process. The most widely used methods for detecting PrP protein in tissues are by 
western blot and by immunohistochemistry (IHC). Although western blot can be 
used to distinguish between PrPc and PrPSc, IHC analysis can precisely identify 
which cells are associated with PrP providing important information on the targeting 
of infection in disease pathogenesis.  
 
In mice, PrP protein is associated with FDCs in both uninfected and TSE infected  
mice (McBride et al, 1992; Ritchie et al, 1999). FDCs are non-lymphoid cells, which 
are found within germinal centres of secondary lymphoid follicles where they trap 
antigens in the form of antigen antibody complexes (Kosco et al, 1992).  
 
PrPSc has been also been detected in association with FDCs in the lymphoid tissues 
of sheep with natural scrapie (van Keulen et al, 1996), in elk with chronic wasting 
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disease (Sigurdson et al, 1999) and humans with vCJD (Hill et al, 1997). Whilst PrP 
on FDCs can be detected by IHC (figure 1.1), lymphocytes are also known to express 
PrP on their cell surface (Cashman et al, 1990; Mabbott et al, 1997) although only at 






Figure 1.1.Confocal analysis showing co-localisation between PrP and FDCs. 
Uninfected spleen immunolabelled for PrP protein (green) and FDCs (red). Analysis 










Although there are no specific antibodies which can discriminate between PrPc and 
PrPSc immunohistochemically, the appearance of PrP in infected mice is quite 
different to that of uninfected mice. In spleen from uninfected mice, PrP labelling is 
very diffuse (figure 1.2) whereas the labelling in infected mice is much more intense 







Figure 1.2. Immunohistochemical detection of PrP protein using the PrP specific 
polyclonal antibody (1B3) in spleen from ME7 infected and uninfected (normal brain 
injected). In normal mice accumulations are diffuse, whereas in infected mouse 
spleen aggregates of PrP can be detected. Image from Brown et al 2000.    
 
 









Analysis of spleen from ME7 scrapie infected mice using electron microscopy has 
revealed that PrPSc in the infected spleen is associated with the plasmalemma (Jeffrey 
et al, 2000) of FDCs and also found within tingible body macrophages (Jeffrey et al, 
2000). PrP labelled cells with the appearance of macrophages can also be visualised 







1.4.4 PrP in other extraneural tissues 
 
PrP has also been detected immunocytochemically in several other tissues including, 
kidney, pancreas, salivary gland, adrenal, liver and thymus (McBride et al, 1992) 
(Brown et al, 2000a) although it is unclear what the function of PrP is in these 
tissues. In all of these tissues PrP is localised to specific regions in both uninfected 
and scrapie infected mice but labelling is more intense in scrapie infected mice. PrP 
is found in the cuboidal epithelium of proximal and distal tubules of kidney, 
pancreatic islets of Langerhans and mucous (but not serous) secreting cells of 
salivary gland and in the adrenal cortex, most prominently in the zona fasiculata 
(Brown et al, 2000a). Low levels can sometimes be detected in a proportion of liver 
hepatocytes. In the thymus, PrP labelling is associated with cells in the thymic 
medulla (Brown et al, 2000a; McBride et al, 1992). Although these have not been 
specifically identified, their morphology and distribution suggests that they are 
interdigitating dendritic cells.  In these tissues, therefore, PrP appears to be 
associated with a range of cell types performing different functions, which include 











1.4.5 Effects of immunodeficiency on TSE pathogenesis. 
In most infectious diseases a deficient immune system is often the catalyst for 
effective transmission of disease. For example, immunosupressed individuals, e.g. 
those with human immunodeficiency virus infection, are highly susceptible to 
bacterial and viral infections, such as the influenza virus.  
 
Paradoxically, the pathogenesis of peripherally acquired TSE infection appears to be 
dependent on a functional immune system. Severely combined immunodefcient 
(SCID) mice lack B and T lymphocytes and carry a mutation which blocks the 
rearrangement of immunoglobulin and T cell receptor genes; resulting in a profound 
deficiency of both T and B lymphocytes. In addition to their defects in lymphocyte 
maturation they lack mature follicular dendritic cells (FDCs), although these cells are 
still present in lymphoid tissues in an undifferentiated form (Kapasi et al, 1993; 
Kapasi et al, 1998). As FDCs are dependent on B and T lymphocytes for their 
maturation these cells remain in an immature state in SCID mice.  
 
SCID mice are resistant to peripheral infection with moderate doses of the ME7 
strain (Fraser et al, 1996; Lasmezas et al, 1996; O'Rourke et al, 1994) although, the 
effect of the scid mutation on TSE pathogenesis can be completely reversed 
following isologous bone marrow reconstitution which also leads to maturation of 
FDCs (Fraser et al, 1996) (figure 1.3). SCID mice are also resistant to challenge with 
the BSE agent using a combination of peripheral and intracerebral (i.c.) infection 
(Brown et al, 1997). As SCID mice are fully susceptible to direct i.c. infection with 
mouse passaged TSE agents these results produced strong evidence that an intact 
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lymphoid system is essential for effective cross species infection. It is possible that 
some form of “obligatory” processing of infectivity occurs in the peripheral 
lymphoid system prior to neuroinvasion when TSE agents are transmitted across 
species. 
 
Interestingly, further studies using a range of challenge doses of the ME7 strain 
found that SCID mice were fully susceptible to high dose peripheral challenge, 
although there was no detectable infectivity or accumulation of PrPSc in spleen. The 
striking effects of dose on the pathogenesis of scrapie in SCID mice most probably 
result from direct infection of the peripheral nerves in lymphoid tissues at high dose, 
with neuroinvasion occurring independently of lymphoid tissue involvement. 
 
  
Figure 1.3 Resident FDCs can be induced to mature in SCID mice following bone 
marrow transplantation from isologous donors. Images show expression of the MFG-
E8 receptor upon FDCs as recognised by the monoclonal antibody FDC-M1 
(Kranich et al, 2008) 
SCID no bone marrow   SCID + bone marrow  
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1.5 Involvement of Follicular dendritic cells in TSE pathogenesis. 
1.5.1 The origin of FDCs 
Follicular dendritic cells are a specialised population of cells found within the 
primary and secondary follicles of the lymphoid tissues (Kosco-Vilbois et al, 1997; 
Kosco et al, 1992). FDCs have the ability to trap and retain antigens in the form of 
antigen-antibody complexes on the surface of their extensive cytoplasmic processes 
for long periods of time. The presence of these antibody complexes are thought to 
play a pivotal role in the development of B cell memory. FDCs express complement 
receptor CR1 and CR2 which are expressed as soon as primary follicles occur (Ierna 
et al, 2006). These receptors bind C3 coated immune complexes, enhancing and 
maintaining the immune response.  
 
The origin of FDCs has been the subject of much debate. Most studies point to a 
stromal/fibroblastic and not a haematopoietic origin, although the subject remains 
controversial. Initial studies conducted by Humphrey and Sundaram (Humphrey et 
al, 1984) found that transfer of allogenic bone marrow into irradiated recipient mice 
detected only FDCs of host origin. Critics of these studies suggested that failure to 
detect donor derived FDCs was a result of low turnover of host cells. Further studies 
in SCID mice found that host FDC maturation could be induced by reconstitution 
with lymphocytes or other haematopoietic  sources (bone marrow) suggesting that 




The most prominent studies suggesting that FDC could be derived from bone 
marrow were conducted by Kapasi and colleagues (Kapasi et al, 1998). In these 
studies newborn SCID mice were reconstituted with rat bone marrow. Several weeks 
later FDCs of rat origin were detected using the monoclonal antibody ED-5 which 
recognises only FDCs of rat origin. However, controversy still exists over the 
possibility that FDCs can be derived from the bone marrow or other haematopoietic 
sources. It is possible that the expression of the ED-5 marker was in-fact transferred 
from the bone marrow derived cells to the host, resident precursor FDCs. A recent 
study where human cord blood was grafted into recipient RAG-2 mice found no 
evidence of human FDC development in lymphoid tissues although murine FDCs 
from the recipient of the graft were induced to mature in the presence of lymphocytes 
of human origin (Traggiai et al, 2004).  
 
1.5.2 Follicular dendritic cells and the germinal centre micro-environment 
 
FDCs are found within the organs of the secondary lymphoid tissues which include 
the spleen, lymph nodes and the Peyer’s patches of the gut. In an inactive state 
(before exposure to antigen) FDCs are found within the primary follicle in these 
lymphoid tissues and following exposure to antigen form germinal centres which 
contain FDCs, B cells, and helper CD4+ T cells. FDCs secrete chemokines which 
result in the recruitment of these cells to form the germinal centre (Kosco-Vilbois, 
2003; Kosco-Vilbois et al, 1997; Kosco et al, 1992). A number of studies of germinal 
centers in vivo indicate that the germinal centre is a dynamic environment facilitating 
many important processes; including immunoglobulin (Ig) class switching, rapid B 
cell proliferation, production of B memory cells, selection of somatically mutated B 
cells with high affinity receptors, apoptosis of low affinity B cells and affinity 
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maturation of B memory cells (Kosco-Vilbois, 2003; Kosco et al, 1992). A major 
function of FDCs is to trap and retain immune complexes on their extensive 
cytoplasmic processes in order to maintain and perpetuate immunological memory 
(Ahmed & Gray, 1996; Gray, 2002; Gray & Matzinger, 1991; Gray & Skarvall, 
1988).  FDCs are thought to trap these immune complexes via cell surface receptors 
including the complement and complement receptors, CR2 (CD21) and CR1 (CD35) 
and through the Fc receptors, FcRIIb (CD32) and FcRII (CD23) (Balogh et al, 2001; 
Qin et al, 2000).  In the germinal centre activated FDCs express a number of markers 
which are not expressed on these cells in their naïve state. These receptors include 
the vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion 
molecule-1 (ICAM-1) (Videm & Albrigtsen, 2008).  
 
1.5.3 The use of chimaeric mouse models to elucidate the role of FDCs  
Although previous studies provided strong evidence that FDCs were involved in TSE 
pathogenesis (Fraser et al, 1996; Fraser & Farquhar, 1987; Fraser et al, 1989) the 
data generated could not exclude the potential involvement of other cell types, 
particularly B lymphocytes. In studies attempting to elucidate the role of these cells 
chimaeric mouse models were produced where FDCs but not lymphocytes would 
carry the PrP gene and vice-versa (Brown et al, 1999). 
 
The production of these models was achieved by exploiting the unique characteristic 
of FDCs; namely their radiation resistance and the fact that these cells are not 
derived from the bone marrow. Although the ultimate origin of FDCs remains 
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controversial it is generally accepted that FDCs are not replaced from the bone 
marrow in adult mice. 
 
To construct the chimaeric models described above, lethally irradiated PrP+/+ or PrP-/- 
deficient and unirradiated SCIDPrP+/+ or SCIDPrP-/- mice were reconstituted with 
bone marrow from PrP+/+ or PrP-/- mice. Bone marrow grafting produces 
lymphocytes of donor origin whereas the FDCs are derived from the host.  
 
In studies with the ME7 strain of scrapie neuroinvasion and replication of infectivity 
in spleen only occurred when FDCs expressed PrP, irrespective of the expression of 
PrP on surrounding lymphocytes (Brown et al, 1999). Moreover, the expression of 
PrP on FDCs in uninfected or ME7 infected mice was only detected when FDCs 
carried the PrP gene (Brown et al, 1999). 
 
In addition, replication of infectivity in spleen only occurred in mice with PrP 
expressing FDCs which was again, not dependent on the PrP status of the graft. No 
replication of infectivity was detected in spleens of PrP deficient mice even when 
reconstituted with PrP expressing bone marrow (figures 1.5 and 1.6). 
 
Although these studies produced compelling evidence for a critical role for FDCs in  
TSE pathogenesis similar studies by another group using the RML strain found 
different results from those described above (Blattler et al, 1997). In these studies, 
replication of infectivity could be detected in spleens of PrP deficient mice grafted 
with PrP expressing bone marrow or fetal liver (Blattler et al, 1997).  These studies 
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led the researchers to initially conclude that cells of haematopoietic origin (most 
probably lymphocytes) and not FDCs were critical for TSE pathogenesis. The 
contrasting results of these studies led to the suggestion that different TSE strains 
may target different cell types as they are known to do in the CNS (experimental 
studies are described in chapter 4). Alternatively, it was suggested that technical 
differences in the way the studies were carried out; for example different doses, 



































Figure 1.5. Immunolabelling for PrP (using the 1B3 antibody) or FDC networks in 
(using the FDC-M1 antibody) in spleens from uninfected mice 28 days post bone 
marrow reconstitution. FDC networks are well developed in all of the spleens (lower 
panel) but PrP protein associated with FDCs is only present when the recipient of the 
graft carries a functional PrP gene (upper panel). Scale bar represents 100µm. From 
Brown et al 1999 
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Figure 1.6.  Immunolabelling for PrP (using the 1B3 antibody) or FDC networks in 
(using the FDC-M1 antibody) spleens from bone marrow reconstituted mice 10 
weeks post ME7 infection. FDC networks are well developed in all spleens (lower 
panel) but PrP associated with FDCs (lower panel) is only present when the recipient 
of the graft carries a functional PrP gene. This labelling is more intense and granular 
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1.5.4 The use of transgenic mice to determine the key cell types involved in TSE 
pathogenesis in lymphoid tissues. 
 
Transgenic mice lacking specific cell types have been used to further explain the role 
of specific cell types in the peripheral pathogenesis of TSEs. The presence of the 
tumour necrosis factor α (TNF-α), which signals through TNF-receptor 1/p55 (TNF-
R1) (Tkachuk et al, 1998) is essential for the maturation of FDCs. In studies with the 
RML strain disease pathogenesis was severely impaired in transgenic mice deficient 
in B lymphocytes (Klein et al, 1997; Klein, 1998), whereas transgenic mice lacking 
FDCs as a result of deficiencies in tumour necrosis factor signalling appeared to be 
fully susceptible to infection. As a result of these findings it was initially concluded 
that B cells were critical for TSE pathogenesis (Klein et al, 2001; Montrasio et al, 
2000). There were a number of difficulties in interpreting the above studies; firstly, B 
cell deficient mice also lack mature FDCs and secondly; no information on the levels 
of infectivity in lymphoid tissues of the TNFR1-/- mice were given. Without knowing 
if the lymphoid tissues of the TNFR1-/- mice contained infectivity the possibility 
exists that neuroinvasion in these mice could have occurred in the absence of 
lymphoid tissue involvement as is known to happen in high dose infection of 
immunodeficient mice (Fraser et al, 1996). In studies carried out with the ME7 strain 
of scrapie however, TNF-α deficient mice, were almost resistant to peripheral 









1.5.5 Effects on disrupted lymphotoxin signalling on peripheral TSE 
pathogenesis following the temporary inactivation of FDCs 
 
Tumor necrosis factor (TNF) family members such as TNF  and lymphotoxin are 
important in the development and maintenance of follicular dendritic cell function 
via membrane bound lymphotoxin (LTα/β), whose signal is mediated through the 
LTβ receptor (LTβR) (Endres et al, 1999). The lymphotoxin signalling pathway can 
be disrupted via the administration of LT beta R-Ig (Tumanov et al, 2003). This 
results in the de-differentiation of FDCs within 72hours, an effect which is 
maintained for approximately 28 days. This technique has been used in a number of 
studies providing a unique opportunity to examine the role of FDCs at specific points 
during peripheral infection. 
 
When LTβR signalling was disrupted, via a single dose of LTβR-Ig, prior to, or up 
until 42 days post intraperitoneal infection with the ME7 strain; incubation period of 
disease was significantly extended (Mabbott et al, 2000a) (Mabbott et al, 2003). 
Moreover, accumulation of infectivity and PrPSc in spleen was also impaired by this 
treatment. Similar results were also seen with the RML TSE strain (Montrasio et al, 
2000). Treatment with LTβR-Ig prior to oral ME7 scrapie infection blocked PrPSc 
accumulation in Peyer's patches and mesenteric lymph nodes and prevented 
neuroinvasion (Mabbott et al, 2003). However, treatment 14 days after oral 
inoculation did not alter incubation period or susceptibility to infection, suggesting 






1.5.6 Effect of complement depletion on TSE pathogenesis 
 
The Nobel prize was awarded in 1919 to Jules Bordet for his discovery of the 
complement system. The complement system is a complex enzyme cascade made up 
of numerous serum glycoproteins that normally exist in an in-active, proenzyme 
form (Carroll, 2004). These proteins circulate in an inactive form, but in response to 
the recognition of molecular components of microorganisms, one of two pathways is 
activated to respond to the invading micro-organism (Nizet, 2007). These pathways 
comprise the classical and alternative pathway. The classical pathway is triggered by 
activation of the C1-complex either by antibody binding of C1q to IgM or IgG or by 
directly binding C1q to the surface of the pathogen. The central component of both 
the complement system is C3. C3 is an abundant serum protein which contains an 
unusual internal thiolester bond. In native C3 this bond is stable but this thiolester 
bond can become highly reactive as a result of conformational changes in the C3 
protein structure. Generally the activation of C3 comes about as a result of 
proteolytic cleavage of the C3 molecule into 2 biologically active fragments. 
Initiation of the alternative pathway relies on the generation of an activated C3 
molecule. There are various ways in this initiating activated C3 can be generated. 
These include proteolysis by enzymes derived from bacteria themselves and, via 
blood clotting enzymes, injury. However activation of C3 can occur spontaneously.  
 
One of the most characteristic features of FDCs is their ability to trap and retain 
antigen for extended periods of time (Humphrey et al, 1984)  (Kosco-Vilbois et al, 
1997; Kosco et al, 1992). This trapping of immune complexes can be mediated via 
the complement system or via other receptors, such as Fc receptors which are 
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expressed on the surface of the FDC. However, depletion of Fc-gamma receptors or 
circulating immunoglobulins had no effect on the peripheral pathogenesis of the 
RML scrapie isolate (Klein et al, 2001). However the effects of complement 
depletion on the peripheral pathogenesis of both the RML and ME7 scrapie agents 
are striking (Klein et al, 2001; Mabbott et al, 2001). In mice temporarily depleted of 
complement component C3 via the administration of cobra venom factor; incubation 
period of disease was significantly extended in comparison with control mice 
(Mabbott et al, 2001). Moreover incubation period was also extended in transgenic 
mice with deletions in C1q or with dual deletions of Factor B and C2 (Klein et al, 
2001). The most significant prolongation of incubation period was seen in the C1q 
deficient mice (Klein et al, 2001; Mabbott et al, 2001). The results of these studies 
suggest that the activation of specific complement components may be involved in 
the initial trapping of TSE in lymphoreticular organs early after infection. Further 
studies investigating the effect of complement C5 deficiency on pathogenesis found 
no effect on incubation period of disease suggesting the functional aspects of C5 do 
not impact on TSE pathogenesis (Mabbott & Bruce, 2004). 
 
 
1.6 Transport of infectivity and neuroinvasion 
 
 
1.6.1 Transport of infectivity from sites of infection to peripheral lymphoid 
tissues  
Although it appears that FDCs play a key role in accumulating or replicating 
infectivity within the germinal centres of the lymphoid follicles how TSE agents are 
transported to these cells is not fully understood.  
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Many TSE agents, including BSE, natural scrapie, CWD and vCJD, are acquired via 
oral exposure (most probably ingestion) to infectious agents. Other potential routes 
of TSE infection in natural situations may include infection via the skin, for example 
in transmission of kuru; skin scarification in experimental models of infection is an 
efficient method of transmission of disease (Taylor et al, 1996).  
 
In the gastrointestinal tract a number of cell-types; including dendritic cells (DC), 
have been postulated as potential candidate cells for the transport of infectivity 
(Huang et al, 2002; Huang & MacPherson, 2004; Raymond & Mabbott, 2007). 
Migratory DCs differ from FDCs in their haematopoietic origin and their mobility, 
while FDCs reside within the germinal centre and are thought to be of a stromal 
rather than bone marrow origin.  
 
There have been a number of studies investigating the possible role of conventional 
DCs in transportation of TSE agent infectivity. In vitro studies suggest that the PrP 
fragment 106–126 can act as a chemoattractant for monocyte-derived DCs (Le et al, 
2001). DCs have been shown to acquire PrPSc in vitro and a sub-population of 
migrating DCs can acquire and transport PrPSc from the gut lumen through the 
lymphatics to lymphoid tissue (Huang et al, 2002; Huang & MacPherson, 2004). In 
these studies the uptake of PrPSc from the gut lumen was restricted to DCs and not 
detected in other lymph cells or cell-free lymph (Huang et al, 2002). Interestingly 
pathogenesis studies investigating the role of DCs in transmission of TSE agent 
infectivity demonstrated contrasting findings.  In one study the presence of infected 
CD11c+ splenic DCs alone resulted in neuroinvasion when they were injected 
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systemically into immunodeficient RAG-1 mice (Aucouturier et al, 2001). However, 
it is possible that the high dose of TSE agent used in these studies may have 
bypassed the need for lymphoreticular system involvement, as is known to occur in 
SCID mice (Fraser et al, 1996). However in a more recent study, (Raymond & 
Mabbott, 2007) CD11c+ splenic DCs were unable to efficiently transmit TSE disease 
directly to the peripheral nervous system (PNS) of FDC-deficient TNFR1−/−mice 
(Raymond & Mabbott, 2007). These findings differ significantly from the study 
described above (Aucouturier et al, 2001). In another study, migration of dendritic 
cells into the brain was demonstrated following infection with a  mouse-adapted GSS 
strain was detected (Rosicarelli et al, 2005). More recently studies in mice with 
alterations in DC migration and tissue localisation found some minor effects on the 
transmission of infectivity via subcutaneous but not oral routes. These studies 
however did appear to find evidence that DCs may contribute to neuroinvasion as 
injection of infected live DCs produced shorter incubation periods than identical 
studies using dead DCs (Levavasseur et al, 2007)  
 
In the skin, Langheran cells (LC) have been postulated as potential candidates for the 
transport of TSE infectivity to the lymphoid tissues. LCs play an important role in 
the immune defences of the skin where they trap antigen and transport it to the skin-
draining lymphoid organs, where the recruitment of antigen-specific T cells occurs. 
LCs require specific stimulation for their migration in sites in the skin to the draining 
lymph node. One such pathway is the CD40-CD40L signalling pathway which is 
involved in the regulation of this process. Studies in transgenic mice deficient in 
CD40 ligand found that transmission of infectivity via the skin was unaffected in 
 54
these mice, and was in-fact significantly shorter than wild-type mice (Mohan et al, 
2005a). Results of these studies show that neuroinvasion via the skin was not 
dependent on migratory LCs and the fact that LCs can degrade PrPSc in-vitro may 
suggest that LCs may contribute to the “clearing” of infectivity (Mohan et al, 2005b) 
following infection in a similar way to macrophages (Beringue et al, 2000).  
Moreover a role for conventional DCs in TSE agent pathogenesis has been described 
as disease pathogenesis is impaired in mice where splenic DCs were depleted 






1.6.2 Mechanisms of neural spread from the peripheral lymphoid system to the 
CNS 
 
Understanding how TSE agents infect the brain (neuroinvasion) has been of critical 
importance as determining the key events in this process may allow the development 
of therapeutic approaches to these diseases. The vast majority of experimental TSE 
strains can be transmitted to rodents via peripheral routes which have provided 
opportunities to determine the mechanisms of transport and spread of infectivity. 
Initial studies investigating the neural spread of the 139A strain following 
intraperitoneal, intravenous or subcutaneous infection found that there appeared to be 
a common neuroinvasive pathway from visceral lymph nodes and spleen along 
visceral autonomic nerves to the mid thoracic cord (Kimberlin et al, 1987; Kimberlin 
& Walker, 1989). Once replication of infectivity was initiated in the thoracic cord 
there was a gradual spread of infection throughout the CNS. In some models, for 
example the 263K strain in hamsters, neuroinvasion appears to occur very rapidly, 
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with extremely short incubation periods of approximately 65days. In this model 
splenectomy has no effect on the incubation period of disease following 
intraperitoneal infection suggesting that the spleen is not critical for neuroinvasion in 
this model (Kimberlin & Walker, 1986).  
Although it is accepted that the spread of infection from peripheral sites to the brain 
occurs primarily along neural routes some studies have suggested that 
haematogenous spread may also occur in TSE infection. This has been primarily 
demonstrated in the 263K hamster model where infectivity in blood could be 
detected for at least 40 days after intraperitoneal infection (Diringer, 1984) 
In more recent studies mapping of the deposition of PrPSc in hamsters following oral 
263K infection found that PrPSc accumulated, in a defined temporal sequence, in 
sites that accurately reflected known autonomic and sensory relays. This data 
confirmed that the infectious agent primarily uses synaptically linked autonomic 
ganglia and efferent fibers of the vagus and splanchnic nerves to invade initial target 
sites in the brain and spinal cord (Beekes et al, 1996; Beekes et al, 1998) (Beekes & 
McBride, 2000) (McBride et al, 2001).  
 
1.7. The influence of the immune system on TSE pathogenesis 
1.7.1 The host response to TSE infection 
Previous studies carried out many years ago failed to find evidence of a classical 
immune response to scrapie infection (Chandler, 1959; Clarke, 1968; Clarke & Haig, 
1966; Pattison et al, 1964). One hypothesis for this phenomenon was that infection 
with the scrapie agent resulted in immunosupression, although little evidence has 
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been found to support this (Clarke, 1968; Gardiner & Marucci, 1969; Garfin et al, 
1978a; Garfin et al, 1978b).  
 
Although there is no evidence for a classical immune response to TSE infection 
(Chandler, 1959; Clarke & Haig, 1966), studies investigating immunoglobulin (Ig) 
levels in sheep from flocks with a high incidence of natural scrapie found that these 
were greatly elevated during the clinical phase of disease (Collis et al, 1979). Further 
studies in sheep experimentally infected with the SSBP/1 strain of scrapie found 
similar results (Collis & Kimberlin, 1983)  and demonstrated that IgG, specifically 
IgG2 was the major Ig sub-class present in the sheep sera. At the time of these 
studies very little was known about the importance of the peripheral lymphoid 
system, or of cells such as FDCs in TSE pathogenesis. It may be that these 
alterations in Ig levels are the result of a TSE induced immune system dysfunction, 
perhaps in cells such as FDCs, which are involved in the regulation of immune 
responses, such affinity selection of B cells. However, it has been suggested that the 
increase in immunoglobulin levels in sheep with natural scrapie is a result of pruritus 
leading to infection and the generation of an immune response (Nora Hunter 
personal communication)   
 
1.7.2. Effects of age on pathogenesis 
Early studies on the influence of age on TSE pathogenesis found that neonatal mice 
were partially resistant to peripheral infection with doses of infectivity that normally 
produced disease in adult mice with 100% efficiency (Ierna et al, 2006 ; Outram et 
al, 1973). In addition, incubation periods in those neonatal mice that did develop 
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disease had a wider incubation period range than those of the older animals. 
Susceptibility to scrapie was restored approximately one week after birth (Outram et 
al, 1973).  In more recent studies this effect on pathogenesis was again observed in 
neonatal mice with the increase in susceptibility with age correlated with the first 
immunohistochemical detection of PrPc, on maturing follicular dendritic cell 
networks (Ierna et al, 2006) (table 1.3) 
 
 
Table 1.3. Neonatal mice are less susceptible to peripheral TSE challenge  
Age at time of inoculation   Susceptibility to infection 
    
 
0-1day       approximately 33% 
10 days      100% 
Extracted from Outram et al 1973 and Ierna et al 2006 
 
Interestingly, lymphoid tissues are more mature at birth in sheep, cattle and humans 
than in mice, suggesting that in species in utero infection with scrapie-like agents is 
theoretically possible in these species. The effect of age appears to be a widespread 
phenomenon and includes BSE in cattle and natural scrapie of sheep. 
Epidemiological evidence indicates that most cattle developing BSE were infected as 
calves (Arnold & Wilesmith, 2004).  Similarly, it has been suggested that young 
lambs are more susceptible than adults to natural infection with scrapie (Elsen et al, 
1999). In addition, since vCJD was first identified, clinical disease has occurred 
predominantly in young adults, suggesting that age-related factors and/or levels of 
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exposure to BSE may influence susceptibility.  In mammals it is widely accepted 
that ageing leads to a gradual decline in immune function (Koch et al, 2006) and the 
term “immunosenescence” can be used to describe these collective alterations in 
immune function. Ageing leads to increased rates of mortality in response to 
infection; for example, pneumonia is more prevalent in the elderly than in younger 
adults (El-Solh et al, 2001). The effects of age on immune function can also be 
demonstrated in responses to vaccination which are notably less effective in the old. 
Aged humans are also more susceptible to cytomegalovirus (Koch et al, 2006) and 
influenza infection. In addition re-current infections such as Varicella zoster (Laube, 
2004) are more prevalent in aged individuals. Ageing is also associated with 
increased rates of some cancers which is thought to be linked to immune system 
dysfunction (Shurin et al, 2007). As cases of vCJD have occurred almost exclusively 
in young adults it is possible that the decline in immune and in FDC function in 
older individuals may provide some explanation for the incidence of clinical vCJD in 
young adults.  The potential influences of old age (senescence) on TSE pathogenesis 











Chapter 3. To further elucidate the role of follicular dendritic cells (FDCs) in the 
peripheral pathogenesis of the ME7 strain of scrapie. 
 
Chapter 4. To determine the cell type or types in the peripheral lymphoid system 
that are important for the peripheral pathogenesis of a range of experimental TSE 
strains.  
 
Chapter 5. To determine the influence of an ageing immune system, using senescent 
mice, on the peripheral pathogenesis of the ME7 strain of scrapie. 
 
Chapter 6. To determine if the generation of a humoral immune response alters or 
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2.1. Mouse strains 
A range of inbred mouse strains were used in these studies. Mouse lines were 
maintained in a conventional animal facility with a 12 hour (h) light and 12 h dark 
cycle under specific pathogen free conditions at the Neuropathogenesis unit (NPU) 
with access to food and water at all times. In some cases immunodeficient mouse 
lines were maintained in positive pressure isolators or in individually ventilated 
cages (IVC).  
 
Mice were normally used between 6 and 8 weeks of age and individual experiments 
were age-matched.  In some studies aged mice were used as part of the experimental 
design. 
All mice used in these studies were individually identified from ear punches which 
relate to individual mouse records.  All experiments were conducted under an 
appropriate home office project licence (PPL 60/2528, PPL 60/3324 held by Karen 
Brown) within the regulations of the Animals (Scientific Procedures) Act 1986.  All 
individual experiments were scrutinised by the Neuropathogenesis Unit’s ethical 
review process prior to commencement. 
 
2.1.1 Immunocompetent wild-type mouse strains 
 
C57BL/Dk 
This mouse strain has been extensively used at the Neuropathogenesis Unit (NPU), 
Edinburgh for nearly 40 years. The line C57BL/Dk, is a sub-strain of C57BL and 
carries the a allele of the PrP gene (Prnp). The C57BL/Dk line, hereafter referred to 
as C57BL has been used extensively in TSE transmission studies and as indicator 
mice in incubation period bioassays to determine scrapie infectivity titres.  
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129/Ola and PrP deficient lines of mice 
The 129/Ola mouse strain was used as a background strain for the generation of 
Prnp-/- mice.  The PrP deficient mouse model (Prnp-/- mice) was generated on the 
129/Ola mouse background by insertion of a neomycin resistance cassette into exon 
3 of the Prnp gene (Manson et al, 1994a). 
 
C57BL/6 
C57BL/6 is a widely used inbred strain. In these studies this line was used as 
experimental controls for the TNF receptor 1 deficient (TNFR1-/-) (Rothe et al, 1993) 
and the B cell deficient (µMT) (Kitamura et al, 1991) mice as these transgenic lines 
were produced on this genetic background. 
 
CB20 (CB20+/+ congenic BALB/c) 
CB20 mice were obtained as a kind gift from Professor John Ansell, Edinburgh 
University. These mice were used as experimental controls for the severe combined 
immunodeficient (SCID) mouse line in our TSE transmission studies.  
 
2.1.2 Immunodeficient mouse lines: SCID, SCID-Prnp+/+and SCID-Prnp-/-mice 
SCID (BALB/c CB17 scid/scid) 
SCID mice have an autosomal recessive mutation (scid) which is located on 
chromosome 16. Mice carrying this mutation fail to produce detectable 
immunoglobulin as a result of impaired B and T cell production and are severely 
immunodeficient (Bosma et al, 1983). SCID mice were obtained as a kind gift from 




The SCID-Prnp+/+ and SCID-Prnp-/- mouse lines were originally produced as 
described by Brown et al (Brown et al, 1999), by crossing SCID mice (C.B-17 
scid/scid, MHC type H-2d) with Prnp-deficient mice (129/Ola Prnp-/- mice, MHC 
type H-2b) (Manson et al, 1994a).  Full details are provided in appendix I. 
 
2.1.3 Genetically altered immunodeficient mouse lines: µMT and TNF-R1-/- 
The µMT mouse line (Kitamura et al, 1991), which lacks mature B lymphocytes, and 
as a consequence follicular dendritic cells, was obtained as a kind gift from Imperial 
College London. This mouse line was originally produced by gene targeting in 
mouse embryonic stem cells by disrupting membrane exons of the gene encoding the 
mu-chain constant region (Kitamura et al, 1991). Tumour necrosis factor receptor 1 
deficient mice (TNFR1–/– )  were obtained from Imperial College London, UK. This 
mouse line was originally produced by gene targeting in embryonic stem cells (Rothe 
et al, 1993) Mice deficient in TNFR1 fail to develop mature FDC networks although 
affinity maturation of lymphocytes, in the absence of germinal centre development, 
still occurs.  
 
2.1.4 Husbandry of mice with immunodeficiencies 
Breeding of SCID mice was carried out in positive pressure isolators to minimise the 
risk of infection to the breeding stock. Experimental mice were maintained in open 
housing or in IVC cages. In the case of the SCID-Prnp+/+ and SCID-Prnp-/- mouse 
lines breeding was initially performed in open housing, however mice were highly 
susceptible to intercurrent infections. To counteract this problem breeding pairs were 
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reconstituted with histocompatible bone marrow from 129/Ola mice via intravenous 
(i.v.) injection.  
 
2.2 Generation of SCID-Prnp+/+ and SCID-Prnp-/- mouse lines 
 
2.2.1 Breeding strategies for selection of the SCID-Prnp+/+ and SCID-Prnp-/- 
mouse lines 
To produce the SCID-Prnp+/+ and SCID-Prnp-/- mouse lines, SCID mice were 
crossed with PrP deficient mice. The resulting progeny were crossed together (F1 
cross) and mice from the subsequent F2 generation selected for the SCID phenotype, 
MHC type H-2b and either the Prnp+/+ or Prnp-/- genotype.   
 
2.2.2 ELISA for the detection of serum immunoglobulin 
Progeny from the F2 generation (2.2.1) were analysed for the SCID phenotype by 
quantitating total serum immunoglobulin by ELISA. Mice were bled from the tail 
under halothane anaesthesia. A portion of tail was removed using a sterile scalpel 
and 50-100µl of blood removed for serum production. Tails were cleaned and sealed 
using a veterinary sealant “vet-seal” (Jorgensen Laboratories, Inc). Tail tips from 
each animal were retained for genotype analysis. Serum was produced by allowing 
blood samples to remain at room temperature for 30 minutes, followed by storage at 
4º C for approximately 24 hours. Serum was removed and stored at -40ºC until 
required. For detection of immunoglobulin levels sera was diluted (1/1000) in 
carbonate bicarbonate buffer (0.5 M, pH 5: Sigma) and adsorbed onto flat bottomed 
microwell plates by overnight incubation at 4°C.  Additional positive (CB20 serum) 
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and negative (SCID serum) control samples were also adsorbed onto the plates. 
Following incubation, plates were blocked with 0.01 M PBS (pH 7.5) containing 1 % 
bovine serum albumin (BSA).  Immunoglobulin was detected using a horseradish 
peroxidase conjugated rabbit anti-mouse Ig (DAKO, Cambridgeshire, UK) diluted 
1/1000 in PBS.  Plates were incubated for 3 h at room temperature and washed 3 
times. Bound peroxidase activity was measured by incubation with o-
phenylenediamine as a substrate (Sigma, UK), stopping the reaction with 3N HCL.  
Optical density (OD) was measured at 490 nm using a V-max kinetic microplate 
reader (Molecular devices, CA, USA).   
 
2.2.3 Flow cytometry and selection of H-2 type 
Mice identified as having a SCID phenotype were bled from the tail as described in 
2.2.2 and 150-250µl of blood collected into heparinised tubes to prevent clotting.  
Blood samples were pelleted by centrifugation and red cell lysis performed by 
subjecting the cells to distilled water shock for 10 seconds, stopping the reaction with 
an equal volume of a balanced salts solution. Cell suspensions were labelled with 
antibodies directed against mouse H-2Db or H-2Dd histocompatibilty types (BD 
Biosciences, UK) as described in appendix II. Animals identified as having a 
histocompatibility type H-2Db were genotyped as described below. Animals with a 
histocompatibility type H-2Dbd or H-2Dd were humanely sacrificed. 
 
2.2. 4 Southern blot analysis for selection of Prnp genotype 
Mice identified as having both a SCID phenotype and histocompatibility type H-2Db 
were subjected to genotype analysis by Southern blot analysis (appendix I). 
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Previously collected tail samples were used to prevent further procedures. Mice with 
a Prnp+/+ genotype were designated SCID-PrP+/+ and mice with a Prnp-/- genotype 
were designated SCID-PrP-/-. Breeding pairs of each strain were constructed and 
lines of inbred mice of each strain produced for experimental studies 
 
2.3 Production and characterisation of chimaeric mouse models  
2.3.1 Whole body gamma irradiation.  
For the production of bone marrow chimaeras in immunocompetent mice lethal
doses of ionising radiation were used. The standard lethal dose for
immunocompetent mice was 9.5 Grays (Gy). The time of exposure was calculated
from previously established radiation dosimetry and adjusted accordingly for ½ life
loss. Mice were placed (3/holding cage) on a rotating turntable in an irradiator
(Gravatom Engineering Systems Ltd, UK) and exposed to ionising radiation from a 
Caesium137source for the appropriate time. Mice were returned to sterile filter top
cages with free access to food and water and the cages aseptically sealed to





2.3.2 Bone-marrow reconstitution  
Immunocompetent 129/Ola or PrP-/-mice were lethally irradiated, as described above, 
approximately 18 h prior to bone marrow transfer.  SCID-Prnp+/+ and SCID-Prnp-/- 
did not require irradiation prior to bone marrow challenge. Bone marrow from the 
femurs and tibias of adult 129/Ola or PrP-/- mice was prepared as a single cell 
suspension to an approximate concentration of 1-3 x107cells/ml in Hanks Balanced 
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Salts solution (HBSS, Invitrogen, UK). Recipient mice were warmed on a heat pad 
for approximately 30 minutes prior to cell transfer to ensure successful intravenous 
(i.v.) injection. Mice were anaesthetised with halothane and 0.1ml injected i.v. into 
the tail vein, if this was unsuccessful mice were injected intraperitoneally (i.p.). For 
the reconstitution of SCID mice with CB20 bone marrow the methods described 
above were used. 
 
2.3.3 Maintenance and characterisation of bone marrow chimaeras 
Following bone marrow transfer mice were maintained for a period of 28 days before 
commencing further experimental studies. This time period was shown to be 
essential for successful reconstitution (Brown et al, 1999) (Brown et al, 2000b). 
Irradiated mice were maintained in filter top cages and cleaned in a laminar flow 
cabinet to minimise the chances of infection. Bone marrow reconstituted 
immunodeficient mice were maintained in conventional open housing. To determine 
the success of the reconstitution immunodeficient mice were bled before and after 
bone marrow reconstitution (28 days post transfer), as described previously. Serum 
was produced to quantitate immunoglobulin levels. Further characterisation to 








2.4 TSE strains and experimental TSE challenge 
 
2.4.1 Experimental TSE strains 
In the majority of these studies the ME7 scrapie stain was used (Zlotnik & Rennie, 
1965). This strain has been used extensively at NPU and has been well characterised. 
For the study of the peripheral lymphoid system this strain is particularly useful as it 
has extensive involvement of these tissues (Fraser et al, 1992b). These studies also 
used the 79A and 139A strains, which were derived from the “chandler” isolate as 
described in chapter one and chapter four (Chandler, 1961; Chandler, 1962; 
Dickinson et al, 1986). The BSE derived strain 301C was also used (Bruce et al, 
1994a; Bruce et al, 2002). According to experimental design of the study uninfected 
control tissues, brain or spleen were used as control tissue homogenates for injection.  
 
2.4.2 Routes of TSE agent inoculation 
Intracerebral injection 
Mice were anaesthetised with halothane and 20µl of tissue homogenate injected 
intracerebrally (through the mid-temporal cortex) using a 1ml syringe fitted with a 26 
gauge (G) needle. Following recovery individually coded mice were returned to 




For oral infection mice were housed individually in cages containing a single food 
pellet inoculated with 50µl of a 10% ME7 brain homogenate. Following successful 
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ingestion of the pellet mice were coded and returned to their holding cages for the 
duration of the study.  
 
Intraperitoneal injection 
For intraperitoneal (i.p.) infection with TSE agents or normal brain homogenates 
mice were injected into the abdomen with 20µl of tissue homogenate using a 1ml 
syringe fitted with a 26G needle. Anaesthetic was not normally used.  
 
2.4.3 Clinical scoring of TSE and incubation period of disease 
Following TSE challenge mice were monitored daily for general health status and 
assessed weekly using a previously established formal TSE clinical scoring system 
(Dickinson et al, 1968). In all studies mice were coded to avoid the introduction of 
experimental bias in the scoring system.  Although there can be variation in clinical 
disease symptoms, depending on the combination of TSE strain and mouse strain, the 
characteristic signs of clinical TSE infection may include; lethargy, hyperactivity, 
ataxia, pruritus, gait effect and aggression.  Non-specific symptoms in the animal 
may be observed for a few weeks prior to the development of definitive neurological 
signs which normally occur during the last 2-3 weeks of the incubation period.  
 Following formal scoring mice were coded as follows:  
1: normal 
2: “possibly affected”: evidence of some abnormalities but not necessarily TSE 
 +: “definitely affected”: animal has clinical TSE   
g: animal has gait abnormality but not clinical TSE 
G: animal has clinical TSE score and gait abnormality 
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According to established criteria mice were culled when they received scores of 
“definitely affected” in two consecutive weeks, or in two out of three consecutive 
weeks. In cases where symptoms were severe, or the clinical period of disease was 
short, mice were culled following one “definitely affected” score to prevent 
unnecessary suffering. Once the clinical end-point was defined animals were 
humanely destroyed and tissues collected for histology, serial passage or further 
analysis. The incubation period for each mouse was defined as the time in days 
between challenge and the clinical end-point. Mice that did not develop TSE disease 
were maintained to a pre-determined time point consistent with the aims of the 
experiment 
 
2.4.4 Histopathological diagnosis of TSE 
Following clinical TSE diagnosis brains were fixed in 10% formal saline for 
approximately 48 h trimmed coronally into 5 defined brain areas and processed in a 
tissue processor (figure 2.1). In some cases brains were fixed in periodate-lysine 
paraformaldehyde solution for a period of 18 h. Brain areas were embedded in 
paraffin wax and 6µm sections cut on a microtome. After overnight drying in a 37ºC 
incubator sections were counterstained with haematoxylin and eosin and 
coverslipped with DPX mountant (BDH, UK.) For pathological confirmation of TSE, 
vacuolation in the brain was scored on a scale of 0-5 in the following grey-matter 
(G1-G9) and white-matter (W1-W3) areas (Fraser & Bruce, 1973):  G1, dorsal 
medulla; G2, cerebellar cortex; G3, superior colliculus; G4, hypothalamus; G5, 
thalamus; G6, hippocampus; G7, septum; G8, retrosplenial and adjacent motor 
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cortex; G9, cingulate and adjacent motor cortex; W1, inferior and middle cerebellar 
peduncles; W2, Decoction of superior cerebellar peduncles; W3, cerebral peduncles 
(figure 2.1) (Fraser & Dickinson, 1967; Fraser & Dickinson, 1968). 
 
Figure 2.1 Sectioning of brain and scoring areas for confirmation of positive 
















1. Medulla.  2. Cerebellum.  3.  Superior colliculus.  4.  Hypothalamus.  5.  Thalamus.











2.4.5 Infectivity measurement by bioassay 
At various time points after challenge or at the terminal stage of disease mice were 
sacrificed and spleen taken to determine infectivity levels. For bioassay of scrapie 
infectivity in spleen individual, whole or half spleens were prepared as a 10 % 
(wt/vol) homogenate in physiological saline and 20μl injected i.c. into groups of up 
to 12 C57BL indicator mice.  The titre of scrapie infectivity in each spleen was 
determined from the mean incubation period response curves for scrapie-infected 
spleen tissue (Dickinson & Fraser, 1969).   
 
2.5 Immune system manipulation 
2.5.1. Ageing mouse models 
In all mammals ageing results in immune system defects termed 
“immunosenescence”. To model the effects of ageing on TSE infection we used 
wild-type C57BL mice which were aged to 20 months under conventional open 
housed facilities. This is a well characterised wild-type mouse model of senescence 
and extensive studies have shown that mice of this age have characteristic defects in 
FDC function (Aydar et al, 2003). In studies involving aged mice additional mice 
were included to allow for age related infections etc. Typically 30% more mice were 







2.5.2 Antigenic challenge of TSE infected mice:Sheep red blood cell  (SRBC) 
immunisation 
 
Mice were antigenically challenged at an early (6 weeks) or at a late (27 weeks), 
stage (27 weeks) following i.p. injection with 20 µl of an ME7 or normal brain 
homogenate.   
 
Sheep red blood cells in Alsevers solution (E and O laboratories, UK) were used. 
Cell suspensions were washed 3 times in sterile saline for 10 minutes at 3000 rpm to 
remove diluent. Cells were re-suspended in saline and concentration adjusted to 1 x 
108/ml. Suspensions were aliquoted in 5ml volumes and frozen at -70ºC until 
required. Prior to antigenic challenge mice were bled from the tail as previously 
described to establish baseline serum immunoglobulin levels. ME7 challenged or 
normal brain injected mice received an i.p. injection containing 1x 107 SRBC in 
0.1ml of saline. Additional ME7 or normal brain injected mice were injected 
intraperitoneally with saline. Mice were boosted with SRBC or saline 3 weeks after 
the primary challenge.   
 
2.5.3 Antigenic challenge of TSE infected mice with DNP-KLH. 
Dinitrophenyl-keyhole limpet hemocyanin (DNP-KLH) (Calbiochem-Novabiochem 
Corp. La Jolla, CA, USA) was prepared for antigenic challenge by mixing equal 
volumes of DNP-KLH solution (5mg/ml: Calbiochem) with 9% potassium alum 
(Sigma A7167, Aluminium potassium sulphate). Solutions were agitated until the 
formation of a precipitate and an equal volume of medium (HBSS, Invitrogen, UK) 
added to stop the reaction. The pH was adjusted to pH7 by the addition of IM NaOH 
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and the solution washed four times by centrifugation in phosphate buffered saline 
(PBS). The concentration of DNP-KLH was adjusted to 1 mg/ml. For antigenic 
challenge mice (ME7 or normal brain injected C57BL mice) were injected i.p. with 
100 µg/100 µl DNP-KLH or an equivalent volume of saline at 3 timepoints 
following challenge (10 20, or 30 weeks). Mice were bled and boosted with antigen 
as described in 2.5.2.  Estimation of mouse Ig levels were performed using the radial 
immunodiffusion assay (The Binding Site, Birmingham, UK) as previously described 
(Mancini et al, 1965). 
 
2.6 Ex-vivo analysis of experimental tissues 
 
2.6.1 Histological preparation of tissues and cells for analysis 
Cryostat sectioning and fixation of cryostat sections 
Spleens were snap frozen in liquid nitrogen and stored in liquid nitrogen until 
required.  Tissues were embedded in OCT medium (leica) and 5-20µm thick sections 
prepared using a cryotome (Reichart).  Glass slides “Superfrost plus” with a 
permanent positive charge (to attract frozen tissue sections thus binding them to the 
slide) were used throughout (Microm, UK).  Sections were air dried overnight and 
then used immediately or frozen at -40ºC for a maximum of 4 weeks. Cryostat 
sections were fixed in dried distilled acetone for 10 minutes and then air dried for a 






Paraffin sections of brain and spleen were cut using a microtome (Leica) and sections 
floated on a water bath heated to 37ºC before collection onto “Superfrost plus” glass 
slides. Slides were incubated for up to 72 hours in a 37ºC oven before being used for 
histopathological or immunohistochemical (IHC) studies. 
 
Vibratome Sectioning 
Vibratome sectioning was used in some of the double labelling studies to construct 
serial images by confocal microscopy. In most cases, tissues for confocal microscopy 
were prepared by perfusion fixation using periodate-lysine-paraformaldehyde (PLP) 
(0.1 M periodate; 0.075M dl-Lysine; 2% paraformaldehyde in 0.05 M phosphate 
buffer pH, as previously described (Brown et al, 2000a). Perfusion fixation was used 
to improve tissue morphology by increasing efficacy of fixation and to reduce 
background labelling by the removal of red blood cells.  Following perfusion (Brown 
et al, 2000a) tissues were immersion fixed in PLP for a period of 6 hours and 
sectioned. Where immersion fixation in PLP was used, tissues were fixed for a 
period of 18 hours. For sectioning, tissues were mounted onto plastic blocks and 
secured with “superglue”. Tissues were placed in the microtome water bath 
containing 0.1M phosphate buffer and 100-200 µm sections cut. Sections were stored 
at 4º C for a maximum period of 24 hours and immunolabelled with a range of 





2.6.2 Immunohistochemical analysis of  brain and lymphoid tissues for PrPSc 
For the detection of PrP protein in brain, spleen or ileum, tissues were immersed in 
PLP fixative for approximately 18 h, processed in a tissue processor and embedded 
in paraffin wax.  Sections (thickness, 6 µm) were de-waxed and pre-treated to 
enhance PrP immunostaining using a hydrated autoclaving technique by immersion 
in water and autoclaving on a standard sterilisation cycle (121°C for 15 minutes) 
(Yokoyama et al, 1996). Sections were immediately cooled in running water and 
subsequently immersed in formic acid (98%) for 5 min.  Sections were then stained 
with the PrP-specific rabbit polyclonal antiserum 1B3 (Bruce et al, 1989b) 
(Appendix II) or the PrP-specific mouse monoclonal antiserum 6H4 (Oesch et al, 
1985) Prionics, Zurich, Switzerland). All immunolabelling for the above antisera was 
carried out using alkaline phosphatase coupled to the avidin-biotin complex (Vector 
Laboratories).  Vector Red (Vector Laboratories) was used as a substrate.  All 
sections were counterstained with haematoxylin to distinguish cell nuclei.   
 
2.6.3 Immunohistochemical analysis of frozen tissues 
Spleen sections were fixed in acetone as described in 2.6.1. Sections were blocked 
appropriately and primary antibody applied at a pre-determined dilution. A range of 
primary antibodies and their specificity is described in appendix II. Following the 
addition of primary antibody, biotin conjugated species specific secondary antibodies 
was (Stratech Scientific, UK) applied. Bound antibody was detected using the 
alkaline phosphatase conjugated streptavidin ABC kit (DAKO) and vector red as the 
substrate (Vector Laboratories, UK).  Sections were counterstained with 
haematoxylin as described previously. In some cases fluorescent microscopy was 
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used employing the use of a range of species specific secondary antibodies coupled 
to a range of fluorescent dyes, appendix II. Sections were mounted using fluorescent 
mounting medium (Dako, UK) and examined using a Zeiss LSM5 confocal 
microscope (Zeiss, UK). 
 
2.6.4 Paraffin embedded tissue (PET) immunoblotting 
This method was developed to allow the detection of PrPSc in paraffin sections 
(Schulz-Schaeffer et al, 2000) affording better morphology than can normally be 
obtained from conventional histoblot methods which use cryostat sections. For the 
detection of PrPSc in spleen and brain, tissues were fixed in PLP for approximately 
18-24 h and embedded in paraffin wax following tissue processing.  Serial sections 
(thickness 6 µm) were mounted on polyvinylidine difluoride membranes (PVDF, 
0.45 µm-pore; Bio-Rad, Hemel, Hempstead, UK) and incubated for 24 hours in an 
incubator set at 55°C.  PET blotting was carried out as previously described (Schulz-
Schaeffer et al, 2000).  Briefly, PVDF membranes were de-waxed and digested with 
20µg/ml of proteinase K (10mM Tris-HCl pH 7.8, 100 mM NaCl and 0.1% Brij) for 
16 h at 55°C.  Membranes were then washed in TBS/Tween (10 mM Tris-HCl pH 
7.8, 100 mM NaCl, 0.5% Tween) before being denatured in 3M guanidine 
isothiocyanate (10 mM Tris-HCl pH 7.8) for 10 minutes. Membranes were blocked 
in 2% casein and PrP was detected with the PrP specific rabbit polyclonal antiserum 
1B3 (Bruce et al, 1989b) (Appendix II) in blocking buffer for 2 h, followed by 
alkaline phosphatase-conjugated goat anti-rabbit antiserum (Jackson 
Immunoresearch Laboratories Inc, West Grove, PA, USA), and bound alkaline 
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phosphatase activity detected with SigmaFast™ NBT/BCIP solution (Sigma).  PET 
blots were assessed using an Olympus dissecting microscope. 
 
2.6.5 Quantification in lymphoid tissues 
Quantification of FDC networks and germinal centres in were carried out 
microscopically by determining the amount and intensity of abnormal PrP 
accumulation and peanut agglutinin binding (PNA) in spleen. This was carried out in 
experiments investigating the effects of antigenic challenge on TSE pathogenesis. To 
carry out the quantification each section was captured using light or 
immunofluorescent microscopy and the area covered by the appropriate antibody 
marker measured using Image Pro Plus (Media Cybernetics, Wokingham, UK).  
 
2.6.6 Preparation of cells for flow cytometry 
Spleens were collected into FACs buffer (PBS pH 7.4 containing 0.1% BSA, 0.1% 
sodium azide and 0.02% EDTA) and dissociated by sieving through 100µm cell 
strainers (BD Biosciences, UK). Cell suspensions were then centrifuged at 1800rpm 
for 10 minutes and re-suspended in1ml of FACS buffer. Cells were counted using 
trypan blue exclusion and adjusted to a concentration of 1 x106 cells in each 50µl 
/test sample. For the preparation of lymphocytes from blood, red blood cells were 
firstly removed by subjecting heparinised blood samples to ammonium chloride lysis 





2.6.7 Antibody labelling and analysis of cells by flow cytometry 
Cells were prepared as described in section 2.6.6. For cell labelling round bottomed 
96 well plates (Nunc, Fisher Scientific, UK) were used and 50 µl of cells suspension 
containing 1 x106 cells was dispensed in each well. Cells were labelled with a range 
of antibodies: the directly conjugated antibodies B220 (CD45R), CD3 and CD4 
antibodies (CALTAG med systems) and the H-2Db and H-2Dd antibodies 
(Pharmingen, BD Biosciences).  For the determination of PrP protein expression the 
1B3 antibody was used (Appendix II) (Farquhar et al, 1989) All antibodies were 
titrated prior to use to determine the appropriate antibody titre.   Cells were incubated 
with appropriately diluted antibodies for 40 minutes on ice and then washed 3 times 
with FACS buffer. Cells were re-suspended in 300 µl of FACS buffer and transferred 
to FACS analysis tubes (BD Biosciences, UK) for analysis. All samples were 
analysed immediately following labelling and flow cytometry conducted on a 
FACSCalibur™ (Becton Dickinson, San Jose, CA, USA) and data analysed using 
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3.1 Summary 
TSEs are primarily considered neurodegenerative diseases where the major 
pathology is confined to the CNS. Although these diseases have devastating effects 
on the CNS, the lymphoid system plays a critical role in disease pathogenesis in 
many natural and experimental TSEs. The understanding of the critical role that the 
lymphoid system plays in pathogenesis is the result of research spanning several 
decades;  primarily focusing on the role and involvement of specific lymphoid 
tissues system in TSE pathogenesis and then in the involvement of specific cell types 
within these tissues. The conclusion of much of this research points to a critical role 
for the follicular dendritic cell (FDC) a long-lived, radiation resistant cell.  More 
recently, the use of chimaeric and immunodeficient mouse models has produced firm 
evidence for a pivotal role for FDCs in pathogenesis and in this chapter the role of 
FDCs is further investigated in immunodeficient and chimaeric mouse models using 
peripheral routes of infection.  
 
In these studies novel lines of SCID mice were generated to allow the transplantation 
of haematopoietic cells from PrP deficient mice (PrP-/-) mice permitting the 
development of resident PrP expressing FDCs. Peripheral infection of these models 
shows that neuroinvasion is dependent on PrP expression on FDCs but not on 
lymphocytes providing further evidence for a critical role for FDCs in pathogenesis. 
Further studies in radiation chimaeric mice also find that neuroinvasion is dependent 
on PrP expressing FDCs although these studies demonstrate an unexpected finding in 
that incubation periods in peripherally challenged mice irradiated and bone marrow 
grafted with PrP deficient bone marrow are significantly shortened in comparison 
with control mice.   
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3.2 Introduction  
The hallmark of most TSE infections is neurodegeneration (Fraser & Dickinson, 
1967; Fraser & Dickinson, 1968) (Bruce, 1981) encompassing widespread neuronal 
loss (Jeffrey et al, 1994b), gliosis and the deposition of PrP within the CNS (Bruce et 
al, 1989b); (Bruce et al, 1994b). However, the peripheral lymphoid system is 
targeted many weeks or months before the detection of infectivity or the appearance 
of pathological changes in the CNS (Kimberlin & Walker, 1979; Kimberlin & 
Walker, 1989). This involvement of the immune or lymphoid system in this “silent” 
phase, before clinical symptoms of disease become apparent highlights the 
importance of defining the events and cells involved as it is at this stage that 
therapies may be most useful. The focus of much research has been in the 
determination of the key cells involved in TSE pathogenesis and in the contribution 
of a fully functional immune system in TSE pathogenesis (Fraser et al, 1992b).  
 
Following infection by peripheral routes, replication of infectivity in lymphoid 
tissues, precedes that of the CNS and reaches a plateau level, which is maintained for 
the duration of the disease. The time taken for infectivity to reach a plateau in 
lymphoid tissues is dependent on the route of infection (Kimberlin & Walker, 1979) 
and strain of TSE used (Bruce, 1985). In some experimental TSE models, for 
example the 79A scrapie agent strain, a very rapid replication phase in lymphoid 
tissues occurs following peripheral infection (Fraser, 1996), however in other strains, 
such as ME7 scrapie agent strain, replication of infectivity in lymphoid tissues rises 
less rapidly (Fraser, 1996).  
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Many studies have focused on defining the cell types which support replication in 
peripheral lymphoid tissues and most point to a central role for the follicular 
dendritic cell (FDC) (Brown et al, 1999; Mabbott et al, 2000a; Montrasio et al, 2000) 
Mabbott et al., 2000b; (Mabbott et al, 2002; Mabbott et al, 2000b; Mabbott et al, 
2003), a long-lived radiation resistant cell found within the germinal centres of 
secondary lymphoid tissues. Within the germinal centre, FDCs interact with antigen 
activated B lymphocytes resulting in the generation of plasma cells and memory B 
cells. One of the major functions of FDCs is to trap and retain antigen, in the form of 
immune complexes, which are presented to B cells in order to generate and maintain 
immunological memory (Kosco et al, 1992).  In contrast, some studies suggest that 
retention of immune complexes are not required for germinal-centre development or 
memory B-cell maintenance. Instead, it is thought that FDCs support B-cell 
proliferation and differentiation in a non-specific manner (Haberman & Shlomchik, 
2003). Studies using ionising radiation found that lethal doses of radiation had no 
effect on the pathogenesis of disease or on the ability to replicate infectivity in spleen 
suggesting that a long-lived radiation resistant cell was involved (Fraser & Farquhar, 
1987). One of the unique characteristics of FDCs is their resistance to doses of 
radiation exceeding those normally considered lethal to mice. In studies carried out 
by Humphrey and Grennan in 1982 the radio-resistance of FDCs has been shown to 
be as great as 18.5Gy and further studies in mouse models have substantiated these 
findings (Balogh et al, 2001).  
 
Further evidence for the involvement of the FDC in peripheral scrapie pathogenesis 
came from the close association of PrP protein with FDCs in both normal and scrapie 
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infected mice (Brown et al, 2000a; McBride et al, 1992; Ritchie et al, 1999) and ultra 
structural studies of infected spleen demonstrate that abnormal PrP accumulates 
within the extracellular spaces between FDC processes (Jeffrey et al, 2000). In 
addition studies, studies investigating the co-localisation of PrP protein in both 
normal and scrapie infected spleen by confocal microscopy confirm that FDCs and 


























       
       
 





Figure 3.1 Immunohistochemical detection of PrP protein within the germinal 
centre in association with FDCs. All tissues were fixed in PLP fixative. Sections A-
C are 100µm thick vibratome sections analysed by confocal microscopy, section (D) 
is a 6µm thick paraffin section All labelling performed using the 1B3 antibody 
(Farquhar et al, 1989) (A) Detection of PrPc in spleen (green) from an uninfected 
C57BL mouse where robust, diffuse staining is extensively associated with the FDC 
network. (B) Detection of PrP (green) in spleen at 7 weeks post ME7 infection. At 
this stage dramatic differences in labelling can be observed with less diffuse labelling 
in the germinal centre and more “punctuate” forms which may represent 
accumulations of PrP within tingible body macrophages. (C-D) Similarly detection 
of PrP in terminally affected mouse spleen also appears in a more aggregated form 
within the germinal centre in association with the FDC network but also with cells 
that have the morphology of macrophages. Images are selected from the following 
publications (Brown et al, 2000a; Ritchie et al, 1999) 
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The use of mice with immunological defects, such as severely combined 
immunodeficient (SCID) mice (Bosma et al, 1983), has proved extremely useful in 
defining the importance of specific cell types in TSE pathogenesis. SCID mice have 
a mutation (scid) which results in the absence of mature B and T lymphocytes, and as 
a consequence, only immature FDCs are present (Kapasi et al, 1993; Kapasi et al, 
1998).  In 1983 a novel mutation in the C.B-17 inbred strain (BALB/c.C57BL/Ka-
Igh-1b/Icr N17F34) was described by Melvin Bosma. This finding was the result of a 
chance observation during a routine serum immunoglobulin quantitation study where 
mice were initially found to lack detectable IgM, IgG1, and IgG2a.   This defect was 
demonstrated to be a heritable trait under the control of a recessive mutation (Bosma, 
et al., 1983). The mutant locus, designated SCID for severe combined 
immunodeficiency, has been mapped to mouse chromosome 16 (Bosma et al, 1983).  
 
SCID mice are resistant to peripheral infection with BSE and experimental scrapie 
(Lasmezas et al, 1996; O'Rourke et al, 1994)Lasmezas et al., 1996; Fraser et al., 
1996; (Brown et al, 1997b; Fraser et al, 1996). In addition, replication of infectivity 
in the spleen of SCID mice is impaired although this can be reversed following bone 
marrow reconstitution (Fraser et al, 1996), which allows FDC maturation and 
lymphoid reconstitution (Kapasi et al, 1993).  Interestingly, the resistance to 
peripheral infection in SCID mice, and other immunological knockout mice (Brown 
et al unpublished, Chapter 4), can be overcome by the use of high doses of infectivity 
(Fraser et al, 1996), probably as the result of direct peripheral nerve infection as 
replication of infectivity does not occur in these spleens (Fraser et al, 1996). While 
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studies in SCID mice produced strong evidence for a critical role for FDCs in 
pathogenesis (Fraser et al, 1996), these studies were unable to exclude the 
involvement of lymphocytes in pathogenesis.  A more conclusive role for FDCs in 
scrapie replication was provided by studies in chimaeric mice. In these studies 
murine bone marrow chimaeras were produced where mice carried the PrP gene, 
essential for disease replication, in FDCs but not in lymphocytes and vice versa. 
Using these models we found strong evidence that replication of the ME7 strain of 
scrapie, and progression of disease to the CNS depended on the presence of mature 
PrP expressing FDCs and was independent of the expression of PrP on lymphocytes 
(Brown et al, 2000b; Brown et al, 1999).  
 
The involvement of the immune system in TSE infection highlights the importance 
of defining the key events and cell types involved in the peripheral lymphoid system 
prior to the infection of the CNS, as the use of therapeutic and preventative strategies 
may be more relevant in early infection. In these studies the involvement of the 
follicular dendritic cell in the pathogenesis of the ME7 scrapie agent strain is further 
investigated using immunodeficient and chimaeric mouse models. Two novel lines of 
SCID mice were produced to further investigate the role of follicular dendritic cells 
following peripheral (intraperitoneal) infection). In addition, the pathogenesis of the 
ME7 strain of scrapie in radiation chimaeras, where there is a mismatch between the 
PrP genotype of the FDCs and surrounding bone marrow derived cells, is discussed.  
A preliminary study investigating the effects of haematopoietic cell graft and TSE 
agent strain on the replication of agent infectivity in spleen of PrP deficient mice is 








3.3.1. Production of two new lines of SCID mice for use in studies investigating 
the peripheral pathogenesis of the ME7 scrapie agent. 
 
The chance observation of impaired lymphocyte and consequently immunoglobulin 
production in an inbred line of C.B-17 mice led to the development of the SCID 
mouse line which has been used extensively in the study of the immune system. The 
ability to reconstitute this mouse model with bone marrow to stimulate the 
development of resident, FDC precursor cells, has produced unique opportunities to 
study the separate role of FDCs and lymphocytes with respect to PrP protein 
expression. In planning these studies however the major histocompatibility type of 
the mouse was considered to avoid rejection of the bone marrow graft. Although it is 
possible to graft xenogenic bone marrow into SCID mice the use of sub-lethal 
irradiation is normally required to destroy specific cell types that may result in 
rejection of the graft (Sakai et al, 1997). In these studies the aim was to primarily 
reconstitute the lymphoid but not the myeloid compartment (which is unaffected in 
SCID mice) without the requirement for irradiation. In-fact SCID mice have a 
radiation repair defect which makes these mice more susceptible to the effects of 
ionising radiation leading to subsequent difficulties in establishing required radiation 
dosage (Chang et al, 1993; Ogiu et al, 2002).  Therefore it was critical to match H-2 
haplotype of the bone marrow donor mice (129Ola/Prn-p-/- or 129Ola/Prn-p+/+) with 
the recipient. In mice the major histocompatibility type is defined by H-2. SCID mice 
carry the H-2d haplotype whereas 129Ola/Prn-p-/-  or  129Ola/Prn-p+/+ mice are H-2b. 
Therefore to allow reconstitution with PrP deficient bone marrow the production of 
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two new lines of SCID mice was achieved by crossing SCID mice with PrP deficient 
mice and selecting at the F2 generation; SCID phenotype, H-2b type and PrP+/+  or 
PrP-/-  deficient genotype by Southern blot analysis.  These mice were designated 
SCID-PrP+/+ (Figure 3.2) or SCID-PrP-/- (not shown). Details of mouse line 






















Figure 3.2 The SCID-PrP+/+ and SCID-PrP-/- mouse lines 
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Figure 3.2 The SCID-PrP+/+ and SCID-PrP-/- mouse lines 
(a) Picture of a SCID-PrP+/+ mouse. This line of mice is now maintained in germ-free 
conditions for breeding purposes. The SCID-PrP-/- line was not available to 
photograph as they are no longer maintained at our unit, but are available as 
embryos. (b) Cryostat section of SCID-PrP-/- spleen immunolabelled for FDCs using 
the FDC-M1 antibody (red). FDC networks are not visible but some labelling can be 
detected which is thought to represent immature FDCs (Ierna et al, 2006) (c ) SCID-
PrP-/- spleen reconstituted with 129Ola/Prn-p+/+  bone marrow showing organised 
lymphoid follicles and extensive FDC network labelling. Spleen was collected 30 
days post reconstitution. Sections counterstained with haematoxylin.  
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3.3.2 TSE disease following peripheral infection with the ME7 scrapie agent is 
not dependent on PrP expressing lymphocytes  
 
The SCID phenotype is characterised by lack of immunoglobulin production as a 
result of B and T cell deficiency (Bosma et al, 1983).  However, a small percentage 
of scid mice exhibit what is termed a “leaky” phenotype (Bosma et al, 1983; Bosma 
et al, 1988); the result of aberrant lymphocyte development resulting in the 
production of immunoglobulin. In published studies this defect is thought to occur in 
approximately 15% of young adult mice (Bosma et al, 1988) although data from our 
unit suggests the figure may be lower (unpublished observation). As the presence of 
this phenotype could have implications for bone marrow reconstitution of lymphoid 
populations (possibly affecting the interpretation of results) all SCID-PrP+/+ mice 
were screened for “leakiness” by bleeding from the tail prior to bone marrow 
reconstitution or scrapie infection (Brown et al, 2000b). Of the 106 SCID-PrP+/+ 
animals tested by ELISA for serum immunoglobulin (Ig), 6 had levels of Ig above 
baseline levels normally recognised for SCID mice and were excluded from the 
study. SCIDPrP+/+ mice were reconstituted with 129Ola/Prn-p-/- or 129Ola/Prn-p+/+ 
(hereafter referred to in this chapter as PrP-/-or PrP+/+ respectively in this chapter) 
expressing bone marrow and maintained under standard husbandry conditions for a 
period of 28 days. Analysis of FDC and lymphocyte development following 
reconstitution previously demonstrated that this is the minimum time period for 
successful reconstitution (Brown et al, 2000b). 
 
Bone marrow reconstituted and unreconstituted SCIDPrP+/+ mice were injected i.p. 
with a 1% ME7 brain homogenate (a dose of approximately 1x 104.5 intracerebral 
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ID50 units). In addition, a group of C57BL mice were infected i.c. to act as a control 
on the source of inoculum. All of the C57BL mice infected mice developed disease 
within the expected range demonstrating high infectivity titre in the original 
inoculum. In the unreconstituted SCID-PrP+/+ mice twenty-two mice died before the 
first positive TSE case in the control mice and were excluded from the analysis. The 
vast majority of these mice that died intercurrently were affected by thymic tumour a 
common occurrence in SCID mice (Ogiu et al, 2002). At the time of conducting 
these studies mice were maintained under standard SPF conditions which almost 
certainly contributed to intercurrent losses, although the development of thymic 
tumours may not have been prevented even if mice had been maintained under germ-
free conditions. Of the remaining animals only 5 survived long enough to be 
included in the analysis, of these, one animal had confirmed TSE pathology the rest 
were pathologically negative. Although one animal developed disease this is not an 
unexpected finding. In previous studies peripheral infection of SCID mice using the 
same infectious dose generally results in disease in 10-15% of animals despite the 
absence of infectivity or the accumulation of abnormal PrP in lymphoid tissues 
(Fraser et al, 1996).  
 
Strikingly, TSE disease occurred in 100% of the bone marrow reconstituted SCID-
PrP+/+ mice (table 3.1, figure 3.3), and no differences in incubation period were 
observed between the mice reconstituted with the PrP deficient or PrP expressing 
bone marrow. Although some intercurrent losses also occurred in the bone marrow 
reconstituted mice (mainly thymic tumour development), the incidence of disease in 
mice surviving past the first positive TSE case was 100% in both experimental 
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groups. These findings demonstrate that expression of PrP protein on lymphocytes is 
not required for neuroinvasion of the ME7 strain of scrapie and provide further 
evidence for a critical role for FDCs in pathogenesis. Immunohistochemical analysis 
of spleen sections from uninfected and scrapie infected spleen (not shown) 
demonstrate that the expression of PrP on FDCs is not dependent on PrP expression 





















Table 3.1 Disease incidence and incubation period (or survival) in SCID-PrP+/+  
mice following peripheral infection with ME7. 
 
 
Mouse    TSE  Mean incubation (days)±SEM 
model    incidence or survival 
 
SCID-PrP+/+   1/5   304 (244,259, 286,303) 
 
SCID-PrP+/+   15/15   322± 7 
+ PrP-/- bm 
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Figure 3.3 Disease pathogenesis in bone marrow reconstituted SCID-PrP+/+ mice 
Incubation periods of disease or survival following intraperitoneal challenge with 
20µl of a 1% ME7 brain homogenate. Intracerebrally challenged mice were also 
included as a control on the infectious titre of the original inoculum. Open symbols 
represent mice with clinical and pathological signs of disease. Closed symbols 
(black) represent clinically and pathologically negative unreconstituted SCID-PrP+/+ 
mice that survived to the endpoint of disease and included in the analysis. Closed 
symbols (grey) represent SCID-PrP+/+ mice that died intercurrently but are not 





Figure 3.4 Expression of PrP protein on FDCs in uninfected SCID-PrP+/+ mice is 





                                 










Figure 3.4 (a-c) Co-localisation of PrP protein (green) and FDCs (red) in spleen 
from uninfected SCID-PrP+/+ mice reconstituted with PrP-/- bone marrow.  Spleen 
collected 30 days post bone marrow reconstitution.Co- localisation of PrP in 
association with FDCs (orange/yellow) occurs independently of the expression of 
















3.3.3 Disease pathogenesis is altered in irradiated mice with PrP chimaeric 
immune systems. 
 
In mice, ionising radiation doses of approximately 950-1000 rads (9.5-10Gy) are 
considered lethal (1 Gy =100rads) and mice receiving such doses in the absence of 
haematopoietic cell reconstitution (bone marrow or fetal liver) invariably die within a 
short period of time (usually 7-10days) (Kretchmar & Congdon, 1967).  However, 
one of the features of follicular dendritic cells is their resistance to radiation, 
surviving doses which are lethal to most dividing cells (such as lymphocytes) 
(Humphrey et al, 1984; Kinet-Denoël et al, 1982). This unique characteristic of 
FDCs provides opportunities to create chimaeric immune systems, using lethal 
irradiation and bone marrow reconstitution, where host FDCs differ from that of the 
haematopoietic cell graft. In previous studies these techniques were used to produce 
mice where the PrP status of the FDCs differed from that of the surrounding 
lymphocytes by grafting bone marrow from PrP deficient mice into PrP-expressing 
mice and vice-versa. In our previous studies we found strong evidence that PrP 
expressing follicular dendritic cells, and not bone marrow derived cells (lymphocytes 
or myeloid cells), were critical for TSE pathogenesis (Brown et al, 1999). In addition 
to providing strong evidence for a critical role for FDCs these previous studies 
produced a novel finding in that incubation periods in peripherally challenged 
129Ola/Prn-p+/+ mice reconstituted with 129Ola/Prn-p-/-  bone marrow were 
significantly shorter than non-irradiated or 129Ola/Prn-p+/+mice irradiated and 
grafted with isologous (129Ola/Prn-p+/+ ) bone-marrow (Table 3.2).  For the purpose 
of this chapter 129Ola/Prn-p+/+ mice are denoted PrP+/+ while 129Ola/Prn-p-/- mice 
are referred to as PrP-/- . 
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To further investigate the role of FDCs in TSE pathogenesis and to determine if this 
unexpected alteration in pathogenesis could be repeated a second experiment was set 
up. Conditions of this study were kept as similar to that of the first experiment for 
example; inoculum from the same experimental source as that of the original study 
was used. In this second study almost identical results were obtained, and, as in the 
previous study mice reconstituted with PrP-/- bone marrow had significantly shorter 
incubation periods than mice that were not irradiated (p= 0.04). In-fact, incubation 
periods in the PrP+/+ mice reconstituted with PrP-/- bone marrow were also 
significantly shorter than those of the PrP+/+ mice irradiated and reconstituted with 
isologous (PrP+/+) bone marrow (p= 0.0025). There was no significant difference in 
incubation periods between PrP+/+ mice reconstituted with isologous bone marrow 
and unreconstituted PrP+/+ mice suggesting that the effects on pathogenesis are not a 
consequence of the irradiation and reconstitution procedure but most probably 
related to the mis-match in PrP status between the host and the bone marrow graft 
(table 3.2 and 3.3). 
 
Although similar incubation periods for each model were obtained in the second 
study greater variation in incubation periods were observed in almost all groups 
(table 3.2), this variation is reflected in the standard errors and significance values 
obtained (table 3.2 and 3.3). A number of factors may account for this variation 
including infectious titre of starting inoculum. Notably, during the incubation period 
of disease in the second study the NPU mouse colony became infected with the 
pinworm Syphacia oblevata. As a consequence the entire NPU mouse colony was 
treated with the bis-acridine compound, piperazine, for a period of 6 weeks. It is 
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possible that the effects of this treatment may have resulted in these minor variations 






























Table 3.2. Disease incidence and incubation periods in PrP+/+ radiation chimaeric 
mice following infection with 20 μl of a 1% ME7 scrapie brain homogenate.   
 
 
              i ntracerebral inoculation                               intraperitoneal inoculation 
 
                                                                                                                                                                
  mouse     Exp scrapie  incubation Exp scrapie  incubation  
  model   incidence period   incidence period   
         
  
  PrP+/+  1 8/8  153 ±3  1 10/10  239 ±3  
 + PrP-/-  2 9/9  164 ±3  2 9/9  235 ±6  
 
       
 
  PrP+/+  1 9/9  157 ±2  1 11/11  252 ±2   
 + PrP+/+ 2 8/8  164 ±3  2 10/10  261 ±2  
    
            
  
  PrP+/+  1 9/9  161 ±2  1 10/10  256 ±3   
  2 7/7  165 ±5  2 10/10  256 ±7 
      
            
 
 
Table 3.3. Statistical analysis of scrapie incubation periods in radiation 
chimaeric mice 
P values (student’s t-test 2 tailed, unpaired) obtained from comparison of incubation 
periods from i.p or i.c. challenged PrP+/+ mice reconstituted with PrP+/+ or PrP-/- bone 
marrow. Statistically significant values are represented in italics. Incubation periods 
in i.c. challenged PrP+/+ mice reconstituted with PrP-/- bone marrow were 




 Model PrP+/+ + PrP-/-  
 








PrP+/+ no bm PrP + PrP+/+ PrP+/+ no bm 
1 0.0002 0.0019 0.22 i.p.   
 2 0.04 0.0024 0.48 
i.c. 1 0.0076 0.07 0.16416 
 2 0.843397 0.59 0.877197 
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3.3.4 Immunohistochemical detection of PrP protein and FDCs in irradiated 
mice with chimaeric immune systems and assessment of reconstitution efficacy 
by flow cytometry. 
 
Following irradiation and bone marrow reconstitution mice were maintained in 
filtered caging and cleaned under sterile laminar flow conditions to minimise 
exposure to infection for 28 days. This timescale has previously been shown to be the 
optimum time for reconstitution of specific cellular population, including the 
maturation of r;esident FDCs (Brown et al, 2000b; Kapasi et al, 1998). After this 
time radiation chimaeric mice were infected with the ME7 strain of scrapie 
intraperitoneally or intracerebrally. Some animals were sacrificed prior to infection 
to assess efficacy of reconstitution using immunohistochemical (IHC) analysis with 
the FDC-M1 antibody which recognises the MFG-E8 marker (Kranich et al, 2008) 
(Figure 3.4). High levels of MFG-E8 staining were detected in all groups. There 
appeared to be greater numbers of FDC networks in the mice subjected to irradiation 
and reconstitution, although clearly quantification studies would be required to 
validate this suggestion. Flow cytometry of lymphocyte populations from radiation 
chimaeric mice prior to infection with the ME7 scrapie agent showed that successful 
reconstitution had occurred (figure 3.4 f and g). 
 
To determine the expression of PrP protein in radiation chimaeric mice animals from 
each group were sacrificed 10 weeks post i.p. challenge and spleens from all groups 
analysed for PrP protein and FDC networks by IHC (figure 3.5). For detection of PrP 
the 6H4 and 1B3 antibodies were used. In previous studies the 6H4 antibody has 
only detected accumulations of PrP by either IHC of FACS analysis, suggesting that 
this antibody may be useful in discriminating between the normal and infection 
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specific form of the protein. Abundant accumulations of PrPSc were detected in 
germinal centres in spleen from all groups of mice with both antibodies 
demonstrating that the lack of PrP expression on bone marrow derived cells had no 














































Figure 3.4  Immunohistochemical detection of MGF-E8 positive FDC networks in 
uninfected radiation chimaeric mice 30 days post bone marrow reconstitution. (a-c 
magnification X40, d-e magnification x100) (a) PrP+/+ mice reconstituted with PrP-/- 
bone marrow (b) PrP+/+ reconstituted with PrP-/- (c) PrP+/+ mice with no bone marrow 
graft. Robust networks are detected in all mouse models demonstrating that effective 
bone marrow reconstitution occurred post irradiation. Notably, FDC size and number 
did appear to be increased in irradiated and reconstituted mice particularly in the 
mice reconstituted with PrP-/- bone marrow (d) in comparison with unreconstituted 
mice (e). Detection of PrPc on splenic lymphocytes from radiation chimaeric mice 30 
days post irradiation and reconstitution using flow cytometry and the 1B3 antibody (f 
)PrP+/+ mice reconstituted with PrP+/+  bone marrow demonstrating low levels of 
expression on lymphocytes (g) PrP+/+ reconstituted with PrP-/-  bone marrow showing 
little PrPc expression above control sample labelling. Shaded area represents FL1 
intensity in cells labelled with FITC labelled secondary antibody (goat anti-rabbit 
FITC) alone as a control. 
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Figure 3.5 Immunohistochemical detection of PrPSc in radiation chimaeric mice  
At 10 weeks post i.p. ME7 infection with the ME7 scrapie agent detection of PrPSc 
was carried out in PLP fixed sections of spleen.  PrPSc was detected using both the 
1B3 and 6H4 antibodies in all of the mouse models demonstrating that PrP 
accumulation on FDCs is not dependent on the expression of PrP protein on 




3.3.5. Analysis of lesion profiles in the brains of scrapie infected mice with 
chimaeric  immune systems 
 
Confirmation of disease in TSE infected rodents is based on a combination of a 
clinical scoring system with defined endpoints of disease and pathological 
assessment (Fraser & Dickinson, 1967; Fraser & Dickinson, 1968). Once positive 
clinical disease is established animals are humanely destroyed and brains examined 
histopathologically for the presence of vacuolation in defined areas within the brain. 
Severity of vacuolation in these defined areas is assessed and a lesion profile 
established (Fraser & Dickinson, 1967; Fraser & Dickinson, 1968).  
 
To further investigate differences in pathogenesis in radiation chimaeric mice lesion 
profiles generated from animals in each of the experimental groups (PrP+/+ + PrP-/-, 
PrP+/+ + PrP+/+ and non-irradiated PrP+/+) were compared (figure 3.6). Lesion 
profiles generated from the i.p. infected mice were examined. As previously 
discussed PrP+/+ mice irradiated and reconstituted with PrP-/- bone marrow had 
significantly shorter incubation periods following peripheral challenge than non-
irradiated PrP+/+ mice or PrP+/+ mice reconstituted with isologous bone marrow. 
Lesion profiles from the peripherally challenged mice in the first experiment were 
almost identical. However, in the second study comparison of the severity of lesion 
profiles between groups showed lower levels of vacuolation in the PrP+/+ mice 
irradiated and reconstituted with PrP-/- bone marrow. It should be noted that severity 
of pathology was generally higher in the second study although the reasons for this 
are not understood. To assess differences in the severity of the pathology statistical 
analysis of these lesion profiles was carried out on individual mice from each group.  
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The area under the lesion profile (AUC) was estimated using the trapezoidal rule, for 
those mice that had valid scores in at least eight of the regions and a one-way 
analysis of variance carried out. PrP+/+ mice receiving PrP-/- bone marrow had a 
significantly lower mean AUC than the other two groups (Mann-Whitney: P < 









































     Figure 3.6 Lesion profiles in the brains of radiation chimaeric mice 
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  Comparison Mean difference Standard error of difference 
PrP+/+ bm v. PrP-/- bm  5.50 1.08  
No bm  (Control)  v. PrP-/- bm  3.75 1.04  
PrP+/+  bm v no bm ( control) 1.75 1.11  
  
Figure 3.6 Lesion profiles in the brains of radiation chimaeric mice 
Lesion profiles and statistical significance (experiment two) in PrP+/+ mice (red line), 
PrP+/+  +PrP+/+  bm (black line) and PrP+/+  +PrP-/- bm (blue line) following i.p. 
infection with the  ME7 scrapie agent. Vacuolation in the brain was scored on a scale 
of 0 to 5 in the following gray-matter (G1 to G9) areas: G1, dorsal medulla; G2, 
cerebellar cortex; G3, superior colliculus; G4, hypothalamus; G5, thalamus; G6, 
hippocampus; G7, septum; G8, retrosplenial and adjacent motor cortex; G9, 
cingulate and adjacent motor cortex. There was no difference in severity of 
vacuolation between groups in experiment one while in experiment two mice 
reconstituted with PrP-/- bone marrow appeared to have lower levels of vacuolation. 
However, in experiment two levels of vacuolation in control and PrP+/+   mice 
reconstituted with PrP+/+   bone marrow appear higher than the same groups in 
experiment one, although the reasons for this difference are not understood. 
Statistical analysis showed strong evidence (P < 0.001) of a difference in the mean 
AUC between the PrP+/+ mice receiving PrP-/- bone marrow and the other groups in 
experiment two. The means of the control PrP+/+ mice and those receiving PrP+/+ 
bone marrow are similar whereas the PrP-/- deficient mice have a significantly lower 
mean AUC than the other two groups. The mean differences and standard errors of 
the three pair-wise comparisons are shown above. 
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3.3.6 Analysis of infectivity levels in spleen from PrP mice reconstituted with 
PrP expressing or PrP deficient fetal liver 
 
Studies using bone marrow chimaeric and immunodeficient mice have strongly 
suggested that replication of the ME7 scrapie agent strain in lymphoid tissues is 
dependent on mature PrP expressing FDCs and not PrP expressing lymphocytes 
(Brown et al, 2000b; Brown et al, 1999; Bruce et al, 2000; Mabbott et al, 2000a). 
However these findings are in contrast to those obtained elsewhere, which suggested 
that PrP expressing bone marrow derived cells (most probably B lymphocytes) and 
not FDCs were required for replication of the RML scrapie isolate in spleen (Klein et 
al, 1997; Klein, 1998). Although the studies were very similar a comparison of 
experimental design revealed several technical differences in methodology; namely 
the use of a different scrapie strain, the RML scrapie isolate and the use of fetal liver 
as the source of haematopoietic cell graft as opposed to bone marrow. In these 
studies PrP deficient mice irradiated and grafted with PrP expressing fetal liver and 
then infected with the RML scrapie isolate had high levels of infectivity in spleen 
(Klein et al, 1997; Klein, 1998).   Similar studies carried out in our laboratory with 
ME7 infected PrP-/- mice grafted with PrP+/+ bone marrow found only trace levels of 
infectivity in spleen (Brown et al, 1999). The possibility that different TSE strains 
may target different cell types in the lymphoid system is examined in detail in 
chapter 4 although a preliminary study using two different TSE strains and two 
different sources of haematopoietic cell grafts is presented here. 
 
To establish firstly if the source of haematopoietic cell graft may have contributed to 
these results radiation chimaeric mice were constructed by lethally irradiating PrP-/- 
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mice  and grafting with either PrP-/- or PrP+/+ fetal liver. These mice were then 
infected i.c. with 20 µl of a 1% brain homogenate from mice terminally affected with 
either the 79A or ME7 scrapie agent strain. Spleens were collected 10 weeks post 
challenge for immunohistochemical analysis and infectivity bioassay. The RML 
“chandler” isolate (Chandler, 1961) while not a classically cloned strain is may 
contain a mixture of the 79A and 139A scrapie agent strains (Chandler, 1961). As the 
RML scrapie isolate was not available for these studies the 79A strain was used.   
 
Scrapie agent infectivity bioassay of spleens from the 79A scrapie agent infected 
mice produced no disease in indicator mice (table 3.4) while bioassay of spleen mice 
infected with the ME7 scrapie agent produced disease in a very small proportion of 
mice, although these represent trace levels of infectivity and are not consistent with 
replication. Likewise, immunohistochemistry was unable to detect the presence of 
PrP protein in spleens of PrP-/- mice reconstituted with PrP+/+ bone marrow (figure 
3.7). As these results are almost identical to those of previously published studies 
using bone marrow as the source of haematopoietic cell graft this suggests that 
source of haematopoietic graft does not appear to influence the replication of 












Table 3.4. Incidence of disease and incubation periods in C57BL bioassay mice 
following intracerebral inoculation with 20 μl of a 10% homogenate of spleen from 
PrP deficient mice irradiated and reconstituted with PrP+/+ or PrP-/- bone marrow and 
infected intracerebrally with a 1%  ME7 or 79A brain homogenate. Spleens for 
bioassay were collected 10 weeks post challenge. 
 
                                                                                                                                                                
mouse       scrapie agent   spleen  scrapie  
model    strain   number incidence 
      
   
 PrP-/- + PrP+/+  79A       1  0/12                    
       2  0/12 
       
    ME7   1  1/11 
       2  3/11 
       
 PrP-/- + PrP-/-    79A   1  0/12 
       2  0/12 
   
    ME7   1  0/11  
       2  0/12  
  
  
      
Figure 3.7 Detection of PrPSc in chimaeric PrP deficient mice 
            
    
a                            b                             c                        d   
Figure 3.7 Detection of PrPSc in chimaeric PrP deficient mice PrPSc (red) is not 
detected in association with FDCs in germinal centres of PrP-/- mice irradiated and 
reconstituted with PrP+/+ bone marrow when infected with either the 79A (a) or  
ME7(b) scrapie agent strains. PrP-/- mice were reconstituted with PrP-/- bone marrow 
as controls and also infected with the 79A (c ) or ME7 strains of scrapie (d). Original 






The congenital syndrome known as severe combined immunodeficiency (SCID) is 
characterised by a loss of both B and T cell immunity. It was first characterised in 
human infants (Glanzmann & Riniker, 1950) and later in Arabian foals (McGuire & 
Poppie, 1973). It has also been recognised in mice (Bosma et al, 1983), and mice 
homozygous for this mutation are hypogammaglobulinaemic and deficient in 
immune functions mediated by T and B lymphocytes. As a consequence the 
maturation of resident precursor FDCs is impaired in SCID mice, although resident 
FDCs can be induced to mature following haematopoietic reconstitution using bone 
marrow or fetal liver (Brown et al, 1997; Brown et al, 2000b; Fraser et al, 1996; 
Kapasi et al, 1993; Kapasi et al, 1998). Although the origin of FDCs remains the 
subject of much controversy it is widely accepted that FDCs are not derived from the 
bone marrow but develop, in the presence of B and T lymphocytes, from stromal 
precursor cells (Humphrey et al, 1984). An elegant series of studies using bone 
marrow chimaeras showed that FDCs always originated from the recipient and never 
from the bone marrow graft itself (Humphrey et al, 1984). Critics of this study 
argued that since FDCs are radioresistant, their presence in recipient animals may 
have inhibited donor FDCs from developing. To overcome the possibility that mature 
FDCs may compete with the putative development of FDC precursor cells from the 
bone marrow newborn SCID mice were grafted with bone marrow or fetal liver from 
rats (Kapasi et al, 1998). Surprisingly, FDCs of rat origin were subsequently detected 
in lymphoid tissues suggesting that in the newborn mouse, but not in the adult, FDCs 
could be replaced from the bone marrow. Despite these interesting findings the vast 
majority of studies suggest that FDCs are not derived from the bone marrow but are 
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derived from a stromal origin (Balogh et al, 2001; Humphrey et al, 1984; Lindhout & 
de Groot, 1995; Tew et al, 1990). However in the studies presented here these 
findings of potential transfer of FDCs were not dismissed and grafting of 
haematopoietic cells was only conducted in adult mice.  
 
Following reconstitution and subsequent FDC maturation neuroinvasion occurred in 
SCID-PrP+/+ mice irrespective of the source of the bone marrow graft. Although it is 
generally accepted that FDCs are critical for pathogenesis (Brown et al, 1999) this 
work provides further evidence in support of these findings and is further supported 
from the findings in the radiation chimaeric mice.  Interestingly the expression of PrP 
protein in association with FDCs was not impaired in SCID-PrP+/+mice reconstituted 
with PrP-/- bone marrow or in radiation chimaeric mice where the source of the bone 
marrow graft was of PrP-/- origin. It has not been determined if FDCs themselves 
produce PrP and although these data may provide evidence in support of this, the 
contribution of other PrP expressing cells, such as peripheral nerves which are not 
affected by the radiation procedure, cannot be ruled out. As a major function of the 
FDC is to acquire and retain immune complexes and other proteins on their cell 
surface (Kosco-Vilbois et al, 1997; Kosco et al, 1992) it is possible that PrP may be 
transported to the FDCs and not produced by the cells themselves.  In studies 
investigating the expression of PrP in the neonatal and post-natal spleen (Ierna et al, 
2006) although PrPc expression occurred coincidently with FDC-M1 network 
development, there was greater co-localisation with PrPc and the FDC-M2 marker 
(which recognises immune complex trapping via the localisation of complement 
component C4) at14 days of age than with the FDC-M1 marker (Ierna et al, 2006).  
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The highly reproducible incubation periods of distinct TSE strains are one of the 
hallmarks of TSE infection (Bruce & Fraser, 1991; Bruce et al, 1992; Dickinson & 
MacKay, 1964; Dickinson et al, 1968). In experimental studies attempts to modulate 
pathogenesis have been carried out using a variety of compounds. Significant 
prolongation of incubation period in scrapie affected mice and hamsters has been 
achieved using a number of sulphated polyanions (Ehlers & Diringer, 1984; Farquhar 
& Dickinson, 1986; Ladogana et al, 1992). Other studies have found effects on the 
conversion/accumulation of PrP in cell culture using heparan sulphate (Schonberger 
et al, 2003) and Congo red derivatives (Ingrosso et al, 1995). Moreover, 
administration of Congo red derivatives to scrapie infected hamsters delays 
incubation period of disease (Ingrosso et al, 1995). These findings are extremely 
important as they may represent potential approaches for treating TSE infections. 
The ability to shorten incubation period and understanding the effects and 
mechanisms involved is also important. In the studies presented in this chapter, 
significantly shorter incubation periods were found in peripherally infected 
PrP+/+reconstituted with PrP-/- bone marrow, in two separate, but identically 
performed, studies. It is not understood why these incubation periods in these 
chimaeric mice are shorter. A number of possibilities exist including the effects of 
the irradiation procedure, the generation of an immune response as a result of 
mismatch between the PrP status of the lymphocyte and the FDCs or CNS related 
effects from the replacement of cells such as microglia.   
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Treatment of mice with lethal doses of ionising radiation results in the destruction of 
actively dividing cells such as lymphocytes. In addition, lethal doses of radiation 
administered to mice result in breach of blood brain barrier following irradiation 
(Nordal & Wong, 2005) and other effects have been documented including the 
induction of astrocyte gliosis following exposure to ionising radiation (Hwang et al, 
2006). However, the effects on pathogenesis in these studies were confined to mice 
reconstituted with PrP-/- bone marrow suggesting the effect is related to the origin of 
the bone marrow graft and not specifically the irradiation procedure itself. In addition 
previous studies using ionising radiation found no effect on pathogenesis (Fraser & 
Farquhar, 1985; Fraser et al, 1989), although in these studies the bone marrow graft 
would always have been sourced from PrP expressing mice (Fraser et al, 1989).  
 
It is known that mitogenic stimulation with phyto-haemagluttinin (PHA) and 
administration of modified BCG vaccine prior to infection with experimental strains 
of scrapie can shorten incubation period of disease (Dickinson et al, 1978; Kimberlin 
& Cunnington, 1978a), most probably as a result of immune system stimulation. It is 
possible that a similar effect has occurred in these experiments. As the effects on 
pathogenesis were only observed in mice reconstituted with PrP-/- bone marrow it 
may be that an immune response was generated from the mismatch in PrP status 
between host FDCs and surrounding lymphocytes resulting in germinal centre 
formation. It is possible that increased replication of infectivity, following increased 
germinal centre formation in lymphoid tissues, resulted in more efficient 
neuroinvasion.  However, there was no significant difference in incubation periods 
between SCID-PrP+/+ mice grafted with PrP-/- or PrP+/+  bone marrow suggesting that 
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the effects in the radiation chimaeric mice may be in part related to the destruction of 
PrP expressing cells within the host and the subsequent replacement with PrP 
deficient cells.  
 
In addition to replacement of lymphoid cells by bone marrow reconstitution, cells of 
the myeloid lineage such as monocytes, macrophages, dendritic cells and natural 
killer cells are also replaced. Depletion of macrophages by the administration of 
substances toxic to these cells results in shortened incubation period of disease 
(Beringue et al, 2000). Although bone marrow grafting would replace 
macrophage/monoctye populations it is possible the lack of PrP expression or 
perhaps lower numbers of these cells post re-population may have contributed to the 
effects on pathogenesis. 
 
In TSE infection and other neurodegenerative conditions it is thought that microglial 
activation contributes to disease pathology (Betmouni et al, 1996; Giese et al, 1998; 
Perry et al, 2003; Perry, 2004; Perry, 2007; Williams et al, 1995). Notably microglia 
are derived from the bone marrow and studies in radiation chimaeric mice infected 
with the RML scrapie isolate demonstrate extensive recruitment of microglia from 
the bone marrow during the incubation period of disease (Priller et al, 2006). In these 
studies the bone marrow derived microglia appeared to replace endogenous 
microglial cells coincident with the deposition of PrPSc in the CNS (Priller et al, 
2006).  Like the results presented here, no difference in incubation period was 
observed between the non-irradiated mice and the PrP+/+ mice reconstituted with 
isologous bone marrow (although bone marrow chimaeras reconstituted with PrP-/- 
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bone marrow were not used in these studies). It is therefore possible that the 
recruitment of PrP-/- deficient microglia into the CNS in the PrP+/+  mice 
reconstituted with PrP-/- bone marrow may have had some influence on incubation 
period, potentially as a result of mismatch in PrP expression between these cells and 
endogenous host cells. Microglia are considered effectors of the innate immune 
response in the brain and function in a similar way to tissue macrophages by 
inducing immune responses. Indeed the generation of an immune response at a late 
stage of infection exacerbates disease possibly via increased migroglial activation in 
the CNS (Combrinck et al, 2002; Perry, 2004). Further studies investigating 
microglial activation in these models as a reason for altered pathogenesis are 
required to explore this suggestion further.  
 
Although results obtained in the second study were strikingly similar to the first 
experiment a wider range of incubation periods in each of the groups was obtained. 
Interestingly during the incubation period of disease in this study the colony became 
infected with the pinworm Syphacia oblevata. To eradicate this parasite the entire 
colony was treated with the bis-acridine compound piperazine. These may be 
important considerations to bear in mind especially when immunological 
assessments are being carried out. However, the wider range of incubation periods 
obtained in the second study may be attributed to the treatment of mice with 
piperazine during the incubation period of disease. Studies in cell culture using a 
scrapie infected cell line suggest that piperazine may impair accumulation of PrPSc in 
these cells (May et al, 2003) suggesting it may also have affects on pathogenesis. 
Alternatively it is possible the variation in incubation periods is simply related to 
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starting titre of inoculum as incubation periods of the i.c. injected mice found those 
in the second study were longer throughout all groups.  
 
TSEs are invariably fatal and it is generally assumed and accepted that the 
pathological changes in the CNS e.g. vacoulation, gliosis and the deposition of 
abnormal PrP are the causal factors in the death of the animal or individual. In the 
studies with the radiation chimaeric mice a less severe pathology (in terms of 
vacoular changes) was observed in the peripherally challenged PrP+/+ mice 
reconstituted with PrP-/- bone marrow, although this was only found in the second 
study. As this finding was only found in one experiment the validity of the findings 
must be questioned and may simply represent variation in pathology as a result of a 
number of factors. Animals in the second study were treated with piperazine during 
the incubation period of disease which may have had some implications by altering 
incubation period of disease. There is evidence that longer incubation periods of 
disease may produce more severe pathology in some models (Bruce, 1996). It is 
possible that the variation in incubation periods in the second study, possibly as a 
result of the piperazine treatment, may have produced this more severe vacuolation. 
However the contribution of vacuolar changes to the development of clinical disease 
is an interesting area of research and one that is not completely understood. Studies 
in transgenic mice with inducible PrP expression found that lack of PrP expression in 
microglia led to lower levels of neuro-degeneration in the retina with the RML 
isolate of scrapie (Kercher et al, 2007). The occurrence of clinical symptoms of 
disease in the absence of vacuolar changes has been described in aged mink of the 
Chediak -Higashi strain (Marsh et al, 1976). The Chediak-Higashi Syndrome (CHS) 
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is documented in humans and several animal species and results in increased 
susceptibility to infection as a result of granulocyte abnormalities.  As TSEs have 
highly reproducible incubation periods the ability to modulate infection is extremely 
significant. In future studies it will be important to establish the exact mechanisms by 
which incubation period may be shortened; for example by infection or 
immunisation. In addition, the contribution of pathology to clinical symptoms of 
disease is also intriguing and understanding the conditions where clinical disease can 
occur with less severe pathology may be significant especially for diagnosis. 
 
Although previously published studies (Brown et al, 1999) and the findings here 
produce strong evidence for FDC involvement in pathogenesis other studies carried 
out elsewhere suggested that B lymphocytes were critical for pathogenesis (Klein et 
al, 1997; Klein, 1998). There were several technical differences in these studies, 
notably the use of fetal liver as a source of cell graft and the RML scrapie isolate as 
source of TSE infection as opposed to the ME7 scrapie agent strain which was used 
here. No differences were found between the 79A and ME7 scrapie agent strains, and 
the use of fetal liver instead of bone marrow produced no difference in infectivity 
levels in spleen from those described previously (Brown et al, 1999). Thus, 
differences in haematopoietic cell graft used in the two studies cannot account for the 
discrepancies in findings between the studies. 
 
In summary, the work presented in this chapter has provided further evidence for a 
role for FDCs in the pathogenesis of the ME7 scrapie agent strain. Despite these 
findings what is not understood is whether FDCs are actively involved in other TSE 
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strains models. This issue is addressed in chapter 4 through the use of a range of TSE 
agent strains and mice with specific immunological defects (chapter 4). The 
significant shortening in pathogenesis in the radiation chimaeric mice is interesting 
and while these findings are not fully understood it seems likely that some form of 
immune system influence has contributed to these effects. The effects of immune 
system stimulation are further investigated using immunisation (chapter 6) and the 
influence of an ageing immune system with reference to effects of age on FDC 
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Although TSE infection results in dramatic pathological changes in the central 
nervous system (CNS), replication of infectivity also occurs in spleen and lymph 
nodes early in the disease.  Previous studies using chimaeric and immunodeficient 
mice demonstrated that mature follicular dendritic cells (FDCs) within the spleen and 
lymphoid system support scrapie agent replication and are critical for neuroinvasion 
following moderate dose peripheral challenge with ME7 scrapie (chapter 3). Despite 
a wealth of evidence supporting the involvement of FDCs in the pathogenesis of the 
ME7 agent strain it is not know if these cells are involved in the peripheral 
pathogenesis of other TSE agent strains. As different TSE agent strains target 
different cell types in the CNS it is possible that these differences exist in the 
peripheral lymphoid system also. The hypothesis that different TSE agent strains 
may target different cell types of the immune system was tested by peripherally 
infecting a range of immunodeficient mice with 4 distinct experimental TSE agent 
strains; ME7, 79A, 139A and the BSE derived strain 301C.  The mouse strains used 
were µMt which lack B cells and mature FDCs, TNFR1-/- which lack mature FDCs 
but have functional B and T lymphocytes and SCID mice which lack mature FDCs 
and B and T lymphocytes. Results indicated that neuroinvasion and replication of 
infectivity in spleen with all TSE agent strains tested appeared to be dependent on 
the presence of mature FDCs. However some variations in pathogenesis between 
TSE agent strains were observed; notably the development of extensively prolonged 
incubation periods with the 79A/139A strains and in some of the 301C infected mice, 
primarily at high dose. The significance of this is not fully understood but may 
suggest some alternative less efficient mechanism of pathogenesis which may occur 
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in the in the absence of mature FDCs. These effects were not apparent following 
peripheral infection with the ME7 scrapie agent strain suggesting that different 
























Previous studies have focused on defining the cell types which support TSE 
replication in peripheral lymphoid tissues and most point to a central role for the 
follicular dendritic cell (FDC) (Fraser et al, 1992b; McBride et al, 1992) (Bruce et al, 
2000; Mabbott et al, 1998)a long-lived radiation resistant cell (Humphrey et al, 1984) 
found within secondary lymphoid tissues (Kosco-Vilbois et al, 1997). A major 
function of FDCs is the trapping of immune complexes on their extensive 
cytoplasmic processes (Williams & Nossal, 1966). More conclusive evidence for a 
critical role for FDCs in scrapie replication has been provided by studies in chimaeric 
and immunodeficient mice (Brown et al, 1999) (chapter 3). In these studies 
chimaeric and immunodeficient mice were created where PrP was expressed on 
FDCs or lymphocytes and vice versa. Using these chimaeric and immunodeficient 
models strong evidence was obtained that replication of the ME7 strain on the 
spleen, and progression of disease to the CNS depended on the presence of mature 
PrP expressing FDCs (Brown et al, 1999) (chapter 3).  
 
However, studies carried out elsewhere using the RML scrapie isolate suggested that 
B cells or bone marrow derived cells, and not FDCs, were critical for replication of 
infectivity and neuroinvasion (Blattler et al, 1997; Klein et al, 1997; Klein, 1998). 
Firstly, studies in radiation chimaeric mice infected with RML found strong evidence 
that replication of agent infectivity depended on cells of a haematopoietic origin and 
not upon FDCs (Blattler et al, 1997). However studies carried out at this unit (Brown 
et al, 1999), found little evidence of infectivity in similar radiation chimaeric mice 
when infected with ME7 (Brown et al, 1999). The possibility that the differences 
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between haematopoietic cell source (HSC), used in the production of the chimaeric 
mice, could influence the ability to replicate infectivity in spleen was tested in 
chapter 3 using ME7 and 79A. However no differences were observed discounting 
this possibility. In a further series of studies carried out by the same researchers 
(Klein et al, 1997; Klein, 1998 ), peripheral challenge of immunological knockout 
mice with RML only resulted in clinical disease in mice with normal B cell 
populations (Klein et al, 1997; Klein, 1998). B cell deficient mice (Kitamura et al, 
1991), which also indirectly lack mature FDCs, were resistant to disease, however T 
cell deficient mice were fully susceptible. In addition, tumour necrosis factor 
receptor 1 deficient (TNFR1-/- ) mice (Rothe et al, 1993), which lack FDCs but have 
normal T and B cell populations, were fully susceptible to peripheral infection 
suggesting that B cells and not FDCs were important for neuroinvasion of the RML 
scrapie isolate. In these studies spleen infectivity levels in spleen were not provided 
from the TNFR1-/- mice therefore it is impossible to determine if normal replication 
of infectivity occurred in these spleens.  However in studies carried out at this unit 
TNF-α deficient mice (Pasparakis et al, 1996), which have similar defects to the 
TNFR1-/- mice, were almost completely resistant to infection with moderate doses of 
ME7 scrapie (Brown et al, 1999). These discrepancies in results between the studies, 
which were carried out under very similar conditions, are difficult to interpret 
however a number of differences between the studies exist (summarised in figure 
4.1).  
 
One of the major differences between the studies is in that of the TSE strain.  In the 
studies carried out in this unit the ME7 scrapie strain was used whereas the other 
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studies used the RML scrapie isolate. The RML (Rocky Mountain Laboratory) 
isolate was originally isolated from a pool of natural scrapie (SSBP/1) following 
passage in goats (discussed in detail in chapter 1). This passage in goats produced 
two distinct lines of phenotype in the goats a “scratching” and “drowsy” line. Sub-
passage in mice of the “drowsy” isolate (Chandler, 1961) produced the “Chandler” 
isolate and RML represents sub-passage of this “chandler” isolate at the Rocky 
Mountain Laboratory (Montana, USA).  Extensive sub-passage of the “drowsy goat” 
isolate in mice by Alan Dickinson and others (Dickinson et al, 1986) at our unit 
produced the 139A and the 79A strains (Dickinson et al, 1986). Although studies 
suggest that RML scrapie isolate and 139A scrapie agent strain are the same agents. 
RML has never been “cloned” by limiting dilution analysis, therefore it remains 
possible that the RML scrapie isolate may contain both the 139A and 79A scrapie 
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Table 4.1 Summary of differences in the design of the studies investigating the  
cellular involvement in peripheral lymphoid system. 
     
    RML studies   ME7 studies 
    Blattler et al 1997   Brown et al 1999 
 
Dose    1% dilution    1% dilution 
    100µl given i.p.  20µl given i.p. 
    (high)    (moderate) 
 
TSE strain   RML    ME7 (cloned) 
Haematopoietic  fetal liver/ bone marrow bone marrow   
Cell source    
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In the CNS dramatic differences in pathology exist between natural and experimental 
strains; for example in brains of mice infected with the ME7 strain, vacuolation and 
PrP deposition is widespread within the CNS (Bruce et al, 1989b). In contrast the 
87V scrapie agent strain produces vacuolation and PrP deposition within defined 
areas for example the CA2 region of the hippocampus (Bruce et al, 1989b). The 
infecting TSE agent strain is not the only factor controlling vacoulation and PrP 
deposition; PrP genotype also plays an important role (Bruce et al, 1991; Dickinson et 
al, 1968).  In the CV mouse strain (an F1 cross between the C57BL Sincs7 or Prnp-a 
and VM Sincp7 or Prnp-b genotype), infection with the ME7 scrapie strain results in 
destruction of the pyramidal cell layer of the CA1 region of the hippocampus by day 
170 of a 250 day incubation period (Scott & Fraser, 1984) whereas in ME7 infected 
C57BL mice there is no specific pathology associated with this area of the CNS. In 
addition, in natural and acquired TSEs there is great strain-specific variation between 
the pathology and cellular targeting in the CNS (Fraser, 1993).  
 
If TSE strains target different cell types in the lymphoid system this may have 
implications for therapeutic approaches and risk assessments of disease transmission. 
To attempt to elucidate these potential differences a range of TSE agent strains were 
used (79A, 139A, ME7 and the BSE derived strain 301C) to peripherally and 
intracerebrally challenge a range of mice (µMT, SCID, TNFR1-/-). Mice with a range 
of immunodeficiencies (figure 4.2) were then challenged with these agent strains and 
disease pathogenesis compared.  An important factor, which was considered in the 
design of these studies, was the potential effect that dose may have following 
peripheral exposure. In previous studies carried out at this unit peripheral infection of 
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SCID mice with high doses of the scrapie agent produced terminal disease in the 
absence of agent replication in spleen (Fraser et al, 1996). However at lower doses 
SCID mice were mainly refractory to disease (Fraser et al, 1996) (Table 4.2). These 
findings suggested that infection of the CNS following exposure to high doses of the 
scrapie agent may have occurred via direct peripheral nerve infection (Fraser et al, 
1996) without the requirement for agent replication within lymphoid tissues.  
Therefore in the studies presented here a range of peripheral challenge doses were 
used. In summary the aims of the studies presented in this chapter are to determine 






























Figure 4.2. µMT mice were produced by gene targeting techniques (Kitamura et al, 
1991). The subsequent B cell deficiency in these mice is a consequence of arrested B 
cell maturation at the stage of pre-B cell maturation.  µMT mice lack B cells and 
mature FDCs. Several members of the TNF ligand and receptor families control 
development and organisation of secondary lymphoid tissues. Transgenic mice 
deficient in the tumour necrosis factor 1 receptor (TNFR1-/-) mice do not have mature 
follicular dendritic cells (FDCs) and are unable to form germinal centres (GC) 
(Karrer et al, 2000; Rothe et al, 1993; Victoratos et al, 2006). SCID mice, described 
extensively in chapter 3, are derived from an inbred line of C.B-17 mice and are not 
produced using transgenic technology. As described in chapter 3, the occurrence of a 
“leaky” phenotype may complicate interpretation of results therefore all animals used 
in these studies were tested for the presence of a “leaky” phenotype and those mice 








4.3.1 Effect of dose on the development of peripherally routed ME7 scrapie 
agent in SCID mice 
 
In previous work conducted by Fraser et al (Fraser et al, 1996) it was noted that 
SCID mice were almost fully susceptible at to peripheral exposure with a high dose 
of the ME7 scrapie agent (10% w/v brain homogenate), but almost resistant to 
infection when the infectious dose was reduced (1%).  In these studies, despite the 
development of terminal disease in SCID mice at high dose, scrapie agent 
accumulation and replication did not occur in spleen suggesting that neuroinvasion 
followed exposure to a high dose of the scrapie agent in the absence of lymphoid 
system involvement. To further investigate these findings a titration was performed 
in SCID and immunocompetent control CB20 mice using the ME7 scrapie strain 
(Table 4.2). This showed that at high dose almost all SCID mice are fully susceptible 
to infection but almost resistant at lower doses (Table 4.2). This finding has 
significance for interpretation of results because in the studies using the RML scrapie 
isolate the peripheral challenge dose was estimated to be 5 times greater than that 
used in the studies with the ME7 strain which may have had some influence on 








Table 4.2 Effect of scrapie agent dose on disease susceptibility following 
peripheral (i.p.) infection of SCID and CB20 mice. 
 
 
Inoculum Concentration Mouse Strain 
CB20 
Incidence       incubation 
x/y                   ±SEM* 
Mouse Strain 
SCID 
Incidence       incubation 
x/y                  (range)  
10% 6/6                     273± 3   7/8                 ( 239-386)  
1% 5/5                     297±10    1/5                   (309) 
0.1% 6/6                     327± 4   0/6                     _ 
0.01% 4/6                    (329-369)    0/9                     _ 
0.001% 0/4 Not done 
0.0001% 0/6 Not done 
 














4.3.2 The peripheral pathogenesis of the ME7, 79A, 139A and 301C strains in 
immunodeficient mice 
 
Immunodeficient (SCID, µMT and TNFR1-/-) and immunocompetent 
(CB20/C57BL/6) mice were injected with four experimental TSE strains (79A, 
139A, ME7 and the BSE derived strain 301C) by the intracerebral route (i.c.) (using 
a 1% TSE brain homogenate) or intraperitoneal (i.p.) routes using 3 different doses 
(10%, 1% and 0.1%). These challenge doses correspond to a high (10%), moderate 
(1%) and low (0.1%) dose challenge.  As the studies presented here involved the use 
of 5 different mouse strains in 20 experiments, each involving peripheral challenge at 
3 separates doses and also i.c. challenge, it was important to ensure that the inoculum 
used for each TSE strain was pooled before use.  
 
Peripheral infection of all of the immunocompetent mouse strains produced 100% 
incidence of disease at all dilutions tested (table 4.3). An exception to this was the 
301C strain where only 15/16 and 13/16 mice developed disease at the 1% and 0.1% 
dilutions and in the 0.1% ME7 infected CB20 mice where only 9/13 mice developed 
disease (Table 4.3 Figure ).  It is possible this represents a lower starting titre of the 
original inoculum. In the µMt, TNFR1-/- and SCID mice the highest overall incidence 
of disease was observed at the 10% dilution with almost all mice developing disease. 
At the 1% and 0.1% dilutions the incidence of disease was greatly reduced in all of 
the immunodeficient mice. Unfortunately in SCID mice, the incidence of intercurrent 
illness was high and survival at the lower dilutions was poor although some analysis 
was possible with the 79A and 139A strains. These findings from the high dose 
infection groups support original observations obtained from the ME7 strain where 
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SCID mice were susceptible to high dose peripheral infection but mainly resistant at 
lower doses (Fraser et al, 1996).  However in these studies only 2/10 SCID mice 
developed clinical and pathological disease following high dose ME7 infection. The 
reasons for this are unclear but as only 9/13 CB20 mice developed disease at the 
0.1% dilution it is possible this represents lower infectious titre of starting inoculum 
when compared to previous experiments. 
 
One of the most striking differences observed in these studies were the extensively 
prolonged incubation periods of disease in both TNFR1-/- and µMT mice infected 
with 79A or 139A agent strains. This was also recorded with the 301C agent strain 
although disease incidence was much lower in general with this strain, perhaps 
suggesting lower titre of starting inoculum. High dose infection of TNFR1-/- mice 
with 79A produced prolonged incubation periods of disease in almost all mice 
whereas infection of µMT mice produced a mixture of short and long incubation 
periods. However at lower doses all of the incubation periods were prolonged in both 
the 79A and 139A in both µMT and TNFR1-/- mice. This is in comparison with the 
ME7 strain where the majority of animals developing disease did so within the 
incubation period anticipated for the ME7 strain (figure 4.3-4.6).  In previous studies 
of ME7 infected SCID mice the 87A strain was isolated following sub-passage of 
SCID spleen suggesting that inefficient replication or processing of infectivity in the 
lymphoid system may lead to the selection of minor strains. In response to this 
original finding lesion profiling was conducted from all of the TNFR-1 mice infected 
with ME7 which demonstrated the presence of the ME7 strain in these animals 
(figure 4.7).  
 
Table 4.3. Pathogenesis of a range of TSE strains in immunodeficient mice. 
      scrapie incidence/incubation period ±SEM   
    C57BL/6  TNFR-1-/-  µMT      CB20   SCID 
 
TSE   Cell none   FDCs   B cells/FDCs  none   B/T cells/FDCs 




ME7  10-1  15/15 256±1  11/13 225-380 14/17 210-308 15/15 307±8  2/10  193, 193 
  10-2  15/15 290±3  2/12 330,343 4/12 291-324 14/14 340±5  * 
  10-3  14/14 313±4  1/13 267  2/20 312, 336 9/13 343-398 *  
   
   
139A  10-1  14/14 205±1  12/15 171-394 10/16 175-483 18/18 216±2  12/16  185-212 
  10-2  14/14 222±3  5/15 233-518 4/16 316-400 17/17 233±1  0/13 
  10-3  14/16 239±2  4/15 240-455 1/16 286  17/17 247±4  0/10 
   
79A  10-1  16/16 215±2  6/11 231-524 11/15 175-601 14/14 226±5  9/16 171-270 
  10-2  14/14 228±3  3/13 285, 371,517 3/15 286,287,505 18/18 244±1  1/8 255 
  10-3  16/16 241±2  4/15 393-553 0/16 314  12/12 260±3  0/8 
   
 
301C  10-1  16/16 258±6  6/13 246-432 12/16 223-490 16/16 322±7  3/11      238, 308, 
313 
  10-2  15/16 320±7  0/16 -  3/15 217,595 15/15 362±6  0/5 
  10-3  13/16 357±5  0/13 -  1/16 400  16/16 383±5  * 
 
  * there were no positive SCID mice in this group and no mice surviving until the first positive CB20 case. 
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Figure 4.3 Incubation period range in immunodeficient mice injected i.p. with 








Figure 4.3 Graph showing incubation period (y axis) range (days) in TNFR1-/-, µMT 
and SCID mice following i.p. infection with the ME7, 79A, 139A and 301C strains. 
Incubation periods shown represent all of the mice with clinical and positive TSE 
disease from all of the dilution groups. The graph also displays the shortest and 
longest incubation periods in the control C57BL/6 (      ) and CB20 (       ) for 
comparison. The most prolonged incubation periods are observed in the TNFR1-/- 
and µMT mice infected with the 139A and 79A agent strains. Although there is also 
evidence of incubation period prolongation in these mouse strains with the 301C 
agent strain, a wide range of incubation periods was also obtained for the control 
C57BL/6 and CB20 mice. Incubation periods of SCID mice with each of the TSE 
strains were shorter than, or within the range of the controls. An exception to this 
was the SCID mice infected with 79A agent strain where slightly longer incubation 





4.3.3 The peripheral pathogenesis of the ME7 scrapie strain in immunodeficient 
mice 
 
Peripheral challenge of immunocompetent C57BL/6 and CB20 mice produced 100% 
incidence of disease at all dilutions with the exception of the CB20 mice infected 
with the 0.1% dilution where only 9/13 mice developed disease (figures 4.4, 4.5, 
4.6). Peripheral infection of SCID, µMT and TNFR1-/- with the ME7 strain deficient 
mice produced the following results. At the highest dose (10%) the incidence of 
clinical and pathological disease was in 2/10 in SCID 14/17 in µMT and 11/13 in 
TNFR1-/- mice. These results obtained with the TNFR1-/- and µMT mice at high dose 
are very similar to those obtained previously with SCID mice (Fraser et al, 1996) 
where a high proportion of mice were susceptible to infection at high dose. 
Moreover, at high dose the majority of incubation periods in the TNFR1-/- and µMT 
mice occurred within the incubation period range of the ME7 strain. At high dose 
several µMT mice and one TNFR1-/- mouse had shorter incubation periods than those 
of the immunocompetent control mice, an occurrence that has been observed 
previously. At the 1% and 0.1% doses the incidence of disease was greatly reduced 
in the µMT and TNFR1-/- mice and those mice that did develop disease did so with 
similar incubation periods to those of the immunocompetent mice.  
 
Disease incidence in SCID mice was lower than obtained previously with the ME7 
strain although 3 mice that died within the incubation period range had pathological 
signs of disease. Notably only 9/13 CB20 mice succumbed to disease at the 0.1% 
dilution perhaps suggesting that the starting titre may have been slightly lower. At 
the lower dilution groups no SCID mice survived long enough to be included in the 
analysis.  
Figure 4.4 Disease pathogenesis in immunocompetent and 
immunodeficient mice following i.p. exposure to a 10% dilution of the 
ME7 scrapie agent.  
Figure 4.4. Disease pathogenesis in immunocompetent (CB20and C57BL/6) 
and immunodeficient (SCID, TNFR1-/- and µMT) mice following i.p. injection 
with a 10% ME7 scrapie brain homogenate. Animals with both clinical and 
pathological disease in brain ( ). Animals without clinical disease but with 
pathological disease in brain (  ). Animals without disease ( ). Mean 
incubation periods in groups with 100% disease incidence (  ) 
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Figure 4.5 Disease pathogenesis in immunocompetent and immunodeficient 
mice following i.p. exposure to a 1% dilution of the ME7 scrapie agent.  
Figure 4.5. Disease pathogenesis in immunocompetent (CB20and 
C57BL/6) and immunodeficient (SCID, TNFR1-/- and µMT) mice 
following i.p. injection with a 1% ME7 scrapie brain homogenate. 
Animals with both clinical and pathological disease in brain( ). 
Animals without clinical disease but with pathological disease in brain 
(  ). Animals without disease ( ). Mean incubation periods in groups 










Figure 4.6 Disease pathogenesis in immunocompetent and immunodeficient 
mice following i.p. exposure to a 0.1% dilution of the ME7 scrapie agent.  
Figure 4.6. Disease pathogenesis in immunocompetent 
(CB20and C57BL/6) and immunodeficient (SCID, TNFR1-/- 
and µMT) mice following i.p. injection with a 0.1% ME7 
scrapie brain homogenate. Animals with both clinical and 
pathological disease in brain ( ). Animals without clinical 
disease but with pathological disease in brain(  ). Animals 
without disease ( ). Mean incubation periods in groups with 
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Figure 4.7. Assessment of the characteristic spongiform pathology in the brains of 
mice terminally affected with the ME7 scrapie agent strain The establishment of 
lesion profiles of terminally affected C57BL/6 and TNFR1-/- infected at the 10% 
dose was carried out. Analysis demonstrated that lesion profiles from the TNFR1-/- 
mice were comparable with that of the ME7 strain. As can be seen from the graph 
lower levels of pathology are observed in almost all of the areas examined in the 












Immunocompetent C57Bl/6 and CB20 mice were fully susceptible to infection 
throughout all the dilutions. At high dose, challenge of TNFR1-/- and µMT mice 
produced clinical and pathological disease in 12/15 and 13/16 mice respectively 
(figures 4.8, 4.9, 4.10). At high dose the majority of the TNFR1-/- mouse had 
incubation periods within the range of C57BL/6 mice, although two animals had 
much longer incubation periods. However infection of µMt mice at high dose 
produced a much wider range of incubation periods with all mice developing clinical 
and pathological signs of disease.  At high dose infection 3 TNFR1-/- and 2 µMT 
mice developed disease before the C57BL/6 mice. At the 1% dilution disease 
incidence was similar in both TNFR1-/- and µMT mice, although the majority of the 
incubation periods were greatly prolonged (one µMT mouse developed clinical and 
pathological signs of disease at 570 days). At the 0.1% dilution (figure 4.10) the 
highest incidence of disease was in the TNFR1-/- mice with 4/15 mice developing 
disease (one was pathologically positive but clinically negative) and only one 
TNFR1-/- mouse developed disease within the incubation period range of the 
C57BL/6 mice. Infection of SCID mice at high dose produced almost 100% 
incidence of disease (7/8). As with the TNFR1-/- and µMT mice a number of SCID 
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Figure 4.8 Disease pathogenesis in immunocompetent and immunodeficient 
mice following i.p. exposure to a 10% dilution of the 139A scrapie agent.  
Figure 4.8. Disease pathogenesis in immunocompetent (CB20and C57BL/6) 
and immunodeficient (SCID, TNFR1-/- and µMT) mice following i.p. 
injection with a 10% 139A scrapie brain homogenate. Animals with both 
clinical and pathological disease in brain ( ). Animals without clinical 
disease but with pathological disease in brain (  ).  Animals without disease 
(  ) ). Mean incubation periods in groups with 100% disease incidence (
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Figure 4.9 Disease pathogenesis in immunocompetent and immunodeficient 
mice following i.p. exposure to a 1% dilution of the 139A scrapie agent.  
Figure 4.9. Disease pathogenesis in immunocompetent (CB20and 
C57BL/6) and immunodeficient (SCID, TNFR1-/- and µMT) mice 
following i.p. injection with a 1% 139A scrapie brain homogenate. 
Animals with both clinical and pathological disease in brain ( ). 
Animals without clinical disease but with pathological disease in 
brain (  ).  Animals without disease ( ). Mean incubation periods in 







Figure 4.10 Disease pathogenesis in immunocompetent and immunodeficient 
mice following i.p. exposure to a 0.1% dilution of the 139A scrapie agent.  
Figure 4.10. Disease pathogenesis in immunocompetent (CB20and 
C57BL/6) and immunodeficient (SCID, TNFR1-/- and µMT) mice 
following i.p. injection with a 0.1% 139A scrapie brain homogenate. 
Animals with both clinical and pathological disease in brain ( ). 
Animals without clinical disease but with pathological disease in brain 
(  ).  Animals without disease ( ). Mean incubation periods in groups 





4.3.5 The peripheral pathogenesis of the 79A scrapie strain in immunodeficient 
mice 
 
Immunocompetent C57BL/6 and CB20 mice were fully susceptible to infection at all 
dilutions. At high dose challenge of TNFR1-/- and µMT mice produced disease in 
6/11 and 11/15 mice respectively. However, only one TNFR1-/- mouse had an 
incubation period within the range of C57BL/6 mice, the remaining mice developing 
disease with much protracted incubation periods (figures 4.11, 4.12, 4.13). All of 
these mice had clinical and pathological signs of disease.  Infection of µMt mice at 
high dose produced some incubation periods within the range of the C57BL mice but 
as with the TNFR1-/- mice, a number of mice had very long incubation periods, all 
with clinical and pathological signs of disease. At the lower dilutions (1% and 0.1%) 
the TNFR1-/- and µMT mice that developed disease had very prolonged incubation 
periods. At the 0.1% dilution nearly 30% of TNFR1-/- mice developed disease again 
with very prolonged incubation periods. Only one µMT mouse had evidence of 
disease at the 0.1% dilution although this animal was killed intercurrently without 
clinical disease. Infection of SCID mice at high dose produced high incidence of 
disease although there were no mice surviving past 260 days in the 10% dilution 
group. Therefore it is not known if longer incubation periods could have developed 
in these mice if more animals had survived.  At the lower dilutions only one SCID 
mouse developed disease in the 1% dilution group at 255 days, again survival was 




Figure 4.11 Disease pathogenesis in immunocompetent and immunodeficient 
mice following i.p. exposure to a 10% dilution of the 79A scrapie agent.  
Figure 4.11. Disease pathogenesis in immunocompetent (CB20and 
C57BL/6) and immunodeficient (SCID, TNFR1-/- and µMT) mice following 
i.p. injection with a 10% 79A scrapie brain homogenate. Animals with both 
clinical and pathological disease in brain ( ). Animals without disease ( ). 







Figure 4.12 Disease pathogenesis in immunocompetent and immunodeficient 
mice following i.p. exposure to a 1% dilution of the 79A scrapie agent.  
Figure 4.12. Disease pathogenesis in immunocompetent (CB20and 
C57BL/6) and immunodeficient (SCID, TNFR1-/- and µMT) mice 
following i.p. injection with a 1% 79A scrapie brain homogenate. Animals 
with both clinical and pathological disease in brain ( ).  Animals without 
disease ( ). Mean incubation periods in groups with 100% disease 






Figure 4.13  Disease pathogenesis in immunocompetent and immunodeficient 
mice following i.p. exposure to a 0.1% dilution of the 79A scrapie agent.  
Figure 4.13. Disease pathogenesis in immunocompetent (CB20and 
C57BL/6) and immunodeficient (SCID, TNFR1-/- and µMT) mice 
following i.p. injection with a 0.1% 79A scrapie brain homogenate. 
Animals with both clinical and pathological disease ( ) in brain. 
Animals without clinical disease but with pathological disease in brain 
(  ).  Animals without disease ( ). Mean incubation periods in groups 
















Immunocompetent CB20 mice were fully susceptible to infection with 301C at all 
dilutions however incidence of disease was not complete at the 1% (15/16) and 0.1% 
(13/16) groups in the C57BL/6 (figures 4.14, 4.15, 4.16). As found with all the other 
TSE strains the highest incidence of disease in the immunodeficient mice occurred at 
the highest infection group (10%).   
 
There were some similarities with the 301C strain and those of the 139A and 79A 
strain in that some very prolonged incubation periods were obtained; primarily at the 
highest dilution (10%). However unlike the 79A and 139A strains few 
immunodeficient mice developed disease at the lower dilutions with the 301C strain. 
At the 1% and 0.1% dilution there was no clinical disease in any of the TNFR1-/- 
mice although one TNFR1-/- mouse in the 1% dilution group had positive vacuolar 
pathology in brain. Two µMT mice had clinical and pathological signs of disease at 
the 1% dilution, with one animal developing clinical signs of disease almost 600 
days after original infection. At the 0.1% dilution only one µMT mouse developed 
clinical disease and this was within the range of the C57BL/6 mice. These findings 
demonstrate that 301C strain requires a functional immune system for effective 
pathogenesis and while some prolongation of incubation periods were recorded it is 
possible this may reflect lower starting titre of inoculum as control C57Bl/6 were not 





Figure 4.14 Disease pathogenesis in immunocompetent and immunodeficient 
mice following i.p. exposure to a 10% dilution of the 301C TSE agent.  
Figure 4.14. Disease pathogenesis in immunocompetent (CB20and 
C57BL/6) and immunodeficient (SCID, TNFR1-/- and µMT) mice following 
i.p. injection with a 10% 301C TSE brain homogenate. Animals with both 
clinical and pathological disease in brain ( ). Animals without clinical 
disease but with pathological disease in brain (  ).  Animals without disease 







Figure 4.15 Disease pathogenesis in immunocompetent and immunodeficient 
mice following i.p. exposure to a 1% dilution of the 301C TSE agent.  
 
Figure 4.15. Disease pathogenesis in immunocompetent (CB20and 
C57BL/6) and immunodeficient (SCID, TNFR1-/- and µMT) mice 
following i.p. injection with a 1% 301C TSE brain homogenate. Animals 
with both clinical and pathological disease in brain ( ). Animals without 
clinical disease but with pathological disease in brain (  ).  Animals 
without disease ( ). Mean incubation periods in groups with 100% 





Figure 4.16 Disease pathogenesis in immunocompetent and immunodeficient 
mice following i.p. exposure to a 0.1% dilution of the 301C TSE agent.  
Figure 4.16. Disease pathogenesis in immunocompetent (CB20and 
C57BL/6) and immunodeficient (SCID, TNFR1-/- and µMT) mice 
following i.p. injection with a 0.1% 301C TSE brain homogenate. 
Animals with both clinical and pathological disease in brain ( ). 
Animals without clinical disease but with pathological disease in brain 
(  ).  Animals without disease ( ). Mean incubation periods in groups 
with 100% disease incidence (  ) 
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4.3.7 Disease pathogenesis following intracerebral infection of immunodeficient 
mice with the ME7, 79A, 139A and 301C strains. 
 
In this study all of the immunodeficient mice were injected i.c. with the TSE agent 
strains to determine if these immune system defects had any implications for 
development of TSE disease itself within the CNS.  
 
As expected, after i.c. injection all SCID, µMT and TNFR1-/- mice were fully 
susceptible to infection indicating that their immunological defects had no direct 
effect on the development of disease in the CNS (table 4.4). Following i.c. injection 
of µMt and TNFR1-/- mice shorter incubation periods of disease were observed with 
all of the TSE agents with the exception of µMT mice infected with the ME7 agent 
strain. In the SCID mice however only the ME7 agent strain infected and 301C agent 
strain injected animals had sorter incubation periods; no differences in incubation 
period were observed following i.c. challenge of SCID mice with the 79A and 139A 
agent strains. 
 
Some ME7 agent strain infected SCID mice were killed prior to the development of 
clinical disease due to intercurrent illness. While analysis of these brains from these 
animals showed they were pathologically positive it is difficult to predict when these 







Table 4.4.  Pathogenesis of a range of TSE agent strains in immunodeficient 
mice following intracerebral injection   
 
TSE    scrapie incidence/incubation period   
strain    
  CB20  SCID  C57BL  TNFR1 µMT     
Cell none  FDCs  none  FDCs           B cells/FDCs 





incidence 9/9       3/3    9/9  10/10  13/13  
incubation 186±1  114±3*  175±5  181±2  160±0.1 
    
139A      
incidence 15/15  8/9  7/7        10/10  12/12  
incubation 155±2  154±2  180±5  172±1  171±1 
 
79A 
incidence 7/7  18/18  12/12     10/10  12/12 
incubation 165±2  166±2  183±1  172±1  171±1 
 
301C 
incidence 8/8  15/15  7/7  11/11  5/5  
incubation 196±1  182±3  183±1  179±3  168±1 
 
 






















4.3.8 TSE agent infectivity levels in spleen of immunodeficient mice following 
i.p. or i.c. injection with the ME7, 79A, 139A and 301C TSE agent strains 
 
TSE agent infectivity bioassay of spleen, collected at the terminal endpoint of disease 
was performed from all of the mouse and TSE strain combinations in the original 
pathogenesis studies. All of the spleens collected were from terminally affected 
animals and all taken from the 10% infection groups. The purpose of these assays 
was to determine if spleens from µMT or TNFR1-/- mice with clinical and 
pathological signs of disease contained TSE agent infectivity. Additional bioassays 
were performed from intracerebrally ME7 challenged µMt and C57BL/6 mice 
collected 5 and 10 weeks post challenge. As the i.c. route of infection represents an 
efficient way of routing infection to the spleen (Fraser & Dickinson, 1970; Kimberlin 
& Walker, 1979; Millson et al, 1979) these assays were performed to establish if 
replication of infectivity was occurring in spleen at these early stages of infection. To 
accurately measure the infectivity titre in spleen, titrations of spleen from terminally 
affected C57BL mice infected with each of the TSE agent strains was also carried 
out to produce a dose response curve for each TSE agent strain. 
 
Bioassay of spleen from C57BL/6 mice terminally affected with the 139A, ME7 and 
79A TSE agent strains produced 100% incidence of disease in all of the recipient 
assay mice demonstrating a high titre of agent infectivity in these spleens.  Bioassays 
of spleens from terminally affected, peripherally infected µMT or TNFR1-/- mice 
showed that low, but consistent, levels of infectivity could be detected in spleen in all 
the TSE strains tested. However levels of infectivity in spleen from µMT mice were 
undetectable at 5 and 10 weeks post infection in comparison with immunocompetent 
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C57BL/6 spleen where high levels of infectivity were detected (table 4.5 and figure 
4.17). 
 
In previous studies the isolation of the 87A strain of scrapie was observed following 
bioassay of SCID spleen. To determine if this had occurred in these studies lesion 
profiles were constructed from brains of bioassay mice following passage of TNFR1-
/- or µMT spleen. However lesion profiles of these brains demonstrated the presence 
of the ME7 scrapie agent strain (figure 4.18).  
Table 4.5. Infectivity bioassay of spleen from control and immunodeficient mice originally infected i.c. or i.p  with the ME7, 139A, 
79A and 301C strains. Bioassay in C57BL mice showing disease incidence/mean incubation period (or incubation range) 
 
    
   TSE strain/original route of inoculation/time of collection of bioassay spleen 
 
TSE strain ME7     ME7   139A   79A   301C 
route  i.c.  i.c.   i.p.   i.p.   i.p   i.p  
 
time of 
collection 5wpi  10wpi   terminal  terminal  terminal  terminal 
 
           
Spleen Origin 
 
C57BL/6 7/7 205±3 11/11 190±2  11/11 204±8  9/9 180±2  12/12 182±3  9/9 216±2  
  8/8 206 ±6 9/9     196±2  12/12  203±3  8/8 177±3  6/6 175±0.5 10/10 200±3 
  
 
µMT-/-  1/11(418) 0/10   9/10 (204-512) 7/11  (215-454) 9/12  (202-258)  5/12 (292-505) 
  0/12  1/12 (242)  7/12      (253-399) 6/12  (189-370) 10/11 (215-250) 2/12 (351, 502) 
 
 
TNFR-1-/- NT  NT   5/12 (313-524) 1/12*  (345)  1/12  (214)*  5/12 (292-505) 
  NT  NT   NT   NT   3/12  (243, 236, 393) 8/12 (242-263) 





* animal was clinically negative but had positive vacuolar pathology
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Figure 4.17 Infectivity titres in spleen from immunocompetent or 
immunodeficient mice  
 
Figure 4.17. Infectivity titres in spleen from immunocompetent or 
immunodeficient mice Estimation of infectivity titres in spleen ME7 (red), 139A 
(black), 301C (blue) or 79A strains (pink). Bioassay of spleen from 
immunocompetent C57BL/6 mice produced 100% incidence of disease in all assay 
mice with all of the TSE strains and all of the timepoints sampled. None of the 
spleens assayed from the immunodeficient mice produced 100% incidence of disease 
in the assay mice however there were clear differences between disease incidence in 
assay mice depending on the original route of inoculation with a greater incidence 
obtained from spleen collected from peripherally challenged immunodeficient mice. 
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Figure 4.18 Analysis of lesion profiles in the brains of recipient mice following 
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Figure 4.18. As described previously sub-passage of spleen from ME7 infected 
SCID mice resulted in the isolation of the 87A agent strain. In these studies the 
establishment of lesion profiles of terminal C57BL mice following bioassay of 
spleen from µMT (-) and TNFR1-/- (-) was conducted to determine if this had 
occurred in these bioassays. However, analysis showed that the TSE strains isolated 










4.3.9 Immunolocalisation of PrP protein in imunodeficient mice following 
infection with the ME7, 139A and 79A TSE agent strains 
 
Immunohistochemical (IHC) analysis of spleen was performed at 10 weeks post i.c. 
and i.p. injection of C57BL/6, TNFR1-/- and µMT mice with the 139A, 79A and 
ME7 TSE agent strains (figure 4.19, figure 4.20, table 4.6) (Farquhar et al, 1989). 
IHC and PET blot analysis of spleens from terminally affected with the ME7 scrapie 
agent strain was also undertaken (figure 4.19).  
 
IHC analysis of spleen from all of the i.p. or i.c. infected immunodeficient TNFR1-/- 
or µMT mice failed to detect PrP protein with the exception of some very limited 
labelling in spleen from mice infected i.c. with the ME7 (n=1) or the 139A (n=1) 
TSE agent strain. These localisations of PrP protein were only detected in association 
with one or two cells in these spleens the cellular specificity of which is unknown 
(figure 4.20, table 4.6). In addition, as the polyclonal antibody used here recognises 
both the normal and disease specific forms of the protein (Farquhar et al, 1989) it is 
impossible to determine whether these foci of labelling represents the disease 
specific form of PrP (PrPSc). Further analysis by PET blotting (Schulz-Schaeffer et 
al, 2000) to discriminate between PrPc and PrPSc is required.   
 
IHC and PET blot analysis of spleen from terminally affected µMT and control 
C57BL/6 mice found robust accumulations of PrPSc in association with FDCs in the 






Figure 4.19. Immunolocalisation of PrP in spleen at the terminal  
stage of disease in i.p. ME7 scrapie infected C57BL/6 and µMT mice. 
 
Figure 4.19. IHC and PET blot analysis of spleens from C57BL/6 or µMT mice 
infected with the ME7 strain of scrapie. Both the µMT and C57BL/6 mice developed 
terminal disease following i.p. challenge with ME7 (a,b). No PrPSc can be detected 
by IHC (a) or PET blot analysis (b) in µMT mice. Heavy deposits of haemosiderin 
can be detected within the µMt spleen (a) (c )PrPSc (red) is localised to FDCs in 
terminal C57BL/6 mice. (d)PET blots from terminal C57BL/6 mice show abundant 
PrPSc (dark blue). (d) IHC analysis using the FDC-M1 antibody to detect FDCs only 
detects labelling in C57BL mice (e). No labelling for FDCs in GCs can be detected 
in µMT mice (f) however some foci of labelling can be seen (black arrow). similar 
results have been found in immunodeficient and neonatal mice with this 
marker(Ierna et al, 2006)and is thought to represent immature FDCs. (figure a, c 
original magnification X40, figures b,d original magnification x20, figures e,f 




       Figure 4.20 Immunolocalisation of PrP in spleen at 10 weeks post infection. 
                                                                           
Figure 4.20  High levels of PrPSc accumulation in spleens from i.p. infected 
C57BL/6 mice collected 10 weeks after exposure (a,b). (a) 79A agent strain infected 
C57BL/6 mouse (b) 139A agent strain infected C57BL/6 mouse. PrPSc is 
undetectable in spleen from peripherally challenged TNFR1-/- mice at 10 weeks post 
infection with either the (c) 79A  or (d)139A agent strains. PrPSc is also undetectable 
in spleen from an i.p. 79A agent strain infected µMT mouse (e). Isolated foci of 
probable PrPSc labelling in spleen from a TNFR1-/- mouse infected with the 139A 
agent strain (f). (a-e) original magnification X100, (f) original magnification X600.   
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Table 4.6 Summary of IHC localisation of PrP in the spleen at 10wpi            
 
                                                                                                                                                                






i.c.                  i.p 
79A  
Route 
i.c.                 i.p. 
139A 
Route 
i.c.            i.p. 
-                      - -                       -        NT            NT µMT 
TNFR1-/- *                    - -                      -         *              - 
+                      +       +                      +       +                + C57BL/6 
 
NT: not tested 
 
+: Detection of PrP in spleen in association with FDCs. 
 



























The primary aim in this chapter was to determine the role of FDCs and/or other cell 
types in the pathogenesis of a range of TSE agent strains following peripheral 
exposure. This work also aimed to determine the effect of infectious dose on disease 
pathogenesis with a range of TSE agent strains.   
 
Although these studies demonstrate some variations in the peripheral pathogenesis of 
different TSE agent strains, the major finding of these studies is that neuroinvasion 
in the absence of FDCs is severely impaired following peripheral exposure to a range 
of TSE strains. As TNFR1-/- mice lack mature FDCs but have normal B and T cell 
populations this would suggest that B cells are not directly responsible for 
neuroinvasion in the TSE strains tested and show that functional FDCs are required 
for efficient pathogenesis. This finding is also supported by studies in µMT mice, 
which lack B cells and as a result functional FDCs.  
 
There was a profound effect of dose on these immunodeficient mice as demonstrated 
previously in studies with SCID mice (Fraser et al, 1996) and the highest incidence 
of disease was observed at high dose in all of the immunodeficient mouse strain and 
agent combinations demonstrating that this effect is not specific to the ME7 strain of 
scrapie. At the lower dilutions incidence of disease was greatly reduced in all of the 
TSE and mouse strain combinations as previously observed with ME7.  
 
In the studies presented here the most notable differences were observed between the 
ME7 strain and the 79A and 139A strains, with perhaps the most extreme differences 
between ME7 and 79A agent strains. The experimental strain termed “ME7” was 
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originally isolated from spleen from a natural scrapie case (Zlotnik & Rennie, 1965). 
ME7 is often used as a “prototype” for the study of natural scrapie and vCJD due to 
its extensive involvement in the lymphoid system and studies in radiation chimaeric 
and immunodeficient mice have shown that this strain depends on functional FDCs 
for neuroinvasion and replication in spleen 
 
With the ME7 strain the development of disease in the immunodeficient (SCID, 
µMT and TNFR1-/-) mice occurred predominantly within the incubation period range 
normally associated with this TSE strain agent. Following infection with moderate 
and lower doses of infectivity (1% and 0.1% dilutions) clinical and pathological 
disease only occurred in a few animals, again with incubation periods within the 
range of the C57BL/6 mice.  
 
 A feature of the 79A and 139A strains in µMT and TNFR1-/- mice was the 
extensively prolonged incubation periods of disease, notably these prolonged 
incubations were not observed with the ME7 strain suggesting these effects on 
pathogenesis may be a feature of the these strains, although a few prolonged 
incubation periods were also observed with 301C agent strain. In-fact, in the 79A 
agent strain most of the incubation periods in the immunodeficient mice that 
developed disease were much extended, even at the highest dilutions. The situation is 
less clear in the 139A strain where a combination of short and long incubation 
periods were observed. Prolonged incubation periods were not seen in SCID mice 
with the 79A or 139A agent strains although only a few 79A infected SCID mice 
survived beyond the incubation periods of the CB20 mice.  However, a proportion of 
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139A infected SCID mice survived until almost 420 days without developing clinical 
or pathological signs of disease.  Both the 79A and 139A strains of scrapie were 
originally derived from a pool of natural sheep scrapie brains following passage 
through goats and then subsequent passage in inbred strains of mice. One of the 
characteristics of the 79A strain of scrapie is its rapid replication of infectivity in 
lymphoid tissues following infection by a variety of routes. As early as 20 days post 
infection high levels of infectivity can be detected in spleen and lymph nodes of 79A 
scrapie infected mice. Preliminary analysis of lesion profiling from immunodeficient 
mice infected with the 79A and 139A agent strains suggests that there are no 
alterations in lesion profiling with either of these strains. 
 
Based on the results presented here it is possible that subtle differences in 
pathogenesis exist between TSE agent strains in the peripheral lymphoid system with 
perhaps the greatest differences observed between the ME7 and 79A strains. With 
the ME7 strain it seems likely that at high dose direct peripheral nerve infection 
occurs, without lymphoid system involvement producing a high incidence of disease, 
with similar incubation periods to those of the control mice. However with the 139A 
and particularly the 79A strains seems there may be alternative mechanisms to 
peripheral nerve infection. These alternative routes may represent inefficient routes 
of pathogenesis resulting in the extensively prolonged incubation periods observed 
with these TSE strains. Although both the µMt and TNFR1-/- mouse strains lack 
functional FDCs µMT mice have functional T cells and TNFR1-/- mice functional B 
and T cells. This “alternative” mechanism may disseminate infection to the CNS via 
haematogenous routes, possibly following low level replication or sequestration of 
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infectivity by cells other than FDCs, e.g. macrophage or lymphocyte populations.  
The fact that prolonged incubation periods were not observed in 139A infected SCID 
mice, which lack B and T lymphocytes, may support these suggestions. However 
such a mechanism does not appear to occur with the ME7 agent strain which may 
rely solely on replication upon FDCs and subsequent peripheral nerve infection to 
infect the CNS. While results suggest there may be differences in pathogenesis 
between TSE strains further analysis of this data is required to explore these 
possibilities further.   
 
Transmission of primary BSE from a number of sources shows remarkable 
uniformity demonstrating that the BSE agent contained a single major agent strain. In 
these transmissions to mice, the 301C and 301V strains were isolated. The 301C 
agent strain was isolated from mice of the (Sincs7or Prnpa) and the 301V agent strain 
from inbred mice of the Sincp7 or Prnpb genotype (Bruce et al, 2002). One of the 
most unique features of these primary BSE transmissions is a 100 day difference in 
mean incubation period between two Sincs7 mouse strains, RIII and C57BL (Bruce et 
al, 1997). However, passage of brain from either Sincs7strain results in the isolation 
of the 301C agent strains demonstrating that this anomaly in incubation period is not 
a result of the selection of different strains (Bruce et al, 2002).  The availability of 
this mouse adapted BSE strain provided the opportunity to investigate the 
lymphoreticular involvement of a BSE derived strain using mouse models.  There 
were some similarities with the 301C strain and those of the 139A and 79A strain in 
that some very prolonged incubation periods were obtained. However unlike the 79A 
and 139A strains few immunodeficient mice developed disease at the lower dilutions 
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with the 301C strain. These findings demonstrate that 301C strain requires a 
functional immune system for effective pathogenesis and while some prolongation of 
incubation periods were recorded it is possible this may reflect lower starting titre of 
inoculum as control C57Bl/6 were not fully susceptible to infection at the lower 
dilution groups.  
 
 
The hypothesis that different TSE strains may have different cellular targets in the 
peripheral lymphoid system was partly generated by the discrepancies in studies 
carried out in our unit with the ME7 agent strain and those carried out elsewhere with 
the RML isolate. Although the results presented in this chapter show some variation 
between strains, especially between the ME7 and 79A agent strains the presence of 
mature FDCs remains a requisite for efficient pathogenesis with all of the strains 
tested although results suggest that other cell types or mechanisms may participate in 
the absence of these cells.  In-fact, studies published within the last few years 
provide support for the role of FDCs in the peripheral pathogenesis of the RML 
isolate (Montrasio et al, 2000). Studies using the lymphotoxin β 
receptor/immunoglobulin fusion protein to temporarily de-differentiate FDCs show 
that the accumulation of the scrapie agent in the spleen and subsequent 
neuroinvasion were impaired following infection with either the ME7 agent strain 
(Mabbott et al, 2000a) or the RML scrapie isolate (Montrasio et al, 2000) 
demonstrating a critical requirement for mature FDCs in the pathogenesis of both the 
ME7 and RML agents.  
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When mouse passaged TSE strains are injected i.c. into immunocompetent mice the 
peripheral lymphoid system becomes infected shortly after infection, most probably 
via haematogenous spread of disease. Indeed the i.c. method of infection is an 
efficient way of routing infection to the lymphoid tissues (Fraser & Dickinson, 1970; 
Kimberlin & Walker, 1979). In previous studies where SCID mice were infected i.c. 
with the ME7 strain of scrapie mice were fully susceptible to infection demonstrating 
that this route of infection does not require the presence of a competent immune 
system, at least with mouse passaged strains (O'Rourke et al, 1994); (Lasmezas et al, 
1996); (Fraser et al, 1996); (Brown et al, 1997). An interesting observation in the 
studies presented here is the shorter i.c. incubation periods in all of the µMt and 
TNFR1-/- mice (with the exception of the ME7 agent strain infected µMT mice) with 
all of the TSE agent strains tested, although incubation periods in SCID mice were 
only shorter with the 301C and ME7 agent strains.  In these instances it is possible 
that immune system deficiencies may impact on this route of infection. One 
possibility is that lack of sites of replication sites or less PrP-expressing cells in 
lymphoid tissues in immunodeficient mice may mean more infectivity is 
concentrated in the CNS and not sequestered by the peripheral lymphoid system 
following infection.  
 
It would seem logical that infection via peripheral routes would be the most efficient 
way of routing infection to lymphoid tissues however infection via intracerebral 
routes is an effective way of initiating infection in the spleen. Paradoxically, 
infectious titre increases more rapidly following i.c. infection as opposed to i.p. 
infection (Fraser & Dickinson, 1970; Kimberlin & Walker, 1979).  Studies by 
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Millson et al (Millson et al, 1979) demonstrated that a proportion of infectivity is 
transported to the spleen via haematogenous routes whereas i.p. routing of infection 
most probably infects the spleen via uptake and transport of infectivity there by cells 
such as dendritic (Huang et al, 2002; Huang & MacPherson, 2004; Mabbott & 
MacPherson, 2006). As only small amounts of infectivity are disseminated via the 
i.c. route this may be a more precise way of determining the ability of the spleen to 
replicate infection. Bioassay of spleens from peripherally infected immunodeficient 
mice at the terminal stage of disease showed low but consistent levels of infectivity 
in many of the spleens assayed, although none of these spleens produced 100% 
incidence of disease in assay mice. The highest incidence of disease obtained 
following spleen bioassay was from the 79A infected µMT spleen although the 
relevance of this is not clear. In contrast, spleen bioassay from i.c. ME7 infected 
C57BL6 and µMT mice found that while C57BL/6 mice had high infectivity levels, 
infectivity levels were almost undetectable in µMT spleens. Similar findings were 
obtained in previous bioassays of spleen from i.p. and i.c. infected SCID mice where 
levels of infectivity were much higher in i.p. infected animals (Fraser et al, 1996). It 
is possible infection via i.p. routes may inadvertently “contaminate” organs within 
the peritoneum, such as the spleen, and studies suggest that infectivity may be 
sequestered in lymphoid tissues for several months following intraperitoneal 
infection (Karen Brown unpublished).  Alternatively, as the spleens from the i.p. 
injected animals were collected at the terminal stage of the disease it is possible that 
the infectivity detected is a result of retrograde spread of infectivity to the spleen 
from the CNS at this stage of infection.  
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The existence of strains is perhaps one of the most intriguing characteristics of the 
TSEs. There are at least 20 experimental TSE strains most of which were originally 
isolated from natural scrapie in sheep and goats (Pattison & Smith, 1963). A number 
of factors are responsible for the definition of a TSE strain. These include; incubation 
period of disease, distribution and severity of vacuolar pathology, inactivation 
properties, and PrPSc glycoform profile (Somerville et al, 2005) and stability and 
preservation of strain characteristics upon passage within the same genotype from 
which the strain was isolated. Perhaps one of the most intriguing aspects of the TSEs 
is the ability of certain TSE strains, for example 87A, to mutate under certain 
conditions (Bruce & Dickinson, 1987).  In previous studies using SCID mice the 87A 
strain was detected in a bioassay animal with a very prolonged incubation period 
following passage of spleen from an ME7 challenged SCID mouse (Fraser et al, 
1996). This raised the possibility that minor strains may be selected perhaps 
following inefficient processing of infectivity in these immunodeficient spleens. In 
the studies presented here a similar prolongation of incubation periods in bioassay 
animals was observed although histopathological examination demonstrated the 
presence of the ME7 strain.   
 
In most natural TSEs such as chronic wasting disease (CWD) (Sigurdson et al, 2002) 
and in the majority of experimental strains PrPSc is found in association with FDCs 
(McBride et al, 1992) (Brown et al, 2000a; Ritchie et al, 1999). As anticipated PrPSc 
was readily detected in immunocompetent mice with all of the TSE strains tested. 
Small foci of PrP labelled single cells were detected in spleen from TNFR1-/- mice 10 
weeks post i.c. infection with the ME7 and 139A agent strains. PrP was not detected 
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in i.p. challenged TNFR1-/- mice or in any of the µMT mice infected i.p. or i.c. with 
any of the strains. Although studies using PET blotting are incomplete, it is possible 
that in the absence of mature FDCs PrPSc, may accumulate in association with other 
cell types. As this work was carried out using the PrP specific polyclonal antibody 
1B3 antibody (Farquhar et al, 1989) which recognises both the normal abnormal 
forms of the PrP protein it is possible this is localisation of PrPc, although the 
localisation of PrPc in uninfected spleen normally produces a very diffuse labelling. 
Further work is required to explore these findings further using co-localisation 
studies with a range of cellular markers or possibly ultrastructural studies. It is 
known that dendritic cells (Huang et al, 2002; Huang & MacPherson, 2004) and 
tingible body macrophages can acquire PrPSc (Jeffrey et al, 2000; McGovern et al, 
2004) so it is possible that this labelling represents accumulations in either of these 
cell types. 
 
In conclusion these findings presented here demonstrate the importance of FDCs to a 
range of TSE agent strains. While these findings are unable to account for the 
marked differences between the original studies conducted with the ME7 and RML 
agents these data show that there are some differences between TSE strains 
following peripheral infection.  
 
This chapter and the previous chapter (chapter 3) highlight the importance of the 
immune system and indeed the presence of functional FDCs to TSE pathogenesis not 
just with the ME7 strain but with a range of strains. These findings are taken forward 
in chapter 5 where the influence of a senescent immune system is examined. The 
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effects of an immune response on the peripheral pathogenesis of the ME7 strain are 
examined in chapter 6.   
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5.1 Summary          
 
Since the identification of variant CJD (vCJD) there have been almost 200 cases of 
the disease worldwide, the majority of which have occurred in the United Kingdom 
(UK). The disease has been confined almost exclusively to young adults although the 
reasons behind this apparent age-related susceptibility are not fully understood. The 
capacity of the immune system to mediate immune responses to pathogens declines 
with age as a result of impaired lymphocyte and follicular dendritic cell (FDC) 
function.  As FDCs are critically involved in the pathogenesis of many TSEs, 
including vCJD, an ageing immune system may impair disease pathogenesis. 
 
To examine the potential age related influences on TSE infection, mice were aged to 
approximately two thirds of their natural lifespan (600 days) and challenged 
peripherally with the ME7 strain of scrapie.  None of the aged mice developed 
clinical disease; however, vacuolar degeneration in brain was detected in 33% of 
intraperitoneally and 42% of orally challenged mice. In addition, infectivity levels in 
lymphoid tissues from aged mice were significantly lower than those of the young 
mice demonstrating that peripheral disease pathogenesis in aged mice is inefficient. 
These data suggest that the impaired pathogenesis in aged mice coincides with 
reduced immune function and provides strong evidence that immunosenescence may 






5.2 Introduction          
 
In most bacterial or viral infections deficiencies in immune function may increase 
susceptibility to infection. Paradoxically, a declining or dysfunctional immune 
system may prevent or impair peripheral infection with TSE agents as demonstrated 
in studies with immunodeficient mice (Fraser et al, 1996; O'Rourke et al, 1994).   
 
In mammals it is widely accepted that ageing leads to a gradual decline in immune 
function. The term “immunosenescence” can be used to describe these collective 
alterations in immune function. Ageing leads to increased rates of mortality in 
response to infection (Gavazzi & Krause, 2002; Vasto et al, 2007); for example, 
pneumonia is more prevalent in the elderly than in younger adults (El-Solh et al, 
2001). The effects of age on immune function can also be demonstrated in responses 
to vaccination which are notably less effective in the old (Aspinall et al, 2007). In 
addition, aged individuals are often associated with an increased risk of developing 
re-current infections such as Varicella zoster (Gunawardena & Attygalle, 2008). 
Ageing is also associated with increased rates of some cancers (Fuller, 2006). 
 
Ageing has effects on a range of immune functions, including FDC function.  In 
humans involution of the thymus is thought to occur around puberty (Ferone et al, 
2000) although it is thought that functional thymic tissue may still be present in 
humans until at least age sixty. Within the thymus, progenitor T cells derived from 
the bone marrow are transferred to secondary lymphoid tissues such as the spleen 
where they are located within the periarteriolar lymphatic sheath (PALS) (Anderson 
& Jenkinson, 2001). Studies in mice and humans have shown that as ageing 
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progresses fewer T cells are produced in the thymus and transferred to secondary 
lymphoid tissues such as the spleen. Studies in young mice adoptively transferred 
with haematopoietic stem cells or bone marrow from aged mice failed to generate 
normal T cell populations suggesting that the age associated defects result from the 
maturation of progenitor cells (Mu & Thoman, 2000).  In cellular immunity there are 
significant decreases in mature and naïve T lymphocytes with increasing age (Linton 
& Dorshkind, 2004; Pawelec & Larbi 2008). This age-associated decline in T cell 
function is preceded by involution of the thymus.    
 
Aging also has effects on B cell development (Frasca et al, 2005) which include 
impaired B cell migration (Labrie et al, 2005) from the bone marrow to secondary 
lymphoid tissues such as the spleen (Dumont et al, 1984). It has been suggested that 
this may be the result of diminished signalling in age which controls the migration of 
these cells to organs such as the spleen. In age there are deficiencies in the immune 
response which consist of a shortened humoral response where the production of 
antibodies are of lower affinity (Frasca et al, 2005; Labrie et al, 2005) and despite the 
existence of isotype switching in the aged, the proportion of IgM antibody produced 
is much higher in aged individuals. It is not fully understood if these effects in the 
immune response are directly attributed to specific B cell associated defects (Frasca 
et al, 2005; Rogerson et al, 2003) or if they are a consequence of the effects of ageing 
on other cell types.  
 
The impact of ageing on conventional dendritic cell (DC) function has been 
considered although not comprehensively (Agrawal et al, 2007; Shurin et al, 2007). 
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In terms of DC number in ageing animals studies have shown a reduction in 
Langerhan cell numbers in skin (Pinto et al, 2003) and oral mucosa (Schwartz et al, 
1983) in aged mice. Another study found increased numbers of DCs in thymus and 
spleen in an aged model of lupus nephritis. This age-dependent increase in DC 
number has been postulated to contribute to autoimmunity (Agrawal et al, 2007).   
 
Follicular dendritic cells (FDCs), as previously described, are critically involved in 
TSE pathogenesis (Brown et al, 1999; Bruce et al, 2000; Mabbott et al, 
1998)(chapter 3). Significantly, a number of studies have demonstrated that ageing 
has intrinsic effects on these cells (Aydar et al, 2003; Aydar et al, 2004; Balogh et al, 
2001). FDCs reside within the secondary lymphoid follicle of the germinal centre 
where they are involved in a number of immune functions; notably the trapping 
immune complexes on the surface of the surface of the FDC reticulum (Kosco-
Vilbois et al, 1997; Kosco et al, 1992). A number of studies have demonstrated 
functional aberrations in FDCs in aged mice. Studies using 600 day old mice 
(approximately two thirds of the natural lifespan of the laboratory mouse) show that 
the expression of number of receptors critical for the regulation of the normal 
immune response are sparsely expressed or absent on the surface of FDCs in the 
ageing germinal centre (Aydar et al, 2003; Aydar et al, 2004; Szakal et al, 2002).  
Within the germinal centre FcγRII/III is highly expressed on FDCs in the germinal 
centre. The expression of this receptor is critical for the conversion of trapped 
immune complexes into a form that supports the development of the normal antibody 
response and in maintaining the structure of the FDC reticulum. One of the most 
widely understood effects of ageing is the reduction in immune complex trapping 
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(Szakal et al, 2002) which can be demonstrated by the reduction in labelling with the 
FDC-M2 antibody, which recognises complement component C4 upon FDCs (Taylor 
et al, 2002). 
 
In humans effects on the gastrointestinal tract as a result of age have been 
documented (Phillips & Powley, 2007). These changes include the age associated 
decline in the numbers Peyers patches (PP) within the ileum of the small intestine. In 
addition, studies in senescent mice have shown that functional aspects of Peyers 
patches (PP) in the ileum are diminished in aged mice (Kato et al, 2003). Further 
studies in sheep have demonstrated that there is an age-related decline in the number 
of PPs in the ileum which may impact on TSE disease susceptibility (St Rose et al, 
2006). In studies with the ME7 scrapie strain neuroinvasion from the intestine was 
severely impaired (Mabbott et al, 2003) in mice treated with a fusion protein 
containing the soluble lymphotoxin β receptor domain linked to the Fc portion of 
human immunoglobulin (LTβR-Ig). This treatment results in the temporary de-
differentiation of FDCs in lymphoid tissues, including PPs. In further studies mice 
lacking both PPs and mesenteric lymph nodes or PPs alone failed to develop disease 
following oral transmission of the ME7 strain of scrapie (Glaysher & Mabbott, 
2007). Thus demonstrating that mature FDCs are required for efficient neuroinvasion 
from the gut suggesting that an age-associated decline in the function of gut 
associated lymphoid tissues may impact on TSE pathogenesis.  
  
In addition to effects on FDC function, studies have demonstrated that age-related 
neuronal losses occur in both the myenteric plexus and submucosal plexus of the 
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intestine (Phillips & Powley, 2007). It appears this loss of neurons, which is specific 
to cholinergic neurons, is instigated in adulthood and continues throughout life. 
Studies have shown that this neuronal loss is more prominent in the distal 
gastrointestinal tract (Phillips & Powley, 2007).  
 
Many TSEs, including bovine spongiform encephalopathy (BSE) in cattle (Wells et 
al, 1987), are acquired by peripheral exposure to infection. BSE has spread to a 
number of other species, including humans (as vCJD) (Will et al, 1996) also by a 
peripheral (dietary) route (Bruce et al, 1997). During the BSE epidemic in the UK it 
was estimated that almost 500,000 infected cattle were slaughtered for consumption; 
suggesting that the number of people exposed to potentially infective doses through 
food may have been extremely high (Valleron et al, 2001)  
 
Despite this probable widespread exposure to the BSE agent, cases of vCJD have 
occurred almost exclusively in young adults (Boelle et al, 2004; Valleron et al, 
2001). It is therefore possible that the decline in immune and in FDC function in 
older individuals may provide some explanation for the incidence of clinical vCJD in 
young adults.   
 
To test this hypothesis a well characterised murine model of senescence was used to 
model the effects of ageing with relation to effects on peripherally acquired TSE 
infection. In this murine model extensive characterisation of immune function has 
been carried out and it has been established that FDC function is impaired in aged 
mice at approximately 20 months (600 days) (Aydar et al, 2003). In the studies 
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presented in this chapter the spleen was used as a model for lymphoid tissue 
involvement, primarily because of the extensive background work that has been 
carried out on the role of spleen in TSE pathogenesis at this unit and elsewhere. In 
addition, the spleen was used for analysis of infectivity levels in lymphoid tissues 
mainly because of the availability of standard dose response curves based on spleen, 
thus enabling the calculation of accurate infectivity levels from these tissues. 
However, it is recognised that the gut associated lymphoid tissues (GALT) are 
equally important in their contribution to TSE agent neuroinvasion from the gut and 
these tissues have been collected from both aged and young animals in these studies 






















5.3.1 Effect of age on the peripheral pathogenesis of the ME7 strain of scrapie. 
To determine the influence of age on TSE pathogenesis aged (600 day old) and 
young adult (42-56 day old) C57BL mice were inoculated with the ME7 scrapie 
strain intracerebrally (i.c.) or using one of two peripheral routes; the oral and 
intraperitoneal (i.p.) routes. The ME7 scrapie strain was used in these studies as, like 
vCJD in humans (Hill et al, 1999a; Hill et al, 1999b; Hill et al, 1997) this 
experimental strain has extensive lymphoid system involvement with agent 
accumulation upon FDCs (Brown et al, 1999; McBride et al, 1992) (Brown et al, 
2000b) (Bruce et al, 2000; Mabbott et al, 2000a; Mabbott et al, 2002; Mabbott et al, 
2000b; Mabbott et al, 2003). 
 
Both aged and young mice were fully susceptible to direct i.c. challenge with no 
differences in clinical signs or incubation period of disease (Table 5.1, 5.2). Young 
adult mice were 100% susceptible to ME7 infection by both peripheral routes (Table  
5.1, 5.2) and all had clinical and neuropathological features of scrapie as defined by 
the presence of vacuolar changes in specific brain areas (9 Grey matter areas and 3 
white matter areas). None of the aged mice developed clinical signs of TSE disease 
however positive vacuolar pathology in brain was detected in 3/9 of i.p. infected 
mice and 5/12 of orally infected mice (table 5.1, table 5.2). Statistical analysis of the 
number of aged mice developing vacuolar pathology in comparison with the young 
mice was assessed using a Fisher’s Exact test. In the i.p. infection group 12/12 young 
mice showed positive vacuolar pathology compared to 3/9 in the older age group. 
This difference in the proportion of aged mice developing vacuolar pathology was 
highly significant (P < 0.001). In the orally challenged mice, 12/12 young mice 
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showed positive vacuolar pathology compared to 5/12 in the older age group. This 














































Table 5.1. TSE incubation periods (or survival rangea), incidence of clinical disease  
and vacuolar pathology in aged (600 days) and young (42-56 days)C57BL mice 
following  i.p., oral or i.c. ME7 challenge.  
           
         
Mouse  Challenge Clinical Vacuolar Mean incubation             
model  route  disease  Pathology period ±sem in days 
    incidence in brain (or survival range)  
                     
  Aged   i.p.  0/9a  3/9  247-323 (P < 0.001) 
   
  C57BL 
    Oral  0/12a  5/12  282-366 (P = 0.002) 
  
     
    i.c.  3/3  3/3  179±7.6  
      
 
  Young   i.p.  12/12  12/12  274±5.2  
   
  C57BL 
    Oral  12/12  12/12  301±3.9  
  
 
    i.c.  6/6  12/12  174±3   
   
 
a: Only aged mice that died after the first positive TSE case in the young mice were  



















Table 5.2. Survival times (days)a, clinical disease, presence of vacuolar pathology and 
detection of PrPSc in brain and spleen in individual, aged (600 day old) C57BL mice 
 following i.p. or oralME7 infection. Collective results are displayed for the young mice.     
 
 Challenge survival Clinical Vacuolar          PrPSc in PrPSc in  
 route  (or mean disease  pathology brain  spleen  
              incubation   in brain 
   period ±SEM) 
   
  i.p.   
  aged  247  no  no   yes  no 
    247  no  no  no  no 
    254  no  no  yes  -b 
    261  no  no  no   no 
    275  no  no  no  no 
    282  no  no  yes  no 
    303  no  yes  yes  yes 
    310  no  yes  yes  yes 
    323  no  yes  yes  yes 
  
        young   274 ± 5 12/12  12/12  12/12  12/12 
   
  Oral       
  aged  282  no  no  yes  yes  
    289  no  yes  yes  no  
    289  no  no  yes  no 
    295  no  no  yes  no   
    295  no  no  yes  no 
    295  no  no  yes  yes 
    310  no  yes  yes  yes 
    310  no  no  yes  yes 
    310  no  yes  yes  yes 
    310  no  no  yes  yes 
    338  no  yes  yes  yes 
    366  no  yes  yes  yes 
 
   young  301 ±4  12/12  12/12  12/12  12/12 
 
  i.c.   
    aged  179 ±8  3/3  3/3  -  - 
  
  young  174 ±3  6/6  6/6  -  - 
 
 
a: Only aged mice that died after the first positive TSE case in the young mice were 
included in the analysis 
 
b: Not done/Not available 
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5.3.2 Severity of TSE pathology is reduced in aged mice  
 
One of the most defining characteristics of TSE infection is the presence of vacuolar 
changes in the brain. The presence and severity of these vacuolar changes in 9 
specific areas in the brain can be used to construct a “lesion profile” (Fraser & 
Dickinson, 1967).  Although none of the orally or intraperitoneally challenged aged 
mice developed clinical signs of TSE disease positive vacuolar pathology was 
detected in 3/9 of i.p. infected aged mice and 5/12 of orally infected aged mice.  To 
determine if the severity of pathology in brain in aged mice was reduced, a 
comparison of the lesion profiles from these aged mice that died within the same 
time period as the young mice with clinical scrapie was carried out (figure 5.1).  
 
For each mouse brain the extent of vacuolation was assessed in each of nine regions, 
with scoring done on a scale of 0 to 3. The area under the lesion profile (AUC) was 
estimated using the trapezoidal rule, for those mice that could be scored in at least 
eight of the nine the brain regions (total number of aged and young mice: n = 14 i.p 
route; n = 15 oral route n=9 ). For each route of infection (i.c., oral or i.p.) the 
differences in median AUC between the aged and young animals was tested using a 
two-tailed Mann-Whitney U-test.  
 
These analyses suggested that the severity of the vacuolar pathology was 
significantly lower in the aged mice following exposure to the scrapie agent by i.p. 
injection (a, P = 0.022, n = 3) and oral exposure (b, P = 0.001, n = 5).  In contrast, 
when young and aged mice were injected with the scrapie agent directly into the 
brain by i.c. injection, each group was fully susceptible to disease and developed 
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clinical scrapie with similar incubation periods (table 5.1, table 5.2).  However, 
analysis of the magnitude of the spongiform pathology in the aged brains (n = 3) 
revealed it was significantly lower on average when compared to the young mice (P 






















Figure 5.1 Severity of Vacuolation is reduced in Aged mice 
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Figure 5.1.  Effect of host age on TSE-specific neuropathology in the brain.  (a-c)  
Lesion profiles are shown from aged (black line) and young (red line) from mice 
infected by the (a) i.p. (b), oral and (c) i.c. routes. Pathological assessment of the 
spongiform change (vacuolation) in the brains of mice with positive vacuolar pathology 
has been constructed to form a lesion profile.  Vacuolation was scored on a scale of 0-5 
in nine grey matter areas: 1, dorsal medulla; 2, cerebellar cortex; 3, superior colliculus; 
4, hypothalamus; 5, thalamus; 6, hippocampus; 7, septum; 8, retrosplenial and adjacent 
motor cortex; 9, cingulate and adjacent motor cortex.  Each point represents mean 
vacuolation score ± SEM for groups of 3-12 mice.  To determine if the severity of the 
vacuolation was significantly altered in aged mice, the median differences in the areas 
under the lesion profile curves (AUC) between the aged and young mice were tested 





5.3.3 Detection of PrP in brain and spleen of scrapie affected aged and young 
mice 
 
A defining characteristic of TSE infection is the accumulation of PrPSc in brain and 
lymphoid tissues following infection. During TSE disease, the deposition of PrPSc in 
the brain typically precedes the vacuolar changes (Bruce et al, 1989a).  As only a 
proportion of aged mice developed vacuolar pathology the detection of PrP in brain 
was used to determine the presence of TSE disease in the brains of the peripherally-
exposed aged mice despite the absence of positive vacuolar pathology.  Large 
accumulations of PrPSc were detected in the brains of all clinically scrapie-affected 
young mice after i.p. injection (figure. 5.2), oral exposure and i.c. injection.  Within 
the brains of the clinically negative aged mice, PrPSc was detected in most brains 
from the i.p. injected mice (six of nine mice; figure 5.2) and all the orally exposed 
mice (details in table 5.2).  
 
Further analysis revealed that there was considerable variation in the detection of 
PrPSc in the spleens of the clinically negative aged survivors (figure 5. 2 and table 
5.2). All the peripherally exposed aged mice that displayed positive vacuolar 
pathology (except one orally exposed animal) had detectable PrPSc in their brains and 
spleens.  In contrast, the aged mice that did not show signs of vacuolar pathology had 
detectable PrPSc in the brain but not in the spleen (Fig. 5.2).  The reasons for these 
differences are uncertain.  In mice deficient in FDCs neuroinvasion can occur in 
some mice by an FDC-independent process such as direct uptake by peripheral 
nerves (Bruce et al, 1996; Bruce et al, 2000; Fraser et al, 1996), implying direct 
transfer of the TSE agent to the nervous system in some aged mice.   
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Figure 5.2. Immunohistochemical localisation of PrPSc in spleen and brain from 
i.p. ME7 scrapie infected aged and young mice at the terminal stage of disease  
 
 
Figure 5.2. Immunohistochemical detection of PrPSc (red) in brains from terminally 
scrapie affected young mice and aged mice that remained free of the clinical signs of 
disease after i.p. injection with the ME7scrapie agent. (a) Large PrPSc accumulations 
(red) were detected in brains of all clinically scrapie-affected young mice.  (b-d) In 
the brains of the clinically-negative survivors, six of nine aged mice had evidence of 
PrPSc in their brains, although vacuolar pathology was only found in three of these 
mice.  Original magnification X40. (e) High levels of PrPSc were detected in 
association with FDCs in spleens from clinically scrapie-affected young mice (e, 
red).  However, there was considerable variation in the detection of PrPSc in the 
spleens of the clinically negative aged mice (f-h).  (f) All the peripherally exposed 
aged mice that displayed positive vacuolar pathology in the brain had detectable 
levels of PrPSc in their spleens.  (g-h) PrPSc was undetectable in the spleens of aged 
mice that did not show histopathological signs of vacuolar pathology in their brains.  







5.3.4 Effect of age on infectivity levels in spleen  
 
Scrapie agent infectivity levels in spleen at 5, 7, 10 and 15 weeks post i.p. injection 
were measured by bioassay in C57BL indicator mice. As many TSE agents are 
known to replicate rapidly in lymphoid tissues early in infection these timepoints 
were chosen to provide information on the efficiency of the early agent replication in 
lymphoid tissues. 
 
Infectivity levels were significantly lower in spleens from aged mice and in some 
cases undetectable (table 5.3) At all timepoints infectivity levels in aged spleens were 
greatly reduced except at 10 weeks post challenge where one of the aged spleens 
contained similar levels to those of the young mice. At 15 weeks post challenge both 
spleens assayed from aged mice produced 100% incidence of disease in the indicator 
mice. However, the levels of infectivity present still represent a reduction of 
approximately 2 log10 i.c.ID50 units/g in comparison with the young mice (table 5.3, 










Table 5.3. Infectivity titres in spleens taken from aged(20 month+) and young (6-8 
weeks+) C57BL mice at 5, 7,10 and 15 weeks following  intraperitoneal challenge 
with the ME7 strain of scrapie. Assay spleens prepared as a 10% homogenate in 
physiological saline and 20µl injected i.c. into C57BL  indicator mice.  
 
 time   spleen  incidence mean   estimated titre 
 post  number   ± SEM  (log10 i.c.ID50  




  5  1  3/5  185,241,262a 1.4 
    2  7/12  217-354a 1.6 
  7  1  0/12  -  UDb 
    2  10/10  223±6  5.2 
 Aged 10  1  7/7  184±2  7.2 
    2  0/8  -  UDb 
            15         1  9/9  226±8  5.1 
  2  11/11  216±6  5.6 
 
 
5  1  11/11  181±3  7.4 
    2  7/7  187±5  7.1   
7  1  11/11  178±2  7.5 
    2  12/12  188±2  7 
 Young 10  1  12/12  182±5  7.3 
    2  12/12  181±3  7.4 
15  1  8/8  174±3  7.7   
  2  12/12  172±3  7.8 
 
 
a:Incubation period range or individual incubation periods are represented in  
assays where TSE  incidence was less than 100%. When one or more animals  
survived, the maximum titre was assumed to be lower than the titre representative  
for the longest incubation period observed; all titres are approximate. 
 
b: outwith the detection limit of the assay. 
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Figure 5.3 Scrapie agent infectivity titres in spleen from aged and young mice 











Figure 5.3. Scrapie agent infectivity titres in spleens from young and aged mice 
collected 5, 7, 10 and 15 weeks after i.p. exposure were determined by transmission 
into groups of indicator C57BL/Dk mice.  Each point represents data for individual 
spleens.  Data below the horizontal line indicate disease incidence in the recipient mice 
below 100% and considered to contain trace levels of infectivity.  High levels of agent 
infectivity were detected in the spleens of young adult mice as soon as 5 weeks after 
exposure.  However, significantly lower agent infectivity levels were detected in the 
spleens of aged mice (P < 0.001, Linear mixed model using the REML directive in 
Genstat 10th edition. Fixed effects tested using F-tests with appropriately modified 


















5.3.5 Effect of age on PrPSc accumulation in spleen  
 
At 5, 7, 10 and 15 weeks post oral or intraperitoneal inoculation spleen (n=2) and gut 
(ileum) (n=2) was collected from aged and young mice for immunohistochemical 
(IHC) and PET blot analysis for the detection of PrPSc (figure 5.4). In each instance 
tissues were fixed in PLP fixative and processed in a tissue processor. This method of 
preparation has been previously found to give optimum detection of PrP and good 
tissue morphology (Brown et al, 2000a). 
 
The precise nature of the TSE agent is uncertain, but PrPSc, a proteinase K (PK)-
resistant form of the cellular prion protein, PrPc, co-purifies with agent infectivity in 
diseased tissues (Bolton et al, 1982).  In this study, PrPSc is used to describe the 
disease-specific PrP accumulations detected by immunohistochemistry.  Within 10 
weeks after peripheral exposure of young adult mice to the ME7 scrapie agent, strong 
accumulations of PrPSc and agent infectivity accumulate within the spleen and are 
sustained until the terminal stages of disease (Brown et al, 1999; Bruce et al, 2000; 
Mabbott et al, 2003).  This early accumulation within lymphoid tissues is critical for 
efficient neuroinvasion (Brown et al, 1999; Bruce et al, 2000; Mabbott et al, 2003).    
Heavy PrPSc accumulations were detected in the spleens of all young adult mice at 5 
weeks (not shown) and 10 weeks after intraperitoneal (i.p.) or oral infection (not 
shown) with the ME7 scrapie agent (Fig. 5.4) and were maintained until the terminal 
stages of disease.  The distribution of PrPSc within these tissues was consistent with 
accumulation upon FDCs (McBride et al, 1992) (Brown et al, 1999; Bruce et al, 2000; 
Mabbott et al, 2003).  PET immunoblot analysis of adjacent sections confirmed that 
these PrP accumulations were PrPSc (Fig. 5.4).  Although gut (ileum) was collected 
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from all of the aged and young mice as detailed above analysis of these tissues remains 




Figure 5.4. PrPSc Localisation in spleen from aged and young mice following 
 i.p. injection with the ME7 scrapie agent 
Figure 5.4 Effect of host age on TSE agent accumulation upon in the spleen.  (a) 
High levels of PrPSc were detected in association with FDCs in spleens from young 
mice from 5 weeks (not shown) and 10 weeks after i.p. injection with the scrapie 
agent (upper row, red).  In contrast, PrPSc was not detected in the spleens of age mice 
until 15 weeks after i.p. exposure (upper row, red).  Analysis of adjacent sections by 
PET immunohistoblot confirmed the presence of proteinase-K-resistant PrPSc (lower 
row,/black). Upper row, magnification X100; lower row, X20. 
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5.3.6 Determination of FDC functionality during the TSE disease incubation 
period  
 
The monoclonal antibody FDC-M2 labels complement component C4 on the surface 
of FDCs  (Taylor et al, 2002). The expression of C4 is a result of interaction between 
trapped immune complexes and complement. Thus the expression of this marker on 
FDCs can be used to demonstrate the ability of FDCs to trap immune complexes.  
 
To establish functionality of FDCs during incubation period of disease in both orally 
and intraperitoneally infected mice immunolabelling for the FDC-M2 marker was 
carried out at 5, 7, 10 and 15 weeks post i.p. or oral ME7 scrapie agent infection. At 
all timepoints post infection C4 expression on FDCs was reduced in all of the aged 
spleens examined (figure 5.5), however in some animals labelling more similar to 
that of young mice could be observed. These variations suggest that the effect of age 
on FDC function is not a complete effect and in some cases FDCs may retain some 
functionality. However, in general, FDCs in spleen from both orally or i.p. infected 
aged mice appeared atrophied with little evidence of C4 expression on these cells.     
 
Mice express three Fc receptors for IgG: Fc RI, Fc RII, and Fc RIII (Qin et al, 
2000) (Balogh et al, 2001). Fc RIIB is a monomeric inhibitory receptor and highly 
expressed on FDCs in secondary follicle germinal centres. It is thought the function 
of Fc RIIB expression on FDCs in germinal centres is important for immune 
complex retention and the conversion of these immune complexes to a highly 
immunogenic form (Qin et al, 2000).  The presence of these Fc receptors on FDCs 
was determined by IHC to further assess their functionality.  At 10 weeks post 
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infection abundant labelling was detected in spleen sections from young mice. In the 
aged animals labelling was absent in spleen from most mice, although a few positive 
follicles were detected (figure 5.5). 






Figure 5.5 Immunohistochemical detection of complement component C4 using 
monoclonal antibody FDC-M2 at 10 weeks post ME7 infection. In young mice (A, 
B) extensive labelling of this marker within the germinal centre can be observed 
using confocal analysis (B) (original magnification X200). In the majority of aged 
mice (C, D) FDC-M2 labelling is dramatically reduced or absent (original 
magnification X200). Light microscopy images (C) show much lower levels of FDC-
M2 labelling in aged mice and when present appears in a condensed punctuate form 
suggesting that aberrant and impaired immune complex trapping occurs upon FDCs 
from aged mice.  (D) Sparse labelling for C4 is similarly detected using confocal 
analysis of spleens from aged mice labelled with the FDC-M2 antibody.   
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Figure 5.6 Expression of the Fc RII/III receptor in spleens of ME7 infected aged 







Figure 5.6. Immunohistochemical detection of the expression of the Fc RII/III 
receptor using monoclonal antibody 2.4G2 (anti-Fc RII/III, PharMingen) at 10 
weeks post infection in i.p. infected young (A, B) and aged mice (C, D). Abundant 
expression of the Fc RII/III marker can be detected in spleen from young mice (A, 
B), whereas the marker is almost undetectable in aged animals (C,D) with the 
exception of  some mice where typically one or two follicles displayed labelling for 




5.3.7 FDC functionality appears to be reduced in aged mice 
 
In murine models of immunosenescence the decline in the secondary antibody 
response is thought to be directly related to FDC function (Aydar et al, 2003). This 
dysfunction is thought to be related to the reduced expression of specific markers, 
including Fc RII/III, which contribute to the development and maintenance of the 
normal immune response. Here, the reduced susceptibility to TSE infection in aged 
mice appears to correlate with a decline in FDC function as demonstrated by 
immunohistochemical analysis of lymphoid tissues from uninfected aged, mice 
(figure 5.7).  In aged mice FDC-M2, which recognises complement component C4 
expression upon FDCs, was greatly reduced in all spleens examined (n=5) reflecting 
the reduced retention of trapped immune complexes on these FDC-networks. In 
young mice however (n=5) abundant FDC-M2 labelling could be detected (Fig. 5.7).  
 
Interestingly detection of complement receptors 1 and 2 (CD21/CD35) was readily 
detected in both aged and young mice, suggesting that the expression of this marker 
is not impaired in aged mice (Aydar et al, 2003). Peripheral nerves were detected 
immunohistochemically using an anti- tyrosine hydroxylase marker. Innervation was 
not reduced in aged mice and in-fact there was some suggestion that greater levels of 
innervation were present in spleens from these aged mice (figure 5.8). 
 
Double immunofluorescent labelling for PrP protein and FDC-M2 in aged spleen 
found considerable variation between aged mice in the detection of normal PrP. In 
some germinal centres where FDC-M2 labelling was more abundant PrPc was readily 
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detected (figure 5.10, b) whereas the labelling was reduced or undetectable in other 
germinal centres where the localisation of FDC-M2 was reduced (figure 5.9, c).    
 



























Figure 5.7 Analysis of spleen from uninfected young mice shows abundant FDC-M2 
labelling using confocal (A) and light microscopy (B). In aged mice (C,D) there was 
some variation in the level and appearance of this labelling between animals and 
within spleens although the overall level of labelling was reduced in all of the 
spleens examined in comparison with that of the young mice. In most aged spleens, 
FDC-M2 labelling appeared atrophied and sparsely distributed. Original 
magnification X200. 
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Figure 5.8 Effect of host age on CR2/CR1 status and peripheral nerve detection 








Figure 5.8 Unlike C4 expression which is dramatically reduced in aged mice (Figure 
5.5) there was no difference in the detection of CR2/CR1 in spleens from young (A) 
or aged mice (C) (original magnification X200). To assess the effect of age on 
innervation of the spleen the immunohistochemical detection of peripheral nerves 
was performed using the noradrenergic marker tyrosine hydroxylase. 
Immunohistochemical analysis demonstrated the presence of  tyrosine hydroxylase 
positive sympathetic nerves (green) in the spleens of both young (B) and aged mice 
(D). In-fact, there was some indication that spleens of aged mice were more highly 
innervated than those of the young mice.  Original magnification X200.   
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Figure 5.9 PrPc expression is reduced in the spleens of aged mice with disrupted 
FDC networks 
 
   
 
 
Figure 5.9. (a) High levels of cellular PrPc expression (green) and complement 
component C4 (red) co-localized upon FDCs in spleens of young mice.  (b) In some 
spleens from aged mice, levels of PrPc and complement C4 were similar to those 
observed in spleens from young mice. (c) In most spleens from aged mice, 
immunolabelling for PrPc and complement C4 was greatly reduced and appeared 
atrophied and sparsely distributed within the follicle. (original magnification X400) 
Light level images from each section are provided to demonstrate the labelling 





 In the majority of naturally acquired and experimental TSEs extensive lymphoid 
tissue involvement occurs. In many experimental TSEs high levels of infectivity and 
PrPSc can be detected in tissues such as spleen and lymph nodes several weeks after 
peripheral infection. In these models, infection in the lymphoid tissues precedes the 
first detection of disease within the CNS by many weeks or months. In vCJD (Hill et 
al, 1999b), but not sCJD (Gambetti et al, 2003), PrP and infectivity accumulates in 
lymphoid tissues of affected individuals suggesting that a functional immune system 
may be critical for the pathogenesis of vCJD (Bruce et al, 2001).  This paradox 
between vCJD and sCJD is not fully understood but may be the result of strain 
specific tissue tropism; for example some experimental TSE strains such as the ME7 
agent strain and the 79A agent strain are known to extensively target lymphoid 
tissues (Fraser, 1996) whereas the 87V agent strain (Bruce, 1985) has very little 
lymphoid tissue involvement. The two forms of CJD differ in other ways including 
clinical presentation and neuropathology (Ironside et al, 2002) but one of the most 
striking differences between vCJD and sCJD is the age distribution of cases (Ghani 
et al, 2000). In vCJD the median age of death is approximately 29 years, whereas it is 
68 years for sCJD. A number of hypothesis exist to explain this predominance of 
young people with vCJD including exposure to vaccination (Minor et al, 2000) and 
preferential dietary exposure (Boelle et al, 2004). However, an epidemiological study 
to consider the effect of diet found that dietary exposure alone could not explain this 
phenomenon. In fact, this study predicted that if dietary exposure was the major 
factor in the age distribution of cases the cumulated proportion of cases over 40 years 
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In these studies aged mice infected with ME7 either orally or by i.p. injection failed 
to develop clinical disease whereas aged mice developed clinical disease following 
direct CNS infection with similar incubation periods to those of the young mice. 
However, subsequent analysis of brain found that 33% of i.p. and 42% of orally 
infected mice had positive vacuolar changes in brain. Analysis of the severity of 
vacuolation in specific brain regions from these aged mice found that it was 
significantly lower than that of the young mice that died within the same time period. 
As these mice were almost 1000 days old at the time of death it is possible that could 
they have survived longer they may have eventually developed clinical signs of 
disease; albeit with prolonged incubation periods to those of the young mice. 
Alternatively,  it is possible that age associated changes in the CNS may modulate 
the clinical symptoms of disease observed or perhaps produce lower levels of 
pathology than those observed in younger mice. As aged mice developed clinical 
disease following i.c. infection this seems a less likely possibility; although the 
severity of pathology was significantly reduced in these mice. Similarly, mink of the 
Chediak-Higashi phenotype, infected with transmissible mink encephalopathy 
(TME) displayed lower levels of vacuolar pathology in the aged but not the young 
mink of the same phenotype (Marsh et al, 1976).  
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Following exposure to many TSEs, including the ME7 agent strain, deposition of the 
disease specific form of PrP (PrPSc) in the CNS precedes vacuolar changes in the 
CNS (Bruce et al, 1989b). Indeed, accumulation of PrP in lymphoid tissues occurs 
very early in infection in a number of experimental (Bruce et al, 1996; McBride et al, 
1992)and naturally acquired infections for example chronic wasting disease (CWD) 
(Sigurdson et al, 2002). In these studies the detection of PrPSc in brain and lymphoid 
tissues was used to establish the level and presence of TSE disease in the absence of 
clinical symptoms of disease or vacuolar brain pathology. 
 
Significantly all of the orally challenged mice had evidence of PrPSc accumulation in 
brain although there was no evidence of clinical disease and only a proportion of 
these animals had positive vacuolar scores. These findings may have important 
implications since the most likely original route of vCJD transmission was via the 
oral route (Bruce et al, 1997), raising the possibility that many people may be 
infected with this disease in the absence of any clinical disease symptoms. There was 
considerable variation in the detection of PrPSc in the spleen of aged mice. All of the 
aged mice with positive vacuolar brain pathology (with the exception of one orally 
challenged animal) had accumulation of PrPSc in both brain and spleen. As PrPSc is 
localised to the surface of FDCs in lymphoid tissues this may suggest that the 
pathogenesis of disease in these mice was more similar to that of the young adult 
mice, possibly as a result of a more functional immune system at the time of 
infection.  In contrast, in the aged mice where there was evidence of PrPSc 
accumulation in brain but not in spleen it is possible that infection of the CNS has 
occurred in the absence of lymphoid system involvement, possibly via direct 
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peripheral nerve infection as is known to occur in immunodeficient mice after high 
dose challenge (Fraser et al, 1996). The reasons for these differences are uncertain.  
In mice deficient in FDCs neuroinvasion may occur in some mice by an FDC-
independent process such as direct uptake by peripheral nerves (Fraser et al, 1996), 
implying direct transfer of the TSE agent to the nervous system in some aged mice.  
Alternatively, it is plausible that the TSE agent initially accumulated upon FDCs 
facilitating subsequent neuroinvasion, but was cleared from the spleen as the status 
of the FDCs declined.  
 
These data have important implications for the development of reliable pre-clinical 
diagnostics, as tests based on the detection of the TSE agent in blood or lymphoid 
tissues may be less sensitive when used on the elderly.  In addition surveillance 
methods attempting to estimate levels of potential disease within the population such 
as analysis of tonsil, appendix or other tissues (Hill et al, 1999b; Hill et al, 1997; 
Hilton et al, 2002; Hilton et al, 2004) (Ironside et al, 2006) may be largely redundant 
in the elderly due to the lack of PrP accumulation in these tissues  
 
The mouse-passaged ME7 scrapie agent strain was used in these studies as its 
pathogenesis in mice appears to closely resemble that of natural sheep scrapie 
(Hunter, 2007), chronic wasting disease (Sigurdson et al, 1999) and vCJD in the 
natural host (Brown et al, 1997; Hill et al, 1997) in that TSE agent accumulation 
occurs in lymphoid tissues before neuroinvasion (Bruce et al, 2001). As TSE agents 
are known to replicate rapidly in lymphoid tissues early in infection (Collis & 
Kimberlin, 1989; Fraser et al, 1992b; Fraser & Dickinson, 1978; Fraser, 1996; 
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Kimberlin & Walker, 1979; Kimberlin & Walker, 1989; Kimberlin & Walker, 
1990)several timepoints in early infection were chosen to provide information on the 
efficiency of disease replication in lymphoid tissues and on the accumulation of 
PrPSc in spleen. The analysis of these tissues was especially important as it was 
impossible to predict at the outset of the study if aged animals would survive to the 
clinical endpoint of disease.  
 
Infectivity levels in aged spleen were significantly lower than those of the young 
spleens and in some cases undetectable.  At 15 weeks post challenge both spleens 
assayed produced 100% incidence of disease in the indicator mice. However, the 
levels of infectivity present still represented a reduction of approximately 2 log10 
i.c.ID50 units/g in comparison with the young mice. Similarly, PrPSc in spleen was not 
detected by PET (histoblot) or immunohistochemistry until 15 weeks after 
intraperitoneal or oral challenge. This suggests that disease pathogenesis in aged 
mice is delayed as a result of inefficient disease transmission. 
 
In murine models of immunosenescence, the decline in the secondary antibody 
response is thought to be directly related to FDC function (Aydar et al, 2003; Szakal 
et al, 2002). This dysfunction is thought to be related to a reduction in the expression 
of specific markers, including Fc RII/RIII, which contribute to the development and 
maintenance of the normal immune response (Qin et al, 2000). Here, studies in this 
chapter show that the reduced susceptibility to TSE infection in aged mice correlates 
with a decline in FDC function as demonstrated by immunohistochemical analysis of 
lymphoid tissues from uninfected aged mice. In these aged mice the association of 
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complement component C4 with FDCs was greatly reduced reflecting the amount 
and location of trapped immune complexes on the FDC-network. In young mice 
however abundant localisation of C4 on FDCs could be detected.   The complement 
receptors CR1/CR2 was readily detected in both aged and young mice, suggesting 
that the expression of this marker is not impaired in aged mice (Aydar et al, 2003). 
Double immunofluorescent labelling for PrP protein and C4 in aged spleen found 
considerable variation between aged mice in the detection of normal PrP. In some 
germinal centres where C4 labelling was more abundant PrPc was readily detected 
whereas the labelling was reduced or undetectable in other germinal centres where 
the localisation of FDC-M2 was reduced (figure 3).   As PrPc expression (Brown et 
al, 1999; Klein, 1998)and opsonising complement components (Klein et al, 2001; 
Mabbott et al, 2001) are critical for the accumulation of TSE agents upon FDCs, it is 
likely their reduced association with FDCs in the spleens provides some explanation 
for the reduction in infectivity levels and in the reduced accumulation of PrPSc in 
lymphoid tissues.  
 
The assessment of C4 and expression of the Fc RII/III receptors were also assessed 
in infected animals from 5-15 weeks post challenge. As demonstrated previously, C4 
labelling was greatly reduced in uninfected aged mice in comparison with younger 
animals. In addition abundant labelling of the Fc RII/III marker was detected in 
infected young mice although the expression of this marker was barely detectable in 
aged mice infected with the ME7 scrapie strain. Interestingly, the expression of the 
IgG Fc receptor Fc RIIB (Qin et al, 2000) is not found in primary follicles, but only 
in mature germinal centres normally in response to a humoral immune response 
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(Aydar et al, 2003).  The expression of Fc RII/III on FDCs in GCs is critical for 
immune complex trapping upon FDCs and in the conversion of these immune 
complexes to a highly immunogenic form (Qin et al, 2000) (Aydar et al, 2003). In 
uninfected aged and young mice Fc RII/III was only sparsely detected in a few 
follicles irrespective of age suggesting that scrapie infection has enhanced the 
expression of Fc RII/III in the young mice indicating that scrapie infection may 
provoke some form of immune response. If infection with scrapie agents does indeed 
provoke an immune response it is possible the lack of expression of this marker in 
infected aged mice is due to impaired replication of infectivity by the FDCs 
themselves (as demonstrated by splenic infectivity measurement). Indeed, studies in 
aged mice find that Fc RII/III labelling on aged FDCs is dramatically reduced 
following immunisation (Aydar et al, 2004). Further studies are required to establish 
the significance of this finding but it may suggest that TSE infection elicits some 
form of immune response within the host leading to this greater expression of Fc RII 
/III within the germinal centre.  
 
Although the findings presented here show that the effects of age on pathogenesis 
coincide with FDC dysfunction, it is not possible to determine from these studies if 
the FDCs themselves are responsible for these effects on pathogenesis. It remains 
possible that this impaired pathogenesis is related to defects in other cell types, such 
as lymphocytes.  In future studies the creation of chimaeric models where a 
mismatch between aged FDCs and young lymphoid cells are created and vice-versa 
may be extremely useful in elucidating which cells directly contribute to these 
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defects in TSE pathogenesis, the design of these potential studies is described in 
chapter 7. 
Although these findings show that increasing age results in impaired TSE 
pathogenesis previous studies have shown that neonatal mice are also less susceptible 
to peripheral TSE infection than adults (Ierna et al, 2006; Outram et al, 1973). 
Similarly, this resistance correlates with an absence of FDCs in the spleens of 
neonatal mice at the time of exposure with the onset of disease susceptibility 
coinciding with the development and maturation of FDCs during the first 10 days 
post birth (Ierna et al, 2006).  
 
Although the reasons associated with the predominance of vCJD cases in young 
people may be complex, our data demonstrates that the pathogenesis of peripherally 
acquired TSE agents, such as vCJD, in older humans is likely to be much less 
efficient than that of young individuals. However, this data also demonstrates that 
inefficient disease transmission in aged individuals may result in significant levels of 
sub-clinical disease within the older population presenting further implications for 
iatrogenic spread of infection.  These findings suggest that this impaired 
pathogenesis in aged mice correlates with FDC function and provides strong 
evidence that immunosenescence may influence susceptibility to vCJD infection.  
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Although TSE infections are thought of primarily as neurodegenerative diseases, the 
immune system is critically involved in the pathogenesis of most experimental and 
natural TSEs. However it is uncertain whether this infection of lymphoid tissues 
results in any associated immune system dysfunction or immune system activation. 
The main aims in this chapter were to investigate the effects of TSE infection on the 
immune system and to determine how the immune system influences TSE 
pathogenesis. Here two distinct T cell dependent antigens were used to immunise 
mice and study their effects on TSE pathogenesis in separate studies. Immunisation 
of mice with sheep red blood cell antigen (SRBC) at 6 and 9 weeks post i.p. injection 
significantly prolonged the disease incubation period (p=0.033). However 
immunisation with DNP-KLH at 10 and 13 weeks post infection significantly 
shortened incubation period (p=0.001).  This finding was highly significant. 
Immunisation with DNP-KLH at a mid-point of infection and a pre-clinical timepoint 
had no effect on incubation period of disease suggesting that these effects on 
pathogenesis are limited to the early stages of infection.  An unexpected finding was 
the sudden death of a third of the ME7 scrapie infected mice following boosting with 
SRBC antigen at a late stage of infection. No deaths or adverse effects occurred in 
any of the other groups suggesting that some form of immune system dysfunction at 
this late stage of infection may have contributed to the deaths of these mice or 
accelerated the onset of clinical TSE disease. Together these findings demonstrate 
that manipulation of the immune system during scrapie infection mice can alter 
disease pathogenesis.       
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 6.2 Introduction 
The majority of TSE infections are most likely acquired by peripheral exposure; for 
example by ingestion of infectious material in food or via transmission through the 
skin or mucous membranes. BSE in cattle (Wells et al, 1987), CWD in deer and elk 
(Sigurdson et al, 1999) and vCJD (Bruce et al, 1997) and kuru in humans (Collinge 
et al, 2006) are all thought to be transmitted via the oral route. The occurrence of 
BSE in cattle almost certainly arose from the feeding of TSE contaminated meat and 
bone meal derivates, this contamination has been attributed to changes in rendering 
practices in the early 1980s permitting the survival of TSE infectivity. A number of 
theories exist for the origin of BSE and most suggest it arose from scrapie in small 
ruminants (Priola & Vorberg, 2004), or from a previously unrecognised form of TSE 
in cattle, although some more controversial theories suggest BSE may have a human 
origin (Colchester & Colchester, 2005). BSE has since been transmitted to a number 
of species including humans as variant CJD; with no deviation in strain 
characteristics even when passaged through other species (Bruce et al, 2002).  
 
CWD has been reported in captive and free-ranging deer and elk from north-eastern 
Colorado and south-eastern Wyoming. In CWD the epidemiology is not fully 
understood but it is thought that horizontal transmission, via oral exposure, is the 
most probable mechanism for infection of free- ranging animals (Sigurdson et al, 
2002). Indeed, experimental studies in orally dosed mule deer have shown that PrPSc 
accumulates in lymphoid tissues of the alimentary tract, in association with FDCs, as 
early as 42 days after infection (Sigurdson et al, 1999).  
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The ritualistic practice of endocannabalism (Zigas & Gadusek, 1957); Gadusek, 
1963; (Alpers, 1965) (Gajdusek, 1963) amongst the Fore tribe of Papua New Guinea 
resulted in the transmission of “kuru” (Gajdusek & Alpers, 1966). The majority of 
affected individuals were women and adolescents who predominantly consumed 
brain and human offal ; males consumed mainly muscle which is not normally 
associated with significant levels of infectivity (Hornabrook & Moir, 1970) (Bosque 
et al, 2002; Collinge et al, 2006). Although most cases of kuru were probably 
transmitted orally, epidemiological evidence suggests that kuru may also have been 
parenterally transmitted via the skin or mucous membrane; by the smearing of ash 
onto the skin from the remains of the deceased or by handling contaminated tissues 
(Collinge et al, 2006). In natural scrapie, infection via the skin or mucous membranes 
is also thought to be an important route of disease transmission (Hunter, 2007). 
Indeed experimental studies in mice have shown that infection via the skin 
(scarification) is an efficient route of transmission (Taylor et al, 1996)  
 
In vCJD high levels of infectivity and the accumulation of PrPSc can be detected in 
lymphoid tissues in association with FDCs. This involvement of the immune system 
and the probable dissemination of infection, or cells associated with infectivity into 
the bloodstream has resulted in four cases of vCJD in individuals who received vCJD 
contaminated blood products (Llewelyn et al, 2004; Peden et al, 2004; Wroe et al, 
2006). It is not understood which cell types participate in dissemination of infection 
in blood and although FDCs are associated with high levels of infectivity these cells 
are non-mobile and remain within the germinal centre. The most likely candidates for 
dissemination of infectivity are lymphocytes. These cells,  through their intimate 
 217
associations with FDCs, may disseminate infectivity into the bloodstream from 
lymphoid tissues which are known to contain infectivity (Bruce et al, 2001). In 
contrast, there is no evidence of disease transmission via blood in sporadic CJD 
(Wilson et al, 2000); however there is no recognized involvement of the lymphoid 
tissues with sCJD (Hill et al, 1999b).   
 
Previous studies carried out many years ago failed to find evidence of a classical 
immune response to scrapie infection (Chandler, 1959; Clarke & Haig, 1966; 
Pattison et al, 1964). One hypothesis for this phenomenon was that infection with the 
scrapie agent resulted in immunosupression, although little evidence has been found 
to support this (Clarke, 1968; Gardiner & Marucci, 1969; Garfin et al, 1978a; Garfin 
et al, 1978b). This lack of immune response to infection is perhaps not unexpected 
since the infectious agent is thought to be at least partly composed of PrPSc 
(Somerville & Dunn, 1996 ; Somerville et al, 1986) the infectious isoform of the host 
protein, PrP (Bolton et al, 1982; Bolton et al, 1985; McKinley et al, 1983). When 
these original studies were conducted PrP protein and its abnormal infectious isoform 
had not been discovered (Bolton et al, 1982; Hunter et al, 1992). Although there is no 
evidence for a classical immune response to TSE infection (Chandler, 1959; Clarke 
& Haig, 1966), studies investigating immunoglobulin (Ig) levels in sheep from flocks 
with a high incidence of natural scrapie found that these were greatly elevated during 
the clinical phase of disease(Collis et al, 1979). Further studies in sheep 
experimentally infected with the SSBP/1 strain of scrapie found similar results 
(Collis & Kimberlin, 1983) and demonstrated that IgG, specifically IgG2a was the 
major Ig sub-class present in the sheep sera. However, evidence now suggests that 
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the increased levels of IgG2a in these scrapie affected animals were in-fact the 
indirect result of animals suffering from pruritus (Nora Hunter, personal 
communication).  
 
In a number of infectious diseases, modulation of the host’s immune system by the 
infectious agent occurs as a result of infection. These diseases include Chagas' 
disease, caused by the intracellular protozoan parasite Trypanosoma cruzi (Medina et 
al, 2007), where molecules released by the infection influence the host’s immune 
system. The effects of human immunodeficiency virus (HIV) and simian 
immunodeficiency virus (SIV) infection on the immune system are also well 
documented (Boasso & Shearer, 2008; Kottilil et al, 2006; Moss et al, 2000; 
Tompkins & Tompkins, 2008; Zhang et al, 2004). In a murine model of HIV 
germinal centre and FDC network formation were impaired as was immunoglobulin 
isotype switching (Poudrier et al, 2001). Furthermore defects in T helper (TH1) 
lymphocyte responses have been noted in tuberculosis (Wu et al, 2008). The 
detection of any alterations in immune function or some form of immune response 
during TSE infection would not only be fundamentally important but could aid the 
development of future diagnostic tests for TSE infection. In addition, any TSE 
associated immune system dysfunction may have implications for human and animal 
health especially if many individuals in a population are infected with a TSE such as 
vCJD.  
 
Studies in mice with immunodeficiencies have demonstrated that the presence of a 
functional immune system is a requisite for efficient peripheral pathogenesis of 
disease. A number of studies have focused on the effects and relevance of 
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immunodeficiency or absence of specific cell types such as FDCs in pathogenesis. 
However, what is little understood is the effect of modulating the immune system by 
generating an immune response either at the time of infection or during incubation 
period of disease.  Studies carried out in the 1970’s showed that a single treatment 
with phytohaemagluttinin (Dickinson et al, 1978) or modified BCG vaccine 
(Kimberlin & Cunnington, 1978a) prior to infection could significantly shorten 
incubation period of TSE disease in rodents. At the time of conducting these studies 
the implications of these findings in relation to the role of FDCs and the immune 
system in pathogenesis was not fully understood. Based on our current understanding 
of FDC involvement in TSE infection (Brown et al, 2000a; Brown et al, 2000b; 
Brown et al, 1999; Mabbott et al, 1998; Mabbott et al, 2002; Mabbott et al, 2000b; 
Mabbott et al, 2003) it seems likely these effects on pathogenesis would have been 
the result of germinal centre activation leading to increased levels of agent 
replication in lymphoid tissues and more efficient neuroinvasion.  
 
In this chapter the aims are to (1) determine the effects of the immune system on 
pathogenesis by generating a humoral immune response at several timpoints during 
pathogenesis, (2) to determine if there are any assoicated alterations in immune 
function for example in germinal centre development in lymphoid tissues and (3) to 
determine if immunisation alters levels of agent infectivity in lymphoid tissues. If 
immunisation alters efficacy of infection or levels of infection within lymphoid 
tissues this may have important implications in determining risk factors in the 
transmission of TSE infection for example in vCJD infection. 
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In the first series of experiments, sheep red blood antigen (SRBC) was used to 
immunise mice at an early and late stage of infection to determine the effects of 
immunisation on pathogenesis and to assess immune function in TSE infected 
animals. However, despite its widespread use, SRBC antigen may not be an ideal T-
dependent immunogen because of differences in the ability of different donor sheep 
to stimulate antibody responses. In the second series of experiments, a hapten-protein 
carrier system (dinitrophenyl-keyhole limpet haemocyanin: DNP-KLH), was used to 
immunise mice at three separate timepoints during the incubation period of disease. 
Dinitrophenyl (DNP) has been used extensively as a model immunogen in the study 
of immunology and much of our current understanding of the antibody response to 



















6. 3.1 Disease pathogenesis in scrapie infected mice following SRBC immunisation 
 
Figure 6.1 Experimental design 
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ME7 or normal brain (NB) infected mice were immunised with SRBC antigen at the 
timepoints shown above. Animals were immunised at an early and late stage of 
infection and a proportion of animals from each group left until the clinical endpoint 
of disease to determine whether immunisation had any effects on incubation period 
at specific timepoints. Immunisation at an early infection timepoint was carried out 
to determine the effects of immunisation before the spread of infection to the CNS 
(neuroinvasion) had occurred. In addition at this stage active replication of agent 
infectivity would be occurring in lymphoid tissues; although infectivity would not 
yet have reached a plateau at this stage. Immunisation at a late (pre-clinical) stage of 
infection was carried out to determine effects on pathogenesis when high levels of 
TSE associated pathology would be present in the CNS.  
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In the early immunisation group mean incubation periods in immunised mice were 
significantly longer (284±7 p=0.033) than those of the ME7 challenged mice which 
were given saline (261±7). Notably the incubation periods in the mice given saline as 
control were slightly shorter than anticipated for this agent strain. In these studies, 
ME7 infected mice alone were not included so it is not known if injection with saline 
alone affected pathogenesis. In the animals immunised at the late stage of infection, 
there were no differences in incubation periods between immunised mice (263±3 p= 
0.65) and the saline control group (271±7). However following immunisation at late 
stage infection, approximately one third of the scrapie infected mice died (7/23 
animals) unexpectedly (all of the mice died within a 24 hour period)following 
boosting with SRBC antigen. No deaths or other clinical effects were recorded in the 
immunised uninfected mice or in the scrapie infected mice given saline instead of the 
SRBC immunisation. In addition, no adverse effects were recorded following 
antigenic challenge at the early stage of scrapie infection. As these adverse effects 
were not anticipated,  mice were returned to their holding cages immediately 
following immunisation and only checked later that day; therefore it can only be 
estimated that the mice died within an 24 hour time period following boosting. To 
establish if clinical status of the mice had any relevance to these unexpected deaths; 
analysis of the TSE scoring records was carried out. This revealed that of the 7 
animals that died only 1 had a “definite” scrapie score and another 2 had a “probably 
affected” score. The remaining 4 animals had been allocated a clinically normal 








Figure 6.2 ME7 pathogensis following immunisation with SRBC 
antigen 
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Figure 6.2 Effect of immunisation on the pathogenesis of the ME7 strain of scrapie.  
Mean incubation periods of mice immunised at an early stage of infection (42 and 63 
days) were signifcantly longer than the saline control (p=0.033). Following 
immunisation with SRBC antigen at the late stage of infection (240 and 261 days) no 
significant difference in incubation period was observed between the immunised and 
non-immunised mice although 7/23 mice died suddenly following the boost 







6.3.2  Effect of immunisation with SRBC antigen on PrP accumulation in the 
spleen 
 
The accumulation of the disease specific form of PrP protein (PrPSc) in lymphoid 
tissues is a characteristic of many natural and experimental TSE infections. As 
antigenic challenge stimulates the number and size of germinal centres and FDC 
networks in lymphoid tissues this may enhance PrPSc accumulation in the spleens of 
scrapie-affected mice. Immunohistochemistry (IHC) and PET blot analysis was used 
to assess the numbers of PrPSc postive FDCs in the spleen (Schulz-Schaeffer et al, 
2000) (Figure 6.3). Data is presented as number of PrPSc positive FDCs in 
spleen/individual animal (two spleen sections from each animal were quantified) and 
also as the mean number of PrPSc positive FDCs in spleen in each experimental 
group. Statistical analysis was carried out using the student’s t-test (two-tailed, 
unpaired), based on comparison of mean counts from individual animals.  
Comparison of  PrPSc labelling one week post boosting (268dpi) from the pre-clincal 
infection groups found almost identical numbers of PrP positive FDCs in SRBC 
immunised mice (mean number of 38 PrPSc positive FDCs per ½ spleen section) 
compared with the saline injected mice (a mean number of 40 PrPSc positive FDCs 
per ½ spleen section) p=0.81. Quantification of  PrP positive FDCs from the mice 
which died suddenly found that there was a mean number of  51 PrP postive FDCs 
per ½ spleen section. However it is not possible to determine if this figure represents 
a significant increase in PrP positive FDCs as due to the sudden death of the 
immunised mice equivalent ME7  saline controls were not collected at the same time. 
Data is not presented from the early infection immunisation timepoints due to small 
sample number (only one spleen was available from the ME7 immunised group and 
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two from the non-immunised group). However there was a mean numbers of 92 PrP 
positive FDCs in spleen from the immunised animal in comparison with a mean of 
29 PrP postive FDCs in the non-immunised infected animals (n=2) (p=0.09) 
suggesting that immunisation at this early stage of infection may have increased 









































Figure 6.3 Quantification of PrPSc positive FDCs following immunisation of 
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Figure 6.3 Estimation of PrPSc positive FDCs in spleen sections from individual 
mice, labelled. PrPSc positive FDC networks were detected using the PET blot 
method and the numbers of PrPSc positive FDCs in each spleen section (2 from each 
mouse) quantified. (a) Number of PrPSc positive FDCs in spleen from ME7 infected 
mice immunised with SRBC or saline at the late stage of infection. Spleens were 
taken 1 week post boosting with SRBC or saline (268 days post infection). (b) PrPSc 
positive FDCs in mice which died suddenly post SRBC boost immunisation.  (c) 
Mean numbers of PrPSc positive FDCs in spleen from animals which died suddenly 
and those taken 1 week post boosting. Statistical analysis was carried out using the 
student’s t-test and based on comparison of average counts from individual animals. 
There was no significant difference in the number of PrP positive FDCs one week 





Figure 6.4 Accumulation of PrPSc in spleen following immunisation 
     
Figure 6.4 Immunohistochemical detection of PrPSc at the late stage of infection 
using the monoclonal antibody 6H4. A, B shows spleen sections from animals that 
died immediately following boost immunisation. C, D are from mice immunised and 
boosted with SRBC antigen and collected at the terminal stage of disease and the E,F 
shows sections from mice injected with saline and collected at the terminal stage of 
disease. Quantification of  PrPSc positive germinal centres in PET blots from SRBC 
immunised mice demonstrates that there is no difference in numbers of PrPSc positive 
germinal between SRBC and saline immunised ME7 infected mice. 
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6.3.3 Immunoglobulin (Ig) levels in the serum of ME7 infected mice following 
immunisation with SRBC antigen.   
 
One of the aims of this study was to determine whether antigen-specific immune 
responses were altered in TSE infected mice. However, attempts to measure specific 
Ig responses to SRBC antigen were unsuccessful; despite many attempts at this 
procedure. Therefore to provide some estimate of Ig levels in sera from infected and 
uninfected mice following SRBC immunisation a radial immunodiffusion (RID) 
assay was performed (Mancini et al, 1965) using sera from uninfected (n=4) and 
infected mice (n=6) collected one week post boost immunisation at a late stage of 
infection (268 dpi). The RID assay is based on the principle of complexing antigen 
and antibody to produce a visible precipitin ring. In these studies the mouse 
BINDARID™ kit was used.  The RID assay is performed in (ready-to-use) agar 
plates, containing specific anti-IgG subclass antibodies. Test samples, standard and 
control sera, are also prepared and added to the plates. After 72 hours incubation at 
room temperature the diameters of the control and sample rings were measured and 
values calculated using the standard reference table provided.  Immunoglobulin sub-
class measurements were performed and the results displayed in figure 6.5. There 
was no significant differences in the total Ig levels in any of the Ig sub-classes 
between the ME7 infected and uninfected mice following immunisation.  However, 
levels of IgM in 3 of the 6 ME7 infected mice exceeded the upper detection limit of 
the assay and these individual values are presented in figure 6.5.  In-fact 4 of the 6 
mice had higher IgM levels than those of the uninfected mice. Clearly more studies 
are required to further investigate these differences and these planned studies will 
also include measurement of Ig levels in non-immunised TSE infected mice for 
comparison. 
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Figure 6.5 Serum immunoglobulin levels as determined by RID in ME7 infected 


























































ME7 infected                             normal brain infected      
Figure 6.5   RID measurement of total serum IgM, IgG2b, IgG2a and IgG1 levels in 
sera of SRBC immunised ME7 infected (blue bars) or normal brain (maroon bars) 
injected mice. Sera samples were collected 7 days post boost immunisation with 
SRBC at a late stage of infection. (A) Mean serum Ig levels in SRBC immunised 
ME7 (n=6) and uninfected (NB) mice (n=4). (B) Individual serum IgM levels in 
infected or uninfected mice following boost immunisation * 3/6 mice had levels  of 
IgM exceeding the upper detection limit of the assay (>833mg/l).  
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6.3.4 Analysis of PNA germinal centres in uninfected and scrapie 
infected mice following immunisation with SRBC antigen 
 
Peanut agglutinin (PNA), isolated from Arachis hypogaea (peanuts), is a 10,000 
molecular weight lectin composed of four identical subunits of approximately 27,000 
Daltons each.  PNA (PNA) (Reisner et al, 1979). Mature B cells, but not immature B 
cells, within active germinal centres exhibit high levels of binding by PNA (Kosco-
Vilbois, 2003).  The enumeration of PNA positive germinal centres in infected and 
non-infected mice following immunisation was carried out to determine any effects 
of TSE infection on the formation of germinal centres.  
 
PNA positive germinal centre numbers in immunised ME7 infected or normal brain 
injected mice were quantified, one week post boost immunisation at an early and late 
stage of infection (figure 6.6). In both the early and late immunisation groups there 
were more PNA positive germinal centres in the immunised ME7 infected mice 
compared with the NB injected controls, although there was considerable variation 
between some animals in the same experimental groups. To display this variation, 
data is presented as germinal centre counts from individual animals (two spleen 
sections from each animal were counted) and the mean number of germinal centres 
in spleen in each experimental group. Statistical analysis was carried out using the 
student’s t-test and based on comparison of average germinal centre counts from 
individual animals. At the early stage of infection the ME7 infected mice had a mean 
number of 13.1 germinal centres per ½ spleen section compared to 3.1 GC in the NB 
injected mice (p=0.08). Similarly, at the late stage of infection the ME7 infected 
mice (n=6) had a mean number of 13.3 GC per ½ spleen section compared with 6.9 
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in the control mice (n=7) (p=0.09).  Analysis of GC numbers at the early stage of 
infection from non-immunised ME7 infected (n=3) and uninfected mice (n=3) also 
demonstrated greater numbers of GC in infected spleen, although this difference was 
not statistically significant (p=0.48) (data not shown).  
 
Although quantification studies failed to demonstrate significant differences between 
germinal centre numbers in uninfected and ME7 scrapie infected spleen, germinal 
centre size appeared greater in ME7 scrapie infected mice. Further studies are clearly 
required using larger sample sizes to establish if indeed germinal number and/or size 
is increased in TSE infection. In addition, in ME7 infected mice high levels of singly 
labelled PNA positive cells could be visualised throughout the splenic white pulp 
(figure 6.7). It is possible this represents distribution of mature B cells throughout the 
white pulp in these scrapie infected spleens although the significance of this is not 














Figure 6.6 Estimation of PNA positive germinal centre number in spleen 








Figure 6.6. PNA positive germinal centre numbers in spleen in uninfected or ME7 
infected spleen 7 days post boost immunisation with sheep red blood cells (SRBC) at 
the early (A) or late stage of infection (B). Mean numbers of PNA positive GCs in 
spleen from animals in each experimental group are displayed. Statistical analysis 
was carried out using the student’s t-test and based on comparison of average counts 














Figure 6.7 Immunohistochemical detection of PNA positive germinal centres 
following immunisation 















Figure 6.7 Immunohistochemical detection of germinal centres in spleen by labelling 
with peanut agglutinin (PNA). Spleens from uninfected (normal brain injected) or 
ME7 infected mice were collected one week post boost immunisation with sheep red 
blood cells (SRBC). (at 268 days post ME7 or NB challenge). Although 
quantification studies failed to demonstrate significant differences between GC 
numbers in uninfected (c,d and e) and ME7 infected spleen (a, b and f) GC size 
appeared greater in ME7 infected mice. In addition in infected mice high levels of 
singly labelled PNA positive cells could be visualised throughout the splenic white 
pulp although the significance of this is not understood. 
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6. 3.5 Effect of immunisation with dinitrophenyl-keyhole limpet haemocyanin 
(DNP-KLH) on scrapie pathogenesis. 
 
Figure 6.8 Experimental design 
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Following the results obtained with the SRBC immunisations another immunisation 
study was set up, this time using a different immunogen: dinitrophenyl-keyhole 
limpet haemocyanin (DNP-KLH.) The main reasons for this change of immunogen 
were concerns over variability in immunogenic properties that can occur with SRBC 
antigen and difficulties in the detection of SRBC specific Ig sub-class by ELISA. As 
shown above in figure 6.8. the effects of immunisation were investigated at three 
timepoints 1) an early timepoint (70 days post injection (dpi) where high levels of 
70pi 91dpi 
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infectivity would be present in spleen but neuroinvasion would not have occurred 2) 
a mid infection timepoint where infection into the CNS would have occurred but 
there would be no clinical signs of disease and minimal CNS pathology and 3) a late 
pre/early clinical timepoint where some early clinical symptoms may be present but 
major pathological changes (deposition of PrP and vacuolar changes) would be 
present.  Mice were injected i.p. with ME7 scrapie agent strain (1% dilution of 
terminal ME7 scrapie brain homogenate) and then immunised with 100 µg of DNP-
KLH in alum in 100 µl PBS given i.p (see section 2.5.3) at the times shown in figure 
6.8. A secondary immunisation with 100 µg of DNP-KLH was given 3 weeks after 
primary immunisation. From each immunisation timepoint tissues were collected 7 
days after primary and boost immunisation to determine the effects of a primary or 
secondary immune response on infectivity levels in the spleen. Groups of immunised 
and control (non-immunised) mice were maintained until the endpoint of disease to 
determine the effects of immunisation on disease pathogenesis. 
 
Mice immunised at an early stage of infection had significantly shorter incubation 
periods in comparison with non-immunised mice (p=0.001) (figure 6.9, figure 6.10). 
There were no effects on pathogenesis in mice immunised at the middle stage of 
infection although this is perhaps not surprising as infection would have already been 
established in the CNS at this stage. Indeed studies involving splenectomy 
(Kimberlin & Walker, 1989) or manipulation of FDCs in the lymphoid system 
(Mabbott et al, 2003) are only effective early in peripheral infection and not in the 
later stages of infection. Because of the adverse effects obtained in the SRBC study 
where a high proportion of mice died suddenly following boost immunisation this 
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raised some issues in relation to home office licencing with this procedure (the use of 
experimental animals in the UK is subject to the regulation of the animals (scientific 
procedures) act of 1986). As a result it was not permitted to boost immunise any 
animals with suspected or confirmed clinical signs of disease and such animals were 
excluded from the study. Thus it is not known if boost immunising these animals 




















Figure 6.9 Effect of immunisation with DNP-KLH on the pathogenesis 




   
 
Figure 6.9 Pathogenesis of the ME7 strain of scrapie in mice immunised with 
DNP-KLH or saline at an early, mid and late stage of infection. Untreated, 
ME7 infected mice are also displayed for comparison.  
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Table 6.1. TSE disease incubation periods in mice immunized with DNP-KLH or 
saline and untreated mice at 3 separate points of infection. Statistical analysis using 
the student’s t-test was performed (two-tailed unpaired) p values represent statistical 
comparison of individual incubation periods obtained from ME7 infected DNP-KLH 
immunised mice and saline treated mice at each immunisation timepoint. Values that 
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Figure 6.10 Boxplots of incubation period data obtained from ME7 infected 
DNP-KLH or saline immunised and untreated control ME7 infected mice at an 
early, mid and late point during incubation period of disease. 
 
 
1 2 3 
Figure 6.10 Boxplots showing incubation periods in days (y-axis) in immunised and 
non-immunised mice at an early (1), mid (2) and late (3) timepoint post infection. 
The highest and lowest data points are demonstrated by ‘whiskers’ with the line 
through the middle of the median value. The box itself contains the middle half of 
the data. Unusual data points are shown by a ×. The coding along the x-axis refers to: 
DNP= mice immunised with DNP-KLH, SAL= mice given saline as control 
immunisation, ME7= mice without any treatment to act as controls for the DNP-
KLH and saline groups. 
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6.3.6 Effects of immunisation with DNP-KLH on splenic infectivity levels and 
the accumulation of PrPSc in spleen.   
 
As immunisation stimulates germinal centre formation and increases the size of FDC 
networks (Kosco-Vilbois et al, 1997) it is possible that immunisation may likewise 
increase infectivity levels in lymphoid tissues or blood.   
 
Levels of infectivity were measured in spleen collected one week post primary and 
boost immunisation from the early immunisation group (spleens collected at 11 and 
14 weeks post infection). Spleen was also collected for assay from the other 
timepoints but the results of these assays are not complete and therefore not included 
in this thesis. In addition, blood samples from these studies have also been collected 
from all the immunisation timepoints and it is proposed to measure infectivity levels 
in these blood samples.  
 
Infectivity levels in spleen from DNP-KLH immunised mice one week post primary 
immunisation ranged from 5.5–6.0 i.c.ID50/g, and 5.3-6.5 i.c.ID50/g in the saline 
control mice. Infectivity titres following boost immunisation ranged from 6.0-6.9 
i.c.ID50/g in spleen from the DNP-KLH immunised mice in comparison with 5.7-6.1 
i.c.ID50/g in the saline control mice. Two of the three spleens from the DNP-KLH 
boost immunised mice contained levels of infectivity that were greater than those of 
the saline injected animals. Although it appeared that levels of infectivity were 
increased in spleen following boost immunisation statistical analysis was carried out 
to establish whether these were significant. A linear mixed model was fitted to the 
data with treatment (saline or DNP-KLH) and immunisation (primary or secondary) 
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included as fixed effects, and mouse sample as a random effect. The parameters of 
the model were estimated using the REML directive in Genstat 10th edition. The 
estimated mean incubation period in the DNP boost immunisation group was lower 
than in the saline group (197.1 ± 4.7 compared to 208.8 ± 4.6) however this 
difference was not significant at the 5% level (figure 6.11 (B)).  
 
The deposition or accumulation of PrPSc in association with FDCs in lymphoid 
tissues is a characteristic of many TSE infections. Immunohistochemical (IHC) of 
spleen was carried out to determine if immunisation produced any subsequent 
increase in PrPSc in association with FDCs (figure 6.12). IHC analysis for PrPSc using 
the monoclonal antibody 6H4 antibody in spleen sections collected one week post 
boosting with DNP-KLH  was carried out at the early stage of infection.  Spleens 
were collected 98 dpi (14 weeks post infection) at the same timepoint for the 
infectivity bioassay (results shown in figure  6.11). Although there appeared to be 
greater levels of PrPSc in spleen from the DNP-KLH immunised mice quantification 
remains to be carried out on these tissues and it is difficult to determine at this stage 









Figure 6.11 Infectivity levels in spleen following primary and boost 




Figure 6.11 (A) Infectivity titres (log i.c.ID50/g) in spleen from C57BL mice 
immunised and boosted with DNP-KLH at an early stage of infection (primary boost 
spleens collected 77 dpi and secondary boost spleens 98 dpi). (B) Statistical analysis 
of the difference in the mean incubation periods in bioassay mice following bioassay 
assay of spleen from DNP or saline immunised mice at 98dpi. In the original study 
animals had received either saline (negative control) or DNP as either a primary or 
secondary immunisation. There was no statistically significant difference in 
infectivity levels in spleen from DNP immunised (red line) or saline control mice 
(green line) at either the primary boost immunisation points (full details of the 
analysis are given in appendix III)  
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Figure 6.12 Immunohistochemical detection of PrPSc in DNP-KLH immunised 
mice 
   
 
   
   
Figure 6.12 Immunohistochemistry for PrPSc using the monoclonal antibody 6H4 
antibody in spleen sections collected one week post boosting with DNP-KLH (a,b) or 
saline (c,d).  Spleens were collected 98 dpi (14 weeks post infection).  Spleens were 
collected at the same timepoint for the infectivity bioassay (results are discussed in 
Fig 6.13). Although there appeared to be greater levels of PrPSc in spleen from the 








As the immune system is critical to a number of experimental and naturally acquired 
TSE infections it would seem logical that manipulation of the immune system may 
impact on TSE agent pathogenesis. In this chapter immunisation of mice infected 
with the ME7 scrapie strain produced some quite dramatic effects on pathogenesis, 
but notably only at specific points following infection. These data demonstrate the 
intrinsic involvement of the immune system, and the state of immune system 
activation to TSE pathogenesis. Implications from the findings obtained in this 
chapter are presented in this discussion. 
 
TSE infections contradict much of what we understand about the nature of many 
“conventional” infectious diseases. In most viral or bacterial infections deficiencies 
in the immune system as a result of senescence (Linton & Dorshkind, 2004) or 
immunosupression increase opportunities for infection (El-Solh et al, 2001).  
Paradoxically, it is likely that individuals with immune system deficiencies may be 
less likely to develop peripherally acquired TSE infections such as vCJD than 
individuals with more competent immune systems. Extensive studies in 
immunodeficient and transgenic mice demonstrate the importance of the immune 
system and FDCs for efficient pathogenesis (Fraser et al, 1996) (Bruce et al, 2000). 
Indeed findings presented in chapter 5 (Brown et al submitted for publication) 
demonstrate that aged individuals are less likely to develop peripherally acquired 
infections such as vCJD, almost certainly as the result of age related immune system 
deficiencies and  dysfunctional FDCs.  
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Immune responses to antigen either following infection or by immunisation 
(vaccination) lead to the generation of a humoral immune response (the production 
of antibody molecules in response to an antigen) (Ahmed & Gray, 1996; Gray & 
Matzinger, 1991). There are a number of steps in the generation of this response 
which culminate in the production of memory B cells which act to initiate a rapid, 
heightened secondary response upon encountering the original antigen (Gray, 2002).  
Follicular dendritic cells (FDCs) are pivotal to the generation and maintenance of the 
humoral immune response which is facilitated via the capture and retention of 
immune complexes on FDCs (Kosco-Vilbois et al, 1997; Kosco et al, 1992). These 
trapped immune complexes are considered to be processed into high immunogenic 
IC-coated bodies (iccosomes) which contribute to the generation of these high-
affinity recall responses (Szakal et al, 1988) (Victoratos et al, 2006).  The generation 
of a humoral immune response leads to the development of germinal centres (Kosco-
Vilbois et al, 1997); unique microenvironments formed as a result of antigenic 
stimuli which contain FDCs, proliferating B lymphocytes and tingible body 
macrophages which ingest remnants of apoptosing B cells (Kosco-Vilbois et al, 
1997). As FDCs are critical for efficient neuroinvasion (Brown et al, 2000b; Brown 
et al, 1999; Bruce et al, 2000; Mabbott et al, 2000a; Mabbott et al, 2000b) subsequent 
increase in FDC cell numbers and germinal centres may impact on peripheral TSE 
pathogenesis. This possibility was investigated in this chapter by eliciting an immune 
response during the disease incubation period.     
 
One of the most unexpected findings from the studies presented in this chapter was 
the sudden deaths in the ME7 infected mice immunised with SRBC antigen at a late 
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stage of infection. This is the first time that such an effect has occurred following 
antigenic challenge of TSE infected mice. There were no deaths in any of the other 
groups at this timepoint, nor were there any adverse effects recorded when infected 
mice were immunised at the early stage of infection. The exact cause of these sudden 
deaths has not been established, although it is possible these effects are the result of 
some form of exaggerated (hyper-immune) response to antigen either as a direct 
result of long-term infection of lymphoid tissues, evoking some form of TSE induced 
immune system dysfunction, or as a secondary result of neural dysfunction.  Indeed, 
ultrastructural studies of ME7 infected spleen demonstrate increased FDC 
hypertrophy and an increased retention of electron-dense material at the  FDC 
plasma membrane in comparison with uninfected mice; these effects were further 
increased in mice immunised and boosted with antigen (McGovern et al, 2004).  
Moreover, in these published studies increased numbers of of morphologically 
mature plasma cells were also observed ultrastructurally within the GC of scrapie-
infected mice (immunised or non-immunised) than in uninfected controls mice 
(McGovern et al, 2004).   
 
In the studies presented here, measurement of specific and total immunoglobulin 
levels by RID (Mancini et al, 1965) found some indication of raised IgM levels in 
SRBC immunised mice in comparison with immunised uninfected mice. This finding 
was not statistically significant but may reflect the small sample size available in the 
study. It is proposed to further investigate these findings and sera are available from 
the animals immunised with DNP-KLH (unfortunately time restraints meant that the 
measurement of specific immune responses to DNP-KLH immunisation could not be 
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completed). In addition, the number of germinal centres were increased in SRBC 
immunised TSE infected mice compared with non-immunised scrapie infected mice 
at both an early and late stage of infection. Here the findings were not statistically 
significant. Although only a small number of tissues have been studied so far, it may 
be that TSE infection alone generates some form of persistent immune response 
leading to the presence of long-term germinal centres in lymphoid tissues 
(McGovern et al, 2004) (McGovern & Jeffrey, 2007), as is known to occur following 
viral infection (Bachmann et al, 1996) . Although these findings require 
substantiation it may be that some form of TSE associated FDC dysfunction results 
in these B cell associated effects, perhaps in immunoglobulin class switching or in 
affinity maturation in the germinal centre, as previously suggested (McGovern et al, 
2004).  The possibility that TSE infection may induce some form of increased 
germinal centre formation and exaggerated immune response to antigen is extremely 
important. This may have serious implications for TSE infected individuals receiving 
routine immunisations which may exacerbate TSE pathogenesis.  In addition, these 
finding may impact on therapeutic strategies against TSE infection involving 
vaccination with anti-PrP antibodies (Heppner et al, 2001; Sigurdsson et al, 2002) 
especially if these are carried out during the clinical phase of infection. However, 
there did not appear to be a correlation between clinical symptoms of disease and 
sudden death in these studies as only one of the seven mice that died had clinical 
signs of disease.  
 
Alternatively, it is possible that these effects were a secondary result of neural 
dysfunction at late stage infection.  Notably, anecdotal evidence exists to suggest that 
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peripheral infections in those with neurodegenerative conditions such as Alzheimer’s 
disease excarbate disease symptons changes and induce “sickness” behaviours 
(Cunningham et al, 2005; Perry, 2004).  In neurodegenerative conditions such as 
TSE diseases or Alzheimer’ disease where there are are high levels of activated 
microglia in the brain (Betmouni et al, 1996; Williams et al, 1995), systemic 
infection or inflammation, leading to increased synthesis of inflammatory cytokines 
by these microglia, may influence progression of neurodegenerative disease. 
Moreover, adminstration of the T cell independent antigen lipopolysaccharide (LPS) 
to ME7 infected mice at an early clinical stage of infection demonstrated behavioural 
and physiological changes in LPS dosed animals (Combrinck et al, 2002). It is 
therefore possible that the sudden deaths of the animals in this study were directly 
attributed to effects of the immunisation on the CNS.  
 
The blood-brain barrier (BBB) is a membranic structure that acts primarily to protect 
the brain from chemicals in the blood, whilst permitting essential metabolic function. 
The breakdown of the BBB is a characteristic of a number of infectious and 
neurodegenerative conditions including; dengue fever (Chaturvedi et al, 1991), 
bacterial meningitis, multiple sclerosis, ishchaemia (Marsala et al, 2004), Alzheimers 
disease (Perry et al, 1997) (Leake et al, 2000) and in TSE infection (Perry et al, 1997; 
Williams et al, 1995). Activation of the innate immune system by bacterial infections 
in individuals affected by multiple sclerosisis is thought to be linked to relapse 
induction (Correale & Farez, 2007). In the studies presented here only ME7 infected 
mice immunised at a late stage of infection with SRBC suffered adverse effects 
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suggesting that TSE associated blood brain barrier breach may have further 
contributed to the adverse effects on the mice.    
 
The abnormal form of the PrP protein is known to at least partially co-purify with 
infectivity (Somerville et al, 1986) and its deposition in tissues can be used 
biochemically (Farquhar et al, 1994) and immunohistochemically (McBride & 
Beekes, 1999) to track the spread of infectious agent throughout the host. 
Preliminary studies using basic quantitative methods suggest that there is no 
significant difference between numbers of PrPSc positive FDCs in immunised mice 
compared with non-immunised infected mice at the terminal stage of infection; 
however biochemical studies will be required for quantitative estimations of PrPSc.  
 
Two separate experiments were carried out to determine the influence of 
immunisation on peripheral ME7 pathogenesis. The first experiment used SRBC 
antigen as immunogen the second, the hapten-protein carrier DNP-KLH. Both of 
these immunogens are T cell dependent antigens, requiring the involvement of T 
lymphocytes (T Helper) cells to generate antibody production by B cells (Ahmed & 
Gray, 1996). T cell independent antigens on the other hand can provoke antibody 
production by B cells in the absence of T cell involvement (Gray & Matzinger, 
1991). In these studies mice were immunised at an early or a late timepoint with 
SRBC and at an early, mid and late timepoint with DNP-KLH. In the first study 
incubation periods of mice immunised with SRBC at 6 and 9 weeks post ME7 
infection were significantly longer than the unimmunised mice, p=0.033.  In the 
second study however incubation periods in mice immunised with DNP-KLH at 10 
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and 13 weeks post infection were significantly shorter than those of the saline 
immunised mice or mice infected with ME7 alone (p=0.001). It is not clear why 
these differences in pathogenesis have occurred. The effects on pathogenesis with the 
SRBC antigen, while still significant were less so than those obtained from the DNP-
KLH immunisation study. Although both SRBC and DNP-KLH function as T cell 
dependent antigens it is possible some subtle difference between the antigens 
resulted in these differences in pathogenesis between the studies. It is known that 
some variability in immunogenic properties can occur with SRBC antigen. 
Alternatively these differences may be related to the timing of the immunisations as 
the primary DNP-KLH immunisation was given 4 weeks later than the SRBC 
immunisation. In planning the studies it was originally intended to use DNP-KLH at 
identical timepoints to those used previously however technical difficulties meant 
these immunisations were delayed.  Previous studies investigating the replication 
kinetics of a number of TSE strains found that levels of infectivity reach a plateau at 
approximately 10 weeks with the ME7 strain (Kimberlin & Walker, 1979). It is 
therefore possible that immunising before maximum levels of infectivity in lymphoid 
have been reached, results in a delay in the spread of infectivity to the CNS; perhaps 
as a result of the generation and subsequent infection of newly formed germinal 
centres as a result of immunisation. Alternatively, it is possible that immunisation 
using SRBC antigen at these timepoints resulted in some form of infectivity 
“clearance” from lymphoid tissues by macrophages. In previously published studies 
clearance of infectivity by macrophages from lymphoid tissues is known to prolong 
incubation periods of disease (Beringue et al, 2000). Although both antigens evoke 
similar immune system functions it may be that SRBC antigen provokes a more 
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pronounced innate response to antigen resulting in macrophage activation and 
subsequent  “clearance” of infectivity from the lymphoid system (Beringue et al, 
2000). It is also possible that higher levels of these cell types were present earlier in 
incubation period, perhaps in response to the initial infection.  At 10 weeks post 
infection however, levels of infectivity and accumulation of PrPSc in GCs would have 
reached a plateau in spleen. It is possible that immunisation at this stage could have 
shortened incubation period of disease by enhancing spread of infection into the CNS 
as a result of increased FDC replication of infectivity in lymphoid tissues already 
“saturated” with infectivity.  There were no effects on pathogenesis in mice 
immunised at the middle stage of infection although this is perhaps not surprising as 
neuroinvasion would have occurred at this stage. Indeed studies involving 
splenectomy (Fraser & Dickinson, 1970) or manipulation of FDCs in the lymphoid 
system are only effective early in infection (Mabbott et al, 2003).  These findings are 
important as they suggest that therapies aimed at manipulating cells such as FDCs 
may only be effective early in peripheral infection. In comparison with the study 
involving SRBC immunisation no adverse effects were obtained following 
immunisation at late stage infection with DNP-KLH. The differences obtained from 
the studies are not fully understood but may be related to the use of two different 
immunogens.    
 
The establishment of specific tissue involvement and infectivity levels within those 
tissues from TSE infected humans and animals is immensely important in 
determining risk of disease transmission. TSE agents are unique in their resistance to 
inactivation provoking concerns over iatrogenic transmission of infectivity via 
 251
surgical procedures and blood transfusion. It is well established that infectivity 
accumulates in the peripheral lymphoid system and transmission of infection via 
blood has been demonstrated in experimental blood transfusion studies in sheep 
(Houston et al, 2000; Hunter et al, 2002) and more recently in human to human 
transmission of vCJD via infected blood products (Llewelyn et al, 2004; Peden et al, 
2004; Wroe et al, 2006).  As immunisation has direct effects on FDC activation and 
germinal centre formation (Kosco-Vilbois et al, 1997) it is possible this could alter 
levels of infectivity in lymphoid tissues potentially disseminating more infection into 
the blood. Although, it is not understood if the presence of infectivity in blood is a 
result of the presence of infected cells or via the passage of blood through infected 
lymphoid tissues.  On a cellular level the most likely candidates for infection of 
blood are B lymphocytes which form close contact with FDCs within the germinal 
centre (Kosco-Vilbois et al, 1997), although the presence of FDC precursor cells has 
also been described in blood (Kapasi et al, 1998). Infectivity bioassay of spleen 
found that there were no statistical differences in infectivity levels between non-
immunised and immunised mice following primary or secondary response at the 
early stage of infection. However, levels of infectivity were higher in 2 of 3 spleens 
from the immunised boost group in comparison with the saline control group. 
Although not a significant result this still represents an important finding but may 
require larger sample numbers to determine if there are increased levels of infectivity 
in lymphoid tissues or blood following immunisation.   
 
In conclusion, these findings presented here suggest that immunisation has effects on 
the pathogenesis of disease. It would have been interesting, and highly relevant, to 
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immunise mice prior to TSE infection to determine how an activated immune system 
at the time of infection would impact on pathogenesis and disease susceptibility. 
Moreover, the effects of immunisation on mice at the late stage of TSE infection 
have not been observed before and may give some indication that infection results in 
some form of immune system dysfunction. These findings will be examined in more 
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The unique properties of TSE agents produce many barriers to understanding and 
researching these diseases. These barriers include; the prolonged incubation periods 
of disease, which in some cases can exceed the animal’s lifespan (Dickinson et al, 
1975); the lack of a reliable ante-mortem diagnostic test, and the uncertainty over the 
nature of the TSE agent. Moreover, the lack of treatments and the fatal nature of 
these diseases demonstrate the importance of research into these devastating 
diseases. 
 
In many naturally acquired and experimental TSEs, transmission of infection by 
peripheral routes involves the lymphoid system (Fraser & Dickinson, 1970), and 
although high levels of infectivity can be detected in lymphoid tissues early in 
infection (Fraser, 1996) there are no clinical or outward signs that the animal or 
individual is infected. The clinical symptoms of disease that eventually arise from 
TSE infection are almost certainly the result of pathological changes within the 
central nervous system (CNS) which includes vacuolation, gliosis and the deposition 
of the abnormal form of PrP, PrPSc (Bruce et al, 1989b) As many naturally acquired 
TSEs are thought to arise from infection by peripheral routes, for example ingestion 
of infectivity (Glaysher & Mabbott, 2007) or via the skin (Mohan et al, 2005a) or 
mucous membranes, understanding the key events and influence in the peripheral 
system before infection in the CNS is initiated may lead to the development of 
intervention strategies or treatments for these diseases. In addition, understanding the 
influences of the immune system on pathogenesis may allow the assessment of risk 
factors that influence disease. 
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One of the main aims of this thesis has been to further elucidate the role of follicular 
dendritic cells (FDCs) in the pathogenesis of the ME7 strain of scrapie and to 
understand what cell types or mechanisms may be important in the peripheral 
pathogenesis of other TSE strains. The aims of this thesis have also been to 
understand how the immune system, and alterations in immune function, such as 
those caused by increasing age or immunisation, can influence the pathogenesis of 
these diseases The findings from these studies and the future areas of research are 
presented in this discussion.  
 
 
7.2. The role of follicular dendritic cells in TSE pathogenesis 
 
A wealth of evidence now suggests that the FDC is critical for neuroinvasion and 
replication of TSE agent infectivity. Initial studies investigating the cellular 
association of infectivity in spleen found that stromal cell populations (FDCs are 
thought to arise from a stromal origin) contained the highest levels of infectivity 
(Clarke & Kimberlin, 1984b). Studies involving ionising radiation produced 
evidence that a radiation resistant cell type was critical for neuroinvasion and 
replication of infectivity in spleen (Fraser et al, 1992b) and in the last decade a 
number of studies in SCID mice, which lack FDCs, produced further evidence for a 
role for FDCs (Fraser et al, 1996; Lasmezas et al, 1996; O'Rourke et al, 1994). In 
addition the localisation of PrP protein to FDCs by IHC and ultrastructural methods 
demonstrated the potential involvement of these cells in TSE infection (Brown et al, 
2000a; Jeffrey et al, 2000; McBride et al, 1992). More recently, chimaeric mouse 
models were created with a mismatch between PrP expression on FDCs and on 
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lymphoid/myeloid cells and vice versa.  In these studies neuroinvasion and 
replication of infectivity was dependent on PrP expressing FDCs and was not 
dependent on PrP expression on lymphoid cells (Brown et al, 1999). These studies 
were extended in this thesis to include the use of two new lines of SCID mice which 
were created on an H-2b background to allow the grafting of bone marrow from PrP 
deficient mice (chapter 3). This design allowed the production of bone marrow 
chimaeras which permitted the development of FDCs from SCID-PrP+/+ mice in the 
presence of isologous PrP +/+ or PrP-/- bone marrow, creating a mis-match between 
the PrP status of the surrounding lymphocytes and that of the host FDCs. Results 
from these studies demonstrated that peripherally routed scrapie was dependent on 
PrP expressing FDCs, irrespective of the PrP status of the lymphocytes in the bone 
marrow graft (Chapter 3.3.3). These findings have provided further evidence in 
support of the critical involvement for the FDC in pathogenesis the pathogenesis of 
scrapie.  
 
7.2.1 Disease pathogenesis in radiation (bone marrow) chimaeras 
 Analysis of data obtained from radiation (bone marrow) chimaeras, created to 
determine which cells were critical for peripheral TSE pathogenesis, produced some 
intriguing results. A significant shortening of incubation period was observed in 
PrP+/+ (129/Ola) mice reconstituted with bone marrow from PrP-/- mice, in 
comparison with unirradiated and reconstituted mice. A second identical experiment 
produced similar results (Chapter 3.3.2).  
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There may be several explanations for these findings. One possibility is that the lack 
of PrP expression on cells in the peripheral lymphoid system (for example on 
lymphocytes, macrophages etc) is related to these shortened incubation periods. 
Sequestration or degradation of infectivity (thus reducing available infectivity in the 
lymphoid tissues) is known to occur by  macrophages, indeed depletion of these cells 
shortens incubation periods of disease (Beringue et al, 2000). If these mechanisms 
require the cellular expression of PrP this “sequestration” of agent infectivity may 
not have occurred in these chimaeric mice where the majority of lymphoid and 
myeloid cells would have been replaced by PrP deficient cells from the donor.   
 
The possibility that the irradiation procedure itself contributed to these effects on 
pathogenesis has been discounted as the shortened incubation periods were not 
observed in PrP+/+ mice reconstituted with isologous PrP+/+ bone marrow suggesting 
these findings are related to the mismatch between the PrP status of the recipient and 
the graft. Alternatively, and perhaps a more plausible explanation, is the possibility 
that the creation of a chimaeric immune system where the PrP status of the FDCs 
differed from the resulting lymphocytes may have resulted in an immune response 
either to the mismatch of the graft or to the inoculum itself which is likely to have 
contained high levels of PrPSc. It is known that PrP deficient mice mount a humoral 
immune response to PrP protein (Heppner et al, 2001) therefore similar effects may 
have occurred here to either the cells expressing PrPc or to PrPSc in the inoculum. 
The possibility that stimulation of the immune system may influence pathogenesis is 
considered in more detail later in this discussion (7.5), but these results have 
similarities with previously published work which showed that mitogenic stimulation 
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shortens incubation period of disease (Dickinson et al, 1978) (Kimberlin & 
Cunnington, 1978a).  
 
Further studies investigating germinal centre formation and expression of markers 
related to FDC activation such as the FcγRII/RIII (Aydar et al, 2004; Qin et al, 
2000), VCAM-1 and MAdCAM-1 antigens which are only expressed on activated 
FDCs (Qin et al, 2000) may be considered to establish if there are differences in FDC 
activation between these chimaeric mice and those of unirradiated or mice irradiated 
with isologous bone marrow in both uninfected and infected mice. In addition sera is 
available from these mice therefore it may be possible to use ELISA methods to 






7.2.2 Do FDCs produce PrP protein? 
 
Although data from our previous studies demonstrates the importance of FDCs in 
pathogenesis (Brown et al, 1999; Bruce et al, 2000; Mabbott et al, 1998; Mabbott et 
al, 2000b) it is not fully understood if the expression of PrP protein on these cells is a 
result of production of PrP by the cells themselves or whether PrP is somehow 
transported to these cells and retained on the cell surface in a similar way to other 
antigens, for example MHC-class II (Denzer et al, 2000). In addition, PrPc is attached 
to the cell surface by a glycosylphosphatidylinositol (GPI) anchor and it is known 
that GPI-anchored proteins can be  transferred from cell to cell (Low, 1998). Within 
the germinal centre B cells and FDCs are intimately associated therefore it is possible 
 260
that transfer of PrPc from these B cells, which are known to express PrP (Mabbott et 
al, 1997), could occur.  
 
An intrinsic mechanism of FDCs is their ability to trap and retain antigen-antibody 
complexes for many weeks or months leading to the maintenance and stimulation of 
immunological memory (Gray & Skarvall, 1988); (Gray & Matzinger, 1991); 
(Ahmed & Gray, 1996; Gray, 2002). The facilitation of immune complex trapping on 
FDCs is partly mediated by complement component C4 and can be recognised by the 
antibody marker FDC-M2 (Taylor et al, 2002). The reactivity of this monoclonal 
antibody FDC-M2 with FDCs is dependent on trapped immune complexes that are 
capable of fixing complement on the FDC cell surface.  Therefore it is possible that 
in the uninfected animal, PrP protein is somehow transported to the FDCs and 
retained and trapped on the extensive network processes of the cells. The detection of 
disease specific PrP on FDCs following infection may therefore result from the 
conversion of trapped PrPc on the cell surface by the infectious agent or it may be 
that the abnormal form of PrP is somehow transported to the FDCs following 
infection.  
 
Several previous studies have demonstrated that a specialised population of 
macrophages, tingible body macrophages, found within the germinal centre can 
ingest and internalise PrPSc in infected mice and sheep (Jeffrey et al, 2000; 
McGovern et al, 2004). In addition, studies have demonstrated that dendritic cells 
can acquire and transport PrPSc (Huang et al, 2002; Huang & MacPherson, 2004; 
Raymond & Mabbott, 2007) or macrophages (Beringue et al, 2000) suggesting that 
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these cells could potentially transfer PrP to these cells. In addition to trapping and 
retraining of immune complexes on FDCs it is known that proteins can be 
sequestered by these cells and expressed on their surface for long periods of time. An 
example of this is the expression of MHC-class 2 antigens which are not considered 
to be produced by the FDCs themselves (Denzer et al, 2000). 
 
Alternatively, cell surface expression of PrP on FDCs may be the result of the 
production of the protein by the FDCs themselves and the subsequent expression of 
PrPSc on these cells, the result of infection of the FDC itself with TSE agents.  There 
are several previous findings which lend support to the possibility that FDCs 
themselves produce PrP; firstly the studies involving ionising radiation (Fraser & 
Farquhar, 1987), where no effect on pathogenesis or infectivity levels in spleen was 
observed. Furthermore our studies (Brown et al, 2000b; Brown et al, 1999) using 
radiation chimaeras where mice were subjected to lethal doses of radiation and 
subsequently grafted with PrP+/+ or PrP-/- bone marrow found no difference in the 
expression levels of PrP in uninfected or ME7 infected spleen. As some cells types, 
including nerve cells are resistant to radiation (Maruyama et al, 1967) it remains 
possible that PrP is somehow sequestered to the FDCs. In a study mapping the 
development of FDCs and specific lymphoid cells in SCID mice following bone 
marrow reconstitution the development of mature FDCs was found to coincide with 
the expression of PrP protein (Brown et al, 2000b). Similarly in a study of the 
development of FDCs and lymphocytes in neonatal mice PrP expression was found 
to coincide with FDC development (Ierna et al, 2006).  
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The determination of whether FDCs express PrP protein is of great importance. If 
PrP is not produced by the FDC itself identifying the key events in the transport of 
this protein will be critical for development of therapeutic or preventative strategies 
in these diseases. Several approaches which aim to elucidate whether FDCs produce 
PrP are being considered in our unit and elsewhere. These include the generation of 
transgenic mice with PrP expression restricted to the FDCs (Neil Mabbott, personal 
communication).  
 
Recently, published studies describe methods for the isolation of highly enriched 
populations of murine FDCs (Sukumar et al, 2006); (Sukumar et al, 2008) and these 
techniques could be useful in elucidating whether FDCs produce PrP protein. In 
SCID mice FDC precursor cells exist within lymphoid tissues which can be 
recognised by the FDC-M1 antibody (Balogh et al, 2001; Ierna et al, 2006); although 
there is no detectable expression of PrP on these cells.  In studies carried out 
previously, and those presented in this thesis (chapter 3), the expression of PrPc on 
FDCs was not dependent on PrP expressing lymphocytes. The two novel lines of 
SCID mice (described in 3.3.2): SCID-PrP+/+ and SCID-PrP-/- could potentially be 
used to isolate FDCs for in-vitro studies using co-culture regimes with PrP-/- or PrP+/+ 
lymphocytes. If successful, this could permit the development of FDCs from PrP 
expressing or PrP deficient mice without the complication of other PrP expressing 
cells such as nerve cells. These cultures may help elucidate if the transfer of PrP 
from lymphocytes can occur.  These cultures could likewise be used in infection 
studies in order to measure the relative contribution of FDCs and/or lymphocytes in 
the accumulation of PrPSc on FDCs. 
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7.3 Do different TSE strains target different cell types in the peripheral 
lymphoid system?  
 
The existence of strains remains one of the most widely debated and perhaps 
controversial aspects of TSE research (Bruce & Dickinson, 1987; Bruce et al, 1991). 
The existence of strains implies that some form of informational molecule must exist 
to denote the unique and often extreme difference between TSE strains (Bruce & 
Dickinson, 1987). Extensive studies in mice using limiting dilution analysis where 
isolated strains are diluted to the lowest dilution capable of producing disease has 
resulted in over 20 experimental TSE strains (Bruce et al, 1991; Chandler, 1961; 
Dickinson et al, 1968; Zlotnik & Rennie, 1965). The vast majority of these strains 
were derived from a pool of natural scrapie brains although some of the experimental 
strains such as 301C and 301V are derived from BSE (Bruce et al, 2002). These 
defined strains, can be identified by their lesion profile (assessment of vacuolar 
changes in defined brain areas) and patterns of PrPSc deposition in the CNS.  For 
example the ME7 strain of scrapie produces widespread deposition of PrP throughout 
the CNS whereas with the 87V strain targets only specific areas with distinct 
characteristics such as the deposition of PrP plaques (Bruce et al, 1989b).    
 
Studies using mice with chimaeric immune systems produced compelling evidence 
for a critical role for FDCs with the ME7 strain of scrapie (Brown et al, 1999) 
however similar studies carried out elsewhere with the RML scrapie isolate produced 
contrasting results suggesting that bone marrow derived cells were critical for 
pathogenesis (Blattler et al, 1997). This led to the hypothesis that different scrape 
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strains may target different cell types as they are known to do in the CNS. To address 
this possibility mice with specific cell type deficits were challenged with a range of 
TSE agent strains (79A, 139A, ME7 and 301C) (Chapter 4 section 4.3.1). 
 
In setting up these studies important consideration was given to the effect of dose on 
disease pathogenesis. Previous studies in SCID mice with the ME7 agent strain 
demonstrated that these mice were almost fully susceptible to peripheral infection at 
high dose but almost completely resistant at lower doses (Fraser et al, 1996).  This 
susceptibility to infection at high dose occurred independently of the lymphoid 
system suggesting that neuroinvasion probably occurred via direct peripheral nerve 
infection. In these studies (chapter 4 section 4.3.1) high dose infection of 
immunodeficient mice produced disease in the majority of mice with all the TSE 
strains tested suggesting that this effect is not specific to the ME7 agent strain. At 
lower doses much lower incidence of disease was observed in all of the 
immunodeficient mice with all of the TSE strains. Despite the detection of trace 
levels of infectivity in many of these spleens (Chapter 4) these levels were not 
consistent with agent replication. In summary, the results from these studies showed 
that all of the TSE strains tested appeared to depend on the presence of mature FDCs 
for efficient neuroinvasion.  In addition, these studies demonstrate the importance of 
considering dose when designing studies which aim to elucidate the requirement of 
specific immune system cells for neuroinvasion as failure to do so could potentially 
lead to misinterpretation of results.  In-fact, the original studies involving the RML 
isolate used a 5 fold higher dose for infection of mice which may have impacted on 
result interpretation (Blattler et al, 1997).   
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However, some subtle differences in the peripheral pathogenesis between the TSE 
agent strains tested was observed. Most notable was the development of extensively 
prolonged incubation periods with the 79A/139A strains. Furthermore some of the 
301C infected immunodeficient mice showed prolonged incubation periods; 
primarily at high dose. The significance of this is not fully understood but may 
suggest evidence of an alternative, less efficient mechanism of pathogenesis which 
may occur in the in the absence of mature FDCs. While pathological assessment of 
these mice with prolonged incubation periods show no difference in TSE agent strain 
characteristics, investigation of the targeting of PrPSc in brain may prove useful in 
determining whether neuroinvasion occurred via a neuroanatomical route.  
 
 
7.4. The effect of age on pathogenesis 
 
 
7.4.1 The influence of senescence on the peripheral pathogenesis of the ME7 
agent strain. 
 
In mammals senescence has wide ranging effects on immune function and in mice 
FDC function is impaired suggesting that this may have implications for TSE 
pathogenesis. In the studies in this thesis old mice were used to model 
immunosenescence in humans in an attempt to establish the effect that host age may 
have on peripheral TSE pathogenesis.   
 
The identification of a “new variant” of CJD in 1996 is almost certainly the result of 
peripheral (ingestion) exposure of the UK human population to the BSE agent (Bruce 
et al, 1997; Will et al, 1996). However, despite probable widespread exposure to the 
BSE agent there have been relatively few cases of variant CJD; and almost without 
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exception, all have occurred in young individuals (mean age of death approximately 
29 years) (Valleron et al, 2001).   
 
Initial research suggested that dietary preference in the young (e.g. consumption of 
foods such as burgers containing high levels of mechanically recovered meat) may 
have contributed to this high incidence of disease in young people however 
epidemiologic analysis has failed to substantiate a link between dietary preference 
alone and incidence of disease (Boelle et al, 2004). Although the reasons behind this 
apparent age-related susceptibility are not fully understood the possibility that age 
related effects on the immune system may influence peripheral disease pathogenesis 
were considered in this thesis.  
 
Using a murine model of senescence where defects in immune and FDC function are 
well documented we found that TSE neuroinvasion from the periphery was severely 
impaired.  None of the aged mice developed clinical disease following peripheral 
exposure; however TSE specific pathology (vacuolar changes and/or the 
accumulation of PrPSc in brain) was detected in a high proportion of peripherally 
infected animals. In contrast, aged mice infected intracerebrally developed clinical 
disease with similar incubation periods to the young mice, but with significantly 
lower levels of vacuolar pathology in the CNS.  
 
The findings from these studies suggest that significant levels of “sub-clinical” or 
pre-clinical infection may exist within the population presenting further implications 
for iatrogenic spread of disease. In addition, alterations in the severity of pathology 
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and in the presentation of clinical symptoms of disease may occur in aged individuals 
which could have significance for the diagnosis of disease in the aged (discussed in 
more detail in 7.4.2). In addition recent studies where lymphoid tissues (tonsil and 
appendix) were sampled to assess potential levels of disease in the UK population 
may have little relevance in older individuals (Hilton et al, 2002; Ironside et al, 
2006). Studies in senescent mice showed that only a few peripherally exposed mice 
had PrPSc in lymphoid tissues despite the presence of PrPSc in brain in a high 
proportion of these mice.  
 
In the studies presented in Chapter 4 (section 4.3.1) it appears that high dose 
infection of immunodeficient mice results in neuroinvasion without the requirement 
for lymphoid system involvement. It would be interesting to test this hypothesis in 
aged mice where there are effects on FDC and immune function, as it may be that 
neuroinvasion, following high dose infection, may readily occur in aged mice.   
 
 
7.4.2 Effects of age on TSE agent transmission via different routes of exposure. 
 
 
In recent years four cases of variant CJD have occurred (Llewelyn et al, 2004)Peden 
et al., 2004; (Wroe et al, 2006), almost certainly via the transfusion of blood or blood 
products to these individuals. These cases represent the first recorded cases of human 
to human transmission of variant CJD and a number of other individuals who have 




Although variant CJD has manifested almost without exception in young individuals, 
three of the four cases of vCJD as a result of blood transfusion have occurred in older 
individuals (Llewelyn et al, 2004); Peden et al., 2004; Hewitt et al., 2006; HPA 
2007). The first case (Llewelyn et al, 2004), a 62 year old methionine homozygote at 
codon 129 of the human prion protein gene (PRNP), had received a non-
leucodepleted red cell component from a donor later confirmed as suffering from 
vCJD. The recipient developed clinical symptoms of disease almost 7 years after the 
blood transfusion.  The second case, an elderly individual (Peden et al., 2004), died 
5 years after transfusion without any clinical symptoms of vCJD, and was found to 
have PrPSc in the spleen and one lymph node (but not in the brain) at post mortem.  
This individual was a codon 129 PRNP heterozygote and this case is thought to 
represent pre- or sub-clinical infection. The third case, initial presentation at 29 years 
and confirmed clinical diagnosis at 31 yeas of age (Wroe et al, 2006), developed 
symptoms of vCJD approximately 6 years after receiving a transfusion of red blood 
cells from a donor who developed vCJD about 20 months after this blood was 
donated. This individual subsequently died almost 9 years after receiving the 
transfusion aged 32 years (Wroe et al., 2006). The fourth case (an 83year old 
individual) (HPA 2007) developed symptoms of vCJD 8.5 years after receiving a 
transfusion of red blood cells from a donor who developed vCJD about 17 months 
after this blood was donated. In the 3rd and 4th cases the same donor donated the 
vCJD-implicated blood.  All of the four cases had received transfusions of non-
leucodepleted red blood cells between 1996 and 1999. 
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The occurrence of these vCJD cases in these older individuals following blood 
transfusion may suggest that route of infection may influence susceptibility to 
infection e.g. older people might be less susceptible to BSE via the oral route than 
they are to vCJD via the intravenous route.  It has been suggested that adaption of the 
BSE agent following secondary passage in humans may result in increased efficacy 
of transmission. However, passage in mice of vCJD brain from the first blood 
transfusion case (Llewellyn et al., 2004) into mice (Bishop et al, 2008) demonstrates 
no significant alteration in transmission characteristics or efficacy. These findings 
suggest that the major factor in these 4 cases of vCJD transmission via blood may be 
the route of transmission and not alterations in agent strain efficacy following 
passage through humans (Bishop et al, 2008). 
 
As described in chapter 5 the effects of age on the immune system have dramatic 
effects on peripherally (oral or i.p.) acquired ME7 scrapie providing strong evidence 
that the predominance of vCJD cases in the young may be related to immune 
function. As vCJD is known to target lymphoid tissues the presence of infectivity in 
blood is perhaps not surprising, and the ability to transmit infection via blood from 
sheep infected with BSE or natural scrapie confirms that blood may represent a 
significant risk factor in disease transmission (Houston et al, 2000 Hunter et al, 
2002). However it must be recognised that not all TSEs have lymphoid tissue 
involvement, for example sCJD, and in these diseases the risk of transmission of 
disease via blood may be minimal. Indeed there have been no recorded cases of sCJD 
transmission via the transfusion of blood or blood products (Gambetti et al., 2003).   
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As previously described, studies have shown that the intravenous (i.v.) route is 
almost as efficient as the i.c. route of infection (Kimberlin & Walker, 1979) (approx. 
100 times more efficient than other peripheral routes) therefore it is possible that the 
i.v. route of infection may influence the age-range of susceptibility.  To test this 
hypothesis, it is proposed to compare TSE disease pathogenesis, using an 
experimental model which has extensive lymphoid tissues involvement in aged in 
young mice using the i.v. and other peripheral routes to establish how these routes 
influence susceptibility to disease in relation to age.  
 
7.4.3 Effect of age on cross-species TSE agent transmission. 
 
 
In addition to investigating the effect of route on pathogenesis in aged mice it will be 
important to establish if age alters susceptibility to TSE infection across a species 
barrier. Previous studies in SCID mice have shown that neuroinvasion is severely 
impaired following infection with BSE (Brown et al, 1997) suggesting that similar 
effects may occur in aged mice.  
 
These studies will be important in determining if aged individuals are less 
susceptible to cross-species infection and may determine if sub-clinical disease is 
present in aged individuals in the absence of disease symptoms. The occurrence of 
sub-clinical disease in the human population, (possibly as a result of inefficient 
disease transmission associated with age) may represent a significant risk factor in 




7.4.4 Effects of age on the central nervous system and possible implications for 
TSE pathogenesis. 
 
Although aged mice were fully susceptible to i.c. infection with the ME7 agent 
severity of vacuolation was significantly lower in the aged mice in comparison with 
the young mice; although both aged and young mice had similar incubation periods 
of disease. In addition, anecdotal evidence from assessment of these animals 
suggested that clinical symptoms following i.c. infection may be subtly altered from 
those of the young mice. The reasons for this less severe pathology are unclear but 
similar findings have been observed in TME infected aged mink of the Chediak-
Higashi (CH) phenotype, which has an abnormality in granulocyte production 
(Marsh et al, 1976). Infection of young mink of the same phenotype, or non-CH 
mink, produced high levels of vacuolation in comparison with the aged mink.     
 
There are extensive effects of ageing on the CNS which include neuron loss (Cowen 
& Gavazzi, 1998).  Although the major findings from the studies in the aged mice 
relate predominantly to effects on the immune system these alterations in pathology 
and possibly clinical presentation of disease following i.c. infection of aged mice 
may have important implications; for example in diagnosis. Precise comparison of 
clinical symptoms of disease between aged and young mice may determine if there 
are alterations in the clinical presentation of disease between young and aged mice. 
In addition, it is not known if this alteration in vacuolar pathology may impact on 
agent infectivity levels in CNS tissues and further analysis of CNS tissues from aged 
and young mice may be useful in establishing whether any such differences exist.   
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7.4.5 Functional effects of age on the immune and the nervous system 
A number of studies have demonstrated that the function of FDCs is impaired in 
mice of from approximately 600 days old. This represents approximately two thirds 
of the natural lifespan of the laboratory mouse. These studies have shown that FDCs 
from these aged mice are atrophied and are unable to effectively trap immune 
complexes leading to impaired responses to antigen (Aydar et al, 2003; Aydar et al, 
2004). Although the findings presented in chapter 5 show that the effects of age on 
pathogenesis coincide with FDC dysfunction, it is not possible to determine from 
these studies if the FDCs themselves are responsible for these effects on 
pathogenesis. It remains possible that this impaired pathogenesis is related to defects 
in other cell types, such as lymphocytes.  
 
To elucidate the effects of age on pathogenesis chimaeric mice, where a mismatch in 
aged FDCs and young lymphocytes and vice- versa could be created. As one of the 
characteristics of FDCs is their resistance to high doses of radiation it is possible to 
use whole body irradiation to ablate dividing cells such as lymphocytes, while 
resident FDCs are unaffected by the effects of the irradiation.  Following the 
radiation procedure grafting of suitable cell populations e.g. bone-marrow can be 
carried out to create a chimaeric immune system. As FDCs are not replaced from the 
bone marrow, dividing cells such as lymphocytes would be derived from the donor 
whereas FDCs would be of a host origin. These chimaeric mice could be used in TSE 
infection studies to determine whether defects in FDCs result in the impaired TSE 
pathogenesis in aged mice as described in chapter 5. Alternatively, in-vitro cultures 
could be obtained to determine FDC function within these cultures.  Similar studies 
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where in-vitro cultures of aged FDCs and young lymphocytes and vice-versa were 
created found that defects in FDCs and not in lymphocytes were responsible for 
impaired immune responses (Aydar et al, 2003).  
 
In addition to examining how age influences susceptibility to TSE infection it may be 
important to determine at what age these defects in FDC function become apparent. 
This could be achieved by examining FDC function in mice at specific timepoints 
during lifespan and then using these data to inform the design of the TSE 
pathogenesis studies to determine if defects in FDC function correlate with impaired 
pathogenesis.   
 
Preliminary studies of uninfected aged mice demonstrate no difference in innervation 
in spleen between aged and young mice using the marker tyrosine hydroxylase to 
detect noradrenergic sympathetic innervation, suggesting that the impaired 
pathogenesis in these aged mice was not directly related to lack of peripheral nerves. 
In-fact, there was some suggestion of greater levels of innervation in aged mice, as 
demonstrated previously in SCID mice (Mitchell et al, 1997). Indeed studies have 
shown that the relative positioning of germinal centres and FDCs to peripheral 
nerves in the spleen influences pathogenesis (Prinz et al, 2003). However further 
studies investigating innervation perhaps in a range of lymphoid tissues from aged 
and young mice may be considered as little information exists with regard to the 






7.5 Immune system influences on TSE pathogenesis 
 
 
7.5.1 Influence of immune system stimulation on pathogenesis 
 
Unlike most infectious agents a functional immune system is critical for the 
peripheral pathogenesis of TSEs. This paradox led to the hypothesis that immune 
system stimulation, in the form of immunisation, may have effects on pathogenesis. 
Some studies were performed in the 1970s and 1980s although these focused on the 
single administration of mitogenic substances such as PHA (Dickinson et al, 1978) or 
modified BCG vaccine (Kimberlin & Cunnington, 1978b). At the time of conducting 
these studies little was known about the role of the immune system or indeed the 
involvement of FDCs in TSE pathogenesis. In the studies presented in this thesis 
(Chapter 6, 6.3.1 and 6.3.6) the aim was to emulate the generation of a primary and 
secondary immune response in a similar way to generating immunity via vaccination 
and study the influence this may have on TSE pathogenesis.   
 
As TSEs have highly reproducible and consistent disease incubation periods the 
modulation of pathogenesis may have wide ranging implications. The demonstration 
that incubation period of disease can be significantly shortened by immunising with 
DNP-KLH at an early stage of infection may have implications for the assessment of 
risk in TSE infection. Immunisation with DNP-KLH at a mid and preclinical stage of 
infection had no effect on incubation period of disease, however at this stage of 
infection it is almost certain that TSE disease would have been initiated in the CNS. 
Thus these data suggest that the spread and progression of infection within the CNS 






7.5.2 Can immunisation alter susceptibility to TSE infection? 
 
What is not understood however is whether a humoral immune response to a non-
TSE related antigen can alter susceptibility to infection.  Following antigenic 
challenge germinal centre formation and maturation of FDCs to form secondary 
follicles occurs (Kosco-Vilbois et al, 1997), therefore it is possible that the increased 
numbers of FDCs and germinal centres may enhance neuroinvasion and increased 
susceptibility to infection. The hypothesis that immunisation may increase 
susceptibility to infection is currently being tested in studies at this unit; a summary 
















Figure 7.1 Determining the effects of immunisation on the susceptibility to 
orally or i.p. routed ME7. 
 
 
Figure 7.1 Infection of mice with ME7 by the oral or intraperitoneal routes was 
designed to coincide with the height of the secondary immune response following 
boosting with the immunogen DNP-KLH.  Tissues and sera were collected from 
groups of immunised or non-immunised uninfected mice just prior to infection to 
















7.5.3 Can immunisation alter susceptibility to cross species TSE infection? 
 
During the height of the BSE epidemic it was estimated that almost 500,000 infected 
cattle were slaughtered for consumption in the UK (Valleron et al, 2001) although 
only 201 clinical cases of vCJD have been recorded (the majority of which have been 
in the UK).  Variant CJD appears to have increased exponentially following its 
identification in 1996 to a peak of cases in 2000 (Ironside et al, 2002). However, 
what is not fully understood is whether further cases will develop in the future, 
perhaps in a similar way to that of the kuru epidemic where incubation periods in 
some individuals were estimated to be as long as 56 years (Collinge et al, 2006). Risk 
factors for development of vCJD susceptibility are not fully understood, however all 
current clinical cases of vCJD have occurred exclusively in individuals homozygous 
for methionine at codon 129 of the PrP gene (Ironside et al, 2002). Moreover, young 
age appears to be as risk factor as discussed in chapter 5 and it appears that effects on 
the immune system, and specifically on FDCs, with increasing age may account for 
this predominance of vCJD cases in the young (Chapter 5; 5.3.1). Although the use 
of mouse adapted experimental strains are extremely useful in determining how 
immune responses influence TSE pathogenesis it is not known how immunisation 
may alter pathogenesis or susceptibility to infection in cross species infection, for 
example in the transmission of BSE to humans. If immunisation increases 
susceptibility to infection in cross species infection this may provide useful 
information in establish risk factors for the transmission of BSE or other TSEs to 
humans.   
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7.5.4 Can immunisation exacerbate TSE infection? 
 
One of the most unexpected findings of this thesis was the sudden death of a third of 
the ME7 scrapie infected mice following boost immunisation with sheep red blood 
cell antigen (SRBC) at a late, pre-clinical stage of infection (Chapter 6; 6.3.1). These 
effects did not occur in uninfected mice boosted with antigen or in ME7 infected 
mice immunised at an early stage of infection. The reasons for these sudden deaths 
are unclear but it is possible the effects may be directly attributed to some form of 
hyper immune response at this late stage of infection, perhaps as a result of some 
associated immune system dysfunction. Indeed, ultrastructural studies of spleens 
from ME7 infected mice demonstrate increased FDC hypertrophy and an increased 
retention of electron-dense material at the FDC plasma membrane in comparison 
with uninfected mice (McGovern et al., 2004); these effects were further increased in 
mice immunised and boosted with antigen (McGovern et al, 2004).  In addition, 
recent studies of natural sheep scrapie find that FDCs are hypertrophied implying 
some form of FDC dysfunction (McGovern & Jeffrey, 2007). Perhaps a potential 
way to test the relative contribution of the immune system to the sudden deaths in 
these animals would be to conduct similar immunisations in TSE infected 
immunodeficient mice where the ability to generate an immune response is impaired.  
 
Alternatively, these effects on the mice may be the result of TSE associated neural 
dysfunction in the CNS at this stage of infection. Notably, anecdotal evidence exists 
to suggest that peripheral infections in those with neurodegenerative conditions such 
as Alzheimer’s disease exacerbate the clinical signs of disease (Cunningham et al, 
2005; Perry, 2004).  In a number of neurodegenerative conditions including the TSEs 
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and in Alzheimer’s  disease where there are high levels of activated microglia in the 
brain (Betmouni et al, 1996; Williams et al, 1995), systemic infection or 
inflammation, leads to increased synthesis of inflammatory cytokines by these 
microglia. Therefore it may be appropriate to examine the effect of immunisation on 
the expression of these markers in the CNS.   
 
 
7.5.5 Does TSE infection alter immune function or generate an immune 
response in the host? 
 
Unlike most infectious diseases, TSE agents do not elicit a classical immune 
response in the host (Clarke, 1968; Clarke & Haig, 1966). This lack of humoral 
response is most likely the result of the inability of the host to recognise PrPSc as a 
foreign antigen due to the widespread expression of PrPSc within the host. However, 
the PrP protein is immunogenic since studies in PrP deficient mice immunised with 
recombinant PrP demonstrate specific antibody responses (Heppner et al, 2001).  
Despite this lack of a classical immune response during TSE disease there may be 
some evidence that TSE infection induces some form of immune system activation in 
the infected host.  The expression of FcγRII/III on FDCs is normally associated with 
the development of secondary follicles in germinal centres in response to antigenic 
stimulation (Aydar et al, 2004; Qin et al, 2000). An observation in chapter 5 was the 
demonstration of high levels of FcγRII/III expression on FDCs in ME7 infected 
young in contrast this marker was expressed at much lower levels in spleen of 
uninfected young mice. This may suggest that TSE infection evokes some form of 
immune response resulting in the activation of FDCs, as has been demonstrated 
recently (McGovern & Jeffrey, 2007). The rationale behind using this marker was to 
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provide comparison between aged and young mice in terms of FDC functionality. 
The lack of expression of Fc RII/III in ME7 in uninfected and scrapie infected aged 
mice is most probably related to defects in the immune system of the aged animals 
that result in sparse expression of Fc RII/III within the germinal centre. Indeed 
studies in aged mice find that Fc RII/III labelling on aged FDCs is dramatically 
reduced following immunisation (Aydar et al, 2004). These observations may be 
very significant and should be extended to include morphometric analysis of this 
marker in uninfected and TSE infected mice. The analysis of the expression of other 
markers related to FDC activation such as should also be considered including the 
VCAM-1 and MAdCAM-1 antigens which are expressed upon activated FDCs 
(Kosco-Vilbois, 2003). Further approaches could include analysis of markers of FDC 
activation in cultured FDCs (Sukumar et al, 2008) or in dissected FDCs using laser 
micro dissection microscopy for molecular analysis. Further observations from 
chapter 6 suggest that germinal centre number and size may be increased in TSE 
infected animals which also support the possibility that TSE infection evokes FDC 
activation. Indeed there is now some evidence that FDC function may be altered 
during TSE infection (McGovern et al, 2004; McGovern & Jeffrey, 2007). 
 
It is not fully understood if immune responses in TSE infected individuals are altered 
although this is clearly an important question to address. Serum samples were 
collected from scrapie infected and uninfected mice immunised with DNP-KLH (as 
described in chapter 6) and it is proposed to measure antigen specific Ig levels at 
specific timepoints from an early stage of infection to the terminal stage of disease. 
 281
Unfortunately results from these studies were not available at this time for inclusion 
in this thesis.   
 
 
7.6. Natural and experimental TSEs with minimal lymphoid system involvement 
 
 
There are some characteristics of TSE infection that are common to all of these 
diseases for example; resistance to standard methods of de-contamination, prolonged 
incubation period of disease and pathological changes in the CNS. However there are 
some important differences that exist between these diseases, notably in the targeting 
of infection to the peripheral lymphoid system. One of the most defining 
characteristics of many naturally acquired and experimental TSEs is the targeting of 
infection and the deposition of PrPSc in lymphoid tissues in association with 
follicular dendritic cells (McBride et al., 1992, Brown et al., 1999, Bruce et al., 
2000). In addition, extensive studies using experimental strains have shown that the 
presence of an intact immune system and the presence of functional FDCs are 
important for pathogenesis (Brown et al., 1999; Mabbott et al., 2001). In many TSE 
infections the lymphoid system plays a key role although there are a number of 
exceptions notably in sporadic CJD, in cattle infected with BSE and in sheep with 
certain PrP genotypes infected scrapie (Hunter, 2007).   
 
In natural or classical scrapie PrPSc targeting to lymphoid tissues appears to vary 
according to the host genotype. Generally, susceptible (VRQ) ovine genotypes have 
greater amounts of PrPSc deposition, in both scrapie and BSE, while those genotypes 
associated with resistance generally have lower levels of lymphoid involvement. 
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However, genotype might not be the only factor determining lymphoid involvement 
since sheep of “resistant” ARQ/ARQ genotypes have lymphoid system involvement 
when infected experimentally with BSE (Foster et al., 2001b).  In addition, it has 
been reported that some “susceptible” sheep genotypes lack detectable PrPSc in 
lymphoid tissues (Jeffrey et al, 2002).  
 
Moreover, although BSE in cattle appears to have minimal lymphoid involvement 
(Fraser et al, 1992a), once passaged into other species e.g. sheep (Foster et al, 2001b) 
(Hunter et al, 2002); and humans as vCJD (Will et al, 1996), extensive lymphoid 
system involvement occurs (Bruce et al, 2001) suggesting that the host and the 
infecting strain may influence the involvement of the lymphoid system.  
 
In recent years there has been great interest and concern following the confirmation 
of several cases of “atypical” scrapie termed Nor98 (Benestad et al, 2003) with all of 
the confirmed cases to date occurring in sheep with genotypes normally associated 
with resistance to classical scrapie. Atypical or Nor98 scrapie was originally 
discovered in Norway in 1998 but has since been detected in small ruminants in most 
European countries (Buschmann et al, 2004). The characteristics of this new strain 
differ greatly from classical scrapie and include; alterations in clinical presentation 
and differences in biochemical characteristics which include a characteristic band of 
apparent low molecular weight (11 kDa) following western blot analysis. Notably, 
cases of atypical/Nor98 scrapie also appear to lack lymphoid system involvement 
which have led to some suggestions of similarities of this strain to that of sCJD.  
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In addition, epidemiological analysis of 60 cases of atypical scrapie and 20 cases of 
“classical” scrapie demonstrate that 60% of the atypical cases were older than 5 years 
in comparison with the classical scrapie cases where almost all of the cases were 
aged 3-5 years (Lühken et al, 2007). 
 
In addition some experimental mouse passaged strains, such as the 87V agent strain, 
appear to minimally involve the lymphoid system (Bruce, 1985). The reasons for this 
lack of lymphoid system involvement with these strains are unclear but perhaps 
suggest some tissue specific agent tropism which is under the direct control of the 
host.   
 
Sporadic CJD (sCJD) is associated with elderly individuals, with a few exceptions 
(Murray et al, 2008) although the converse occurs with vCJD where the 
predominance of cases is in the young. In sCJD the mean age at onset of the 
symptoms is 65 years with an average clinical duration of 4 months (Gambetti et a., 
2003). Sporadic CJD has been classified into a number of sub-types, the most 
common of these sub-types represent individuals who are MM homozygous or MV 
heterozygous at codon 129 of the PrP gene and carry PrPSc type 1 (Gambetti et al, 
2003). In contrast to vCJD where there is extensive lymphoid system involvement, 
there does not appear to be targeting to the lymphoid system in sCJD, and unlike 
vCJD there are no recorded cases of disease transmission from sCJD infected blood 
donors. The lack of lymphoid system involvement with sCJD is not fully understood 
but is likely to represent strain-specific tropism perhaps in a similar way to the 
experimental strain 87V which also lacks lymphoid tissue involvement. Alternatively 
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it may be possible that age-associated immune dysfunction may prevent infection of 
lymphoid tissues in a similar way to that observed with the aged mice (chapter 5).  
However, recent studies in transgenic mice over-expressing human PrP, failed to find 
evidence of disease in lymphoid tissues of these mice infected with sCJD (Béringue 
et al, 2008) suggesting that sCJD does not target the lymphoid system. The cause of 
sCJD remains unresolved and as a result it is difficult to provide estimates of the 
probable incubation period length for this disease. It is possible that the development 
of sCJD in old age may reflect very prolonged incubation periods of disease in a 
similar way to that observed with some individuals with Kuru (Collinge et al, 2006).   
 
The recognition that the lymphoid system is not involved in all TSE infections is 
important, particularly in determining the risk of iatrogenic infection and in relation 
to the design of therapies that may interfere with components of the lymphoid system 
these approaches may have little relevance to those diseases with minimal lymphoid 
system involvement.  
 
7.7. Diagnosing and treating TSEs: where we are now. 
 
TSEs are fatal diseases for which there is currently no cure. During the last quarter of 
a century extensive advances in the fundamental understanding of these diseases 
have been made but despite this no reliable ante-mortem diagnostic test exists for 
these diseases. No classical immune response exists in TSE infection precluding the 
use of standard antibody responses to infection. The disease specific form of the PrP 
protein, PrPSc, is considered a marker for disease, although studies show that TSE 
disease can exist and be perpetuated in the absence of this marker (Barron et al, 
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2007; Lasmezas et al, 1997). Also, studies have shown that the disease specific form 
of PrP may not be transmissible (Piccardo et al, 2007). Nevertheless, the presence of 
PrP in the majority of TSE infections is considered diagnostic for disease. In infected 
humans and animals the presence of PrPSc is detected in tissues of the CNS and in 
many, but not all, TSEs, in lymphoid tissues also. Despite this involvement of the 
peripheral lymphoid system the detection of PrPSc in blood remains to be accurately 
and reliably achieved, meaning that confirmation of disease is currently restricted to 
invasive biopsies and normally only considered when the presence of disease is 
strongly suspected. In the vast majority of suspected human and animal TSEs (for 
example testing in abattoirs) definitive diagnosis of infection is carried out after 
death (Grassi et al, 2008). Confirmation of human TSE infection is based on a 
number of factors (Ironside et al, 2002). In the last few years the use of the protein 
misfolding cyclic amplification (PMCA) technique has demonstrated that this 
method may be an extremely powerful tool for the diagnosis of TSE infection due to 
its apparent sensitivity (Grassi et al, 2008). Thus it may detect the presence of 
disease in tissues or fluids (blood) where very low levels of infectivity are present 
perhaps in the very earliest stages of infection where treatments may be most 
appropriate. However the technique remains to be fully validated for use as a 
diagnostic test and the lack of an early diagnostic test means that treatment of these 
diseases is often limited to the late stages of infection (Grassi et al, 2008).  
 
Infection of the lymphoid tissues occurs many weeks or months before infection of 
the CNS or clinical signs of disease are detected, and this asymptomatic phase may 
offer opportunities for intervention. A number of studies demonstrate that 
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neuroinvasion following infection from a number of peripheral routes can be 
impaired using treatments to de-differentiate FDCs in-situ (Mabbott et al, 2000a; 
Mabbott et al, 2002; Mabbott et al, 2003; Montrasio et al, 2000). More recently in-
vivo depletion of conventional dendritic cells was shown to impair neuroinvasion 
suggesting that these cells may also play a role in TSE pathogenesis (Raymond et al, 
2007).  
 
However the use of these treatments may be most appropriate in early stage infection 
as shown in studies involving oral ME7 infection where de-differentiation of FDCs 
after 2 weeks of infection had no effect on pathogenesis (Mabbott et al, 2003). These 
treatment show promise however for prophylaxis or early treatment of TSEs e.g. in 
iatrogenic transmission in the case of inadvertent cases of infection; such as needle 
stick injuries or potential infection via surgery or blood transfusion 
 
The administration of pentosan polysulphate (PPS), a sulphated, semi-synthetic, 
polyanion, to mice with experimental scrapie and BSE (Farquhar et al, 2003) shows 
promise in prolonging incubation period of disease. More recently, treatments with 
PPS show that disease can be significantly extended in humans with vCJD, over the 
range of those individuals not treated with PPS. One individual with vCJD is still 
alive 7 years after administration of this compound (Christine Farquhar, personal 
communication).   
 
The effects of TSE infection on the CNS include neuron loss and subsequent 
vacuolation, deposition of PrPSc and gliosis.  It is thought these effects on the CNS 
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lead to the development of clinical disease and eventual death of the individual. In 
recent years the potential of cell replacement strategies for a number of 
neurodegenerative conditions has been demonstrated (Pluchino et al, 2005). These 
strategies include the replacement of neuronal cells into the damaged CNS using 
stem cells or less frequently embryonic cells (Pluchino et al, 2005). The use of cell 
replacement strategies has been explored in TSE infection and shows some potential 
in ameliorating pathology (Brown et al, 2001) and potentially extending incubation 
period of disease at a late pre-clinical stage of infection (Brown et al unpublished) 
The use of these cell replacement strategies demonstrate a potential use in the late 
stage treatment of TSEs, and could potentially be used in combination with other 
treatments such as the sulphated polyanions to potentially extend lifespan and 




Data presented in this thesis provide further evidence for a critical role for the FDC 
not just in the pathogenesis of the ME7 strain (Chapter 3), but in a range of TSE 
strains (Chapter 4). These findings may be important in the development of 
therapeutic strategies. If differential targeting of cells in the peripheral lymphoid 
occurs this would require strain dependent approaches to therapies. Although these 
results show that FDCs are critical for neuroinvasion in a range of TSE agent strains 
some subtle differences in pathogenesis was observed, particularly between the 
139A/79A agent strains and the ME7 agent strain. These findings suggest that 
alternative, less efficient routes of neuroinvasion can be exploited by some strains 
(chapter 4). The dependence of mature FDCs for the pathogenesis of the BSE 
 288
derived strain 301C was also demonstrated which has relevance to the transmission 
of vCJD, since BSE and vCJD are considered to be the same agent strains. Further 
evidence that neuroinvasion, following high dose infection, can occur in the absence 
of lymphoid system involvement was obtained from studies in immunodeficient mice 
(Chapter 4). These findings may have implications for naturally acquired infections 
which demonstrate that neuroinvasion can still occur in the absence of a functional 
immune system if the infecting dose is high enough.  One of the most poignant 
aspects of vCJD infection is the young age of those affected. The determination that 
age impairs neuroinvasion in mouse models provides some explanation for this age 
related distribution of vCJD cases most likely as a result of impaired FDC function in 
aged mice (Chapter 5). The ability to modulate pathogenesis was demonstrated in 
studies where mice were immunised at several points in infection.  These findings 
demonstrated that immunisation may only impact on pathogenesis during the early 
stages of infection, before infection of the CNS occurs. Finally, these studies have 
found some preliminary evidence that TSE infection may induce FDC activation 
demonstrating that TSE infection does result in some form of immune response. 
Together these data show that a functional immune system and specifically, the 
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Appendix I. Generation of SCID-Prnp+/+ and SCID-Prnp-/- mouse lines  
 
Step 1  SCID x PrP-/- F2 generation (224 animals) 
 
   Selection of SCID phenotype by ELISA  
   Ig producing   SCID phenotype 
     189         36                        
 
  Step 2 Selection of H-2 type by flow cytometry(n=23 due to death/exclusion) 
   H-2d  H-2bd             H-2b  
 1  10      11 
  Step 3Selection of PrP+/+ or PrP-/-  genotype using southern blot analysis*  
   PrP+/+ 2 (animals 130b and 134b*) > SCID-Prnp+/+ (SCID-PrP+/+) line 
      
   PrP-/-  2 (animals 91b and 158b) > SCID-Prnp-/-  (SCID-PrP-/- ) line 
  Step 4: Lines established and used experimentally at the 7th inbred generation.  
 
* animal 134b was a heterozygous phenotype 
*from original production of 224 animals two pairs of each genotype selected for 
each line 
    










Appendix II. List of primary antibodies used in this thesis 
 
List of primary antibodies 
 
 










of the PrP 
protein 
Rabbit Polyclonal (Farquhar et al., 1989) 




MFG-E8 Rat monoclonal Pharmingen, BD 
Biosciences, UK. 





Rat monoclonal ImmunoKontact, UK. 
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Appendix III: Analysis of bioassay data from Chapter 6 figure 6.11 
 
Bioassay results (incubation periods) were available for samples from three mice for 
each of four treatment combinations. In the original study animals had received either 
saline (negative control) or DNP as either a primary or secondary immunisation. 
 
A linear mixed model was fitted to the data with treatment (saline or DNP) and 
immunisation (primary or secondary) included as fixed effects, and mouse sample as 
a random effect. The parameters of the model were estimated using the REML 
directive in Genstat 10th edition. 
 
  77  VCOMPONENTS [FIXED=Treatment*Immunisation; FACTORIAL=9] RANDOM=Sample; 
INITIAL=1; CONSTRAINTS=none 
  78  REML [PRINT=model,components,waldTests; PSE=differences; FMETHOD=automatic; 
MVINCLUDE=*;\ 
  79   METHOD=AI; MAXCYCLE=20] Incubation 
  
  
REML variance components analysis 
  
Response variate: Incubation 
Fixed model: Constant + Treatment + Immunisation + Treatment.Immunisation 
Random model: Sample 
Number of units: 132 
  
 
Estimated variance components 
  
Random term component s.e. 
Sample  51.4  32.4 
  
Residual variance model 
  
Term Factor Model(order) Parameter Estimate s.e. 
Residual  Identity Sigma2 145.6  18.8 
  
Tests for fixed effects 
  
Sequentially adding terms to fixed model 
  
Fixed term Wald statistic n.d.f. F statistic d.d.f. F pr 
Treatment 0.82 1 0.82 8.0  0.391 
Immunisation 2.39 1 2.39 8.0  0.161 
Treatment.Immunisation 2.55 1 2.55 8.0  0.149 
  
Dropping individual terms from full fixed model 
  
Fixed term Wald statistic n.d.f. F statistic d.d.f. F pr 
Treatment.Immunisation 2.55 1 2.55 8.0  0.149 
  
Table of predicted means for Constant 
  
  206.5    Standard error:  2.32 
  
Table of predicted means for Treatment 
  
 Treatment DNP SAL 




 Treatment DNP SAL 
  3.3 3.3 
  
Table of predicted means for Immunisation 
  
  
 Immunisation 1 2 





 Immunisation 1 2 
  3.3 3.3 
  
Table of predicted means for Treatment.Immunisation 
  
 Immunisation 1 2 
 Treatment   
 DNP 211.7 197.1 




 Immunisation 1 2 
 Treatment   
 DNP 4.6 4.7 
 SAL 4.6 4.6 
   
 
 
The estimated mean incubation period in the DNP secondary immunisation group is 
lower than in the saline group (197.1 ± 4.7 compared to 208.8 ± 4.6) but this 
difference is not significant at the 5% level. 
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